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Preface
The incidence of a chronic disease is often preceded by a period in which precursory
factors are present. For example, a myocardial infarction is an acute serious episode,
possibly concluding many years of hypertension or hypercholesterolaemia not seldom
passed unrecognized. Medical intervention is defined as an action that intends to decel-
erate such an aggravating process so as to delay its transition to the incidence. In the
area of cardiovascular diseases, for example, one may try to make people aware of their
blood pressure or cholesterol level and to help them in reducing raised levels, so that
the probability of developing a myocardial infarction is decreased. More generally, on
the total population level, the effect of intervention may be a compression of the inci-
dence of chronic diseases towards later in the life time. Hopefully, it increases total life
expedancy_and it_causes_chronic dheass to develop  at  ailat_sr  agein  a_smaUe podbn  _
of the population. The purpose of this book is to provide the statistical instruments
necessary to quantify and to evaluate such an effect.
The key statistical analysis dealt with in this book is survival analysis, perhaps more
generally to be called event history analysis. With such an analysis one can assess the
relationship between certain explanatory variables (e.g., blood pressure and cholesterol
level)  and  the  time  to the incidence  of the chronic disease considered (e.g., rnyocardial
infarction) or the time of death. The development of this analysis technique in the
statistical world has to a large extent taken place while preparing the first drafts of the
various chapters in this book. Professional readers will undoubtedly see this develop-
ment reflected in certain chapters. The traditional assumption in survival analysis is
that the explanatory variables are given and non-stochastic, which assumption is often
made in clinical studies where the explanatory variables may constitute a prognostic
index measured at some baseline time. However, in epidemiological studies one would
like to make unconditional inferences for a general population, in which the explana-
tory variables have to be considered random variables, evolving in time (with age) in a
stochastic way, jointly with the time (age) of the event. This requires a more elaborate
approach that is not yet very common among biostatisticians, it is one of the purposes
of this book to try to clarify this approach. Another purpose is to provide a more formal
approach to the evaluation of life time using statistical decision theory. The concept
of "QALY" (= Quality-Adjusted Life Year) will appear to get a more formal meaning
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-              -As-ofthe-early -70's-analysis-oftime-to-event data hasgot  mueh-attention in-the-medical,-    -     -   -
(bio)statistical and economical sciences. Undoubtedly, its development is largely due to
major contributions from the biostatistical sciences, so it is not surprising that "survival
analysis" nowadays has become an essential tool for any biostatistician. The biomedical
sciences constitute an important area of application. This is because the ultimate goal
of almost any medical therapy or interventive action is to increase (disease-free) life
time - and what is more important in life than life itself?
The purpose of survival analysis is to investigate how a certain covariable z affects
the life time distribution in a population. A relevant relationship is specified through
the mortality rate A(tlz) which may be implicitly defined as
A(tlz)dt = the expected probability of dying in a small time interval [t, 1 + dt), condi-
tional upon having covariable z and being alive just before time t.
This function A(t  z) is all that is needed for specifying the dependency of survival on
the  covariable  z.    It  may be tempting to consider  A(t lz) the longitudinal  time  path  of
the mortality rate in a particular patient or subject with covariable z.  This need not
be so. Theoretically, a particular patient's rate may grow faster in time than A(tlz)
in the presence of other, unobserved, covariables ("unobserved heterogeneity").    As  a
particular patient only dies once, statistical inference about his own survivor function
cannot be made, causing unobserved heterogeneity to be a theoretical problem. The
above definition of A(t z) merely says that it is the mean rate among those subjects alive
at time t with covariable z. This is sufficient for obtaining unbiased point estimates
of the conditional (i.e., given the covariable z) survivor function, being exactly the
survivor function that one should want to estimate. Hence, the so-called problem [2}
of unobserved heterogeneity causing bias in the point estimates is a rather illusory one,
see also Chapter 10. However, there is another problem of unobserved heterogeneity
causing dependency between competing death causes, to which we will come back later.
So far we assumed that z is a given covariable value. If we would want to know the
survivor function in the total population (cohort), we have to consider z a value drawn
from some baseline distribution with pdf h(z 0) in the population at baseline t = 0.
The cohort survivor function then simply becomes the expectation of the conditional
survivor function with respect   to   h(z F). Interventive action is intended to influence
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this distribution of z so that the cohort survivor function changes in a desirable way
(for example, so that life expectancy increases).
Discarding a possible time-dependency of the covariable z is appropriate in situa-
tions where z i s constant in time or where z i s the value at some baseline time t=O o f
a prognostic variable in a clinical study. In longitudinal epidemiologic studies, a more
general (and also more abstract) approach may take account of "tracking" (= system-
atic evolution in time) and "diffusion" (= random walk) in the covariable z. In such
an approach, the time-dependent covariable z(t) and time of death t are considered
simultaneously distributed random variables. The mortality rate A(tlz(t)) can still be
defined properly at time t, conditional upon the value of z(t) just before time t, but
not further. This mortality rate has no individual forward time path and, consequently,
bears no relationship to an individual survivor function (see [1, p.125]). In Chapter
2 a more general approach for continuously observed time-dependent covariables will
be introduced briefly, where we do not need the use of individual survivor functions
to derive the likelihood function. The purpose of intervention is to affect the life time
distribution in a population through influencing the evolution process of the covariables.
A more extensive treatment of this approach will be given in Chapter 7.
Taking interventive action in a population would be beneficial if its costs are out-
weighed by incremental life expectancy. A complication here is how incremental life
expectancy is built up. The more it is built up at older ages, the less beneficial it is to
society. Hence, life expectancy may not be so good an effect measure. It is simply the
mean of life time in the population, and the mean is not uniquely enough a parameter
for characterizing the life time distribution.  A more unique way of judging (changes
in) a distribution is offered by the statistical decision theory. According to this theory
a utility function of life time can be defined, so that judgements about changes in the
life time distribution can be more properly made through expected utility. What is
often loosely called the "QALY"-function (QALY = Quality-Adjusted Life Year) [6, pp
26-271, actually appears to be the marginal utility function of life time. Chapters 8 and
9 deal with this in more detail.
Of course, a stochastic process has to be defined first before a utility function can be
defined to characterize the process,  and not the other way around as  in  [3].   In the above
we considered a simple process with only two states (alive and dead) and one argument
(life time) in the utility function. When interest is in chronic disease intervention, the
stochastic process has to be extended with a third state, viz., the disease state.  Also the
utility function has to be extended accordingly: disease and sojourn tinie in the disease
state then become additional arguments of the utility function, along with sojourn time
in the "healthy" state; see Chapter 9.
By definition, the forward time-behaviour of a time-dependent covariable z is only
observable in survivors, being the reason why there is no properly defined individual
survivor function. Hence, tracking and diffusion (together called "ageing process")  are
defined under this survivor condition and thus are conditional processes. The param-
eters of these processes themselves are assumed to be autonomous and unaffected by
survivor selection, because any dependency of these parameters on survivor selection is
unidentifiable in observational studies. The same holds for the mortality process: the
mortality rate is defined conditionally upon survival. Any dependency of the parameters
in the mortality rate itself on survivor selection is unidentifiable in observational studies.
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A well-known problem here is the unidentifiability of dependency between competing
death causes  [4], to which we will come back in Chapter 4. An obvious and not-unlikely
instance where such a dependency between two death causes arise is the presence of an
unobserved covariable explaining both death causes.
Overall Summary
Chapter 2
If the covariables in survival analysis are assumed to be time-dependent and to be
internally generated and continuously observed iii subjects as long as they survive,
the covariable-dependent mortality rate bears no relationship to an individual survivor
function. In this chapter we introduce an alternative (more general) way to derive the
likelihood function, using a mean survivor function instead of individual survivor func-
tions. We start this general approach With  considering  the-tihie-dependent -covariable
a random variable, jointly distributed with the time of death. The stochastic evolu-
tion process of the covariable, rather than its distribution at some (arbitrary) point in
time, then becomes relevant for explaining mortality. We will also briefly show how this
stochastic evolution process has to be incorporated. This process is also called "ageing
process", consisting of "tracking" and "diffusion".
Chapter 3
This chapter deals with a classical subject in epidemiologic research being one of the first
forms of multivariable survival analysis: the dependency of the mortality (morbidity)
incidence on a dichotomous exposure variable, when data are stratified in joint categories
of a number of confounding factors. It is concerned with statistical inference about the
relative risk (or risk ratio) in a cohort (or prospective) study with dichotomous exposure
when the number of mortality cases (numerator) is a Poisson distributed variable and
the denominator is a number of person-years. The exact procedure for testing the null
hypothesis for the relative risk and the exact computation of its confidence interval for
a single 2 x 2 table is presented. Maximum likelihood methods and the homogeneity
test are presented for the common risk ratio when data is stratified in several 2 x 2
tables. These methods are based upon a sufficient statistic and therefore are considered
proper statistical alternatives to the more descriptive epidemiological measures such as
(in)directly standardized mortality (morbidity) ratios. By making use of the Conditional
Poisson approach, computations can be simplified so as to become performable on a
programmable pocket calculator.
Chapter 4
In this chapter firstly a summary of the theory of competing risks is presented; it
shows how cause specific failure time distributions, failure probabilities and failure rate
functions relate to the joint survivor function in the presence of various competing
failure causes. This first part of this chapter gives the insight useful for the second
part, which concerns the way in which the dependency of the failure process on given
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time-dependent observations of covariables is specified and estimated. An application
is presented briefly.
The first publication of this chapter was in November 1981 as internal research
memorandum FEW 104 of the Tilburg University, Department of Economics.
Chapter 5
In this chapter the dependency of 9-year survival on a number of cardiovascular risk
factors is analysed in 3284 middle-aged Rotterdam men. The purpose of this analysis
is twofold. First, there is interest in the relationship between total mortality and the
continuous variables blood pressure and plasma cholesterol. In accordance with other
studies, the results provide further evidence for a U-shaped relationship. The second
purpose is to compare three models theoretically as well as empirically: a piecewise
exponential distribution of survival time, Cox's proportional hazards model (both with
a log-linear dependency specification of the mortality rate), and a logistic model.  The
disadvantage of a logistic model is that it is theoretically not appropriate in longitu-
dinal (prospective) epidemiologic studies. The theoretical advantage of the piecewise
exponential distribution to Cox's model is that longitudinal (time) effects on the mor-
tality rate can be specified and estimated directly. Empirically, with 342 deaths all
three methods yield quite similar estimates and therefore are almost equally capable of
detecting relationships between mortality and the risk factors in the data set.
The first publication of this chapter was in August 1984 as internal research memo-
randum FEW 152 of the Tilburg University, Department of Economics.
Chapter 6
In this chapter a FORTRAN program is presented for multivariate survival or life table
regression analysis in a competing risks' situation. The relevant failure rate ( for example,
a particular disease or mortality rate) is modelled as a log-linear function of a vector of
(possibly time-dependent) explanatory variables. The explanatory variables may also
include the variable time itself, which is useful for parameterizing piecewise exponential
time-to-failure distributions in a Gompertz like or Weibull like way as a more efficient
alternative to Cox's proportional hazards model. Maximum likelihood estimates of the
coefficients of the log-linear relationship are obtained from the iterative Newton Raphson
method. The program runs on a personal Computer under DOS and puts no limits to
the size of the data set, in contrast to available programs for personal computers at the
time it was developed.
Chapters 7 and 8
When studying the stochastic process of mortality related to observed covariables in a
cohort of subjects followed in time, it is usually assumed that the observed covariables
are given, non-stochastic quantities. In this way one can predict only the subject's
survivor function, given certain values of the covariables at baseline. Continuous co-
variables are assumed to have (approximately) a multivariate Gaussian distribution in
a cohort and to evolve with random fluctuation in subjects as a consequence of ageing.
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Woodbury et al. elaborated a model where this evolution-diffusion process (called age-
ing process) is incorporated and kept in balance by an appropriately modelled mortality
selection process, so that the distribution of the covariables in the cohort remains (ap-
proximately) Gaussian. The analytical tractability of this model allows one to readily
calculate the cohort survivor function as ultimately being epidemiologically more rele-
vant than the conditional survivor function, given a single baseline measurement of the
covariables. In Chapter 7 an overview of the theoretical model is presented. The model
will be used in Chapter 8 in order to show how the effect of population-based health
intervention programmes on the population's life time distribution can be evaluated
from a decision-theoretical point of view.  Also an illustrative application will be given.
Chapter 9
In this chapter the model is extended with an intermediate chronic disease state. Inter-
ventive action aimed at reducing the incidence of the irreversible chronic noncommuni-
cable disease in a population has various effects. Hopefully, it increases tota116ngevity
in the population and it causes the disease to develop later in time in a snialler portion
of the population. A statistical model is built by which these effects can be estimated.
A three dimensional probability density function that underlies this model is changed
by the interventive action. It is shown how a three dimensional utility function can be
defined to appropriately judge this change.
The first publication of this chapter was in November 1982 as internal research
memorandum FEW 121 of the Tilburg University, Department of Economics.
Chapter 10
In survival analysis subjects of a cohort satisfying certain values for the observed co-
variables may still be heterogeneous with respect to a number of other, unobserved,
covariables. This so called unobserved heterogeneity causes a distinction between the
empirical (observable) mortality rate of the cohort and the theoretical (unobservable)
mortality rate of a particular subject. Conditioning, as it should, lets conclusions only
pertain to the cohort considered (or to an "arbitrary subject" of the cohort) and not to
a particular subject. However, theoretical interest  lets one investigate the nature of this
distinction by comparing the empirical situation where there is unobserved heterogene-
ity with a theoretical situation where this heterogeneity is absent. This is done under
the assumption that unobserved heterogeneity is represented by a constant "frailty"
term [5] in the mortality rate.
6
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Chapter 2




If the covariables in survival analysis are assumed to be time-dependent and to
be internally generated and continuously observed in subjects as long as they survive,
the covariable-dependent mortality rate bears no relationship to an individual survivor
function. In this chapter we introduce an alternative (more general) way to derive the
likelihood function, using a mean survivor function instead of individual survivor func-
tions. We start this general approach with considering the time-dependent covariable
a random variable, jointly distributed with the time of death. The stochastic evolu-
tion process of the covariable, rather than its distribution at some (arbitrary) point in
time, then becomes relevant for explaining mortality. We will also briefly show how this
stochastic evolution process has to be incorporated. This process is also called "ageing
process", consisting of "tracking" and 'diffusion"
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2.1 Introduction
The purpose of survival analysis is to investigate how a certain time-dependent covari-
able Z(t) affects the life time distribution in a population. The covariable is supposed
to be internally generated and continuously observed in surviving subjects. Generally,
the forward time path of such a covariable is, at least partly, supposed to be stochastic
due to random walk. A relevant relationship is specified through the mortality rate
A(tlz(t)), which may be implicitly defined as
A(tlz(t))dt = the expected probability of dying in a small time interval [t, t + dt), con-
ditional upon having covariable z(t) and being alive just before time t.
We will see in Section 2.3 that this function A(tlz(t)) is all that is needed for specifying
the dependency of survival on the covariable z(t). This mortality rate A(tlz(t)) cati
be defined properly at time t, conditional upon the value of z(t) just before time t or,
more generally, on the patient's history {z(r); 0 I f T<t}u p t o time t, but not further.
This mortality rate has no individual forward time path and, consequently, bears no
relationship  to an individual survivor function  (see  [4,  p.125}).    Knowing the forward
change of a covariable that is not completely deterministic in a subject would mean
that the survivor function of that subject would be equal to 1 over the forward time
interval. Hence, the likelihood function cannot be legitimately expressed as a product
of all subject's density and survivor functions. An alternative approach is presented
in Section 2.2, where we will consider the covariable z(t) and time of death t jointly
distributed random variables. It appears that the likelihood function (Section 2.4) can
be legitimately derived using the mean survivor function instead of individual survivor
functions. Also the partial likelihood function follows straightforwardly from this Inore
general approach. In Section 2.5 we show how the evolution (or "ageing") process of
the covariable z(t), consisting of "tracking" and "diffusion", has to be involved so as to
yield a forward time path for the mean survivor fuliction.
2.2 The Joint Distribution
Survival analysis is concerned with the dependency between time of death t and a
covariable z(t) in a cohort of subjects. In this geiieral approach we assuitie that z(t)
is continuously observed in subjects as loiig as they survive. We start with tlie joint
distribution of t and z(t), denoted by the probability density function (pdf) p(t, z(t)).
This pdf can be forniulated as
p(t, Z(t)) = p(z(t)ET 2 t) · p(T 2 t) · p(liz(t), T 2 t), (2.1)
t 20, -00 < 2(t) < 00,
as follows from the definition of conditional probability. The first term in the right-hand
side of (2.1) is p(z(t)IT 2 t), which is the pdf of z(t) in the portion of the cohort that
survives just before time t, which we will write as h(z(t) jt).  The second term p(T 2 t)
is the unconditional probability of surviving just before time t, which is written as  9(t)
It simply equals the proportion of the original cohort that still survives just before time
t; it is called here the mean survivor functioii. The third terni p(tlz(t). T 2 t) is known
as the mortality rate at time t, which we will write as A(tlz(t))
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Using the notation defined above, the joint  pdf p(t, z(t))  can be reformulated as
p(t, z(t)) = h(z(t)It). 0(t)· A(tlz(t)), t 2 0, -co < z(t) < 00. (2.2)
The mortality rate A(t 11(t)) has only an instantaneous dependency on z(t) and is con-
ditional upon the total collort's survival, this is the property of memorylessness that is
inherent to the assumed Markovian cliaracter of the mortality process.  It can be proved
easily that the mean survivor function Q(t) can be expressed in the mean mortality rate
A(t) as
C      rt_          1
0(t) = exp <-  1   A(u) du Jo
with A(t)  =  f_13' A(t z(t))h(z(t))t) dz(t),  the mean of A(t z(t))  in the portion of the
cohort that still survives just before time t. The proof follows from the marginal dis-
-     -     -tribution-p»),-whieh -ean-be-calculated-as-0(+)Aft)-by-integrating-(23)-over zit)-ancE   -  -    -   -
which, by definition, also equals -dQ(t) dt. The pdf h(z(t) t) and, consequently, A(t)
and 0(t) have a forward time path that can be derived from the theory introduced in
Section 2.5.
2.3 The Dependency Specification
Dependency between mortality at time t and covariable z(t) is present if and only if
p(t, z(t)) 4 p(t) ·p(z(t)IT 2 t)
As the marginal distribution P(t) equals 0(t)A(t), it follows that dependency is talita-
mount to
A(tlz(t)) il A(t) (2.3)
In survival analysis one is usually only interested in the dependency between time of
death t and a covariable z(t); it follows from here that a dependency relation can be
specified by modelling A(tlz(t)) as an appropriate function of z(t). Either one of the
conditional distributions p(217(t)) or p(z(t) t) gives sufiicient information therefor. These
conditional pdf's can be calculated from (2.2) as
p(tlz(t)) = Q(t)A(tlz(t)) (2.4)
and
p(z(t)It) = A(tlz(t)) h(z(t)It). (2.5)
A(t)
Both (2.4) and (2.5) are legitimate pdf's due to the existence of a forward continuous
time path for h(z(t) t), A(t) and Q(t).  Each of these pdf's can be used to estimate
the dependency relation between mortality and the covariable by maximum likelihood
technique. The relevant (log) likelihood functions can be specified as follows.
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2.4 The Likelihood Function
A cohort of initially n subjects is followed in time until all n subjects have died.  Also
suppose that subjects   do  not   drop   out for other reasons, i.e., there  is no censoring.
Subjects i are numbered in the same order as their time of death ti:  ti  <1 2< · · · < tn.
In each subject  i the covariable  z, (t),   t  <  ti, is continuously observed.   Let R, denote
the set of subjects still alive just before time 4.  This set is also called the "risk set" at
time ti. Hence, the original cohort is denoted  by Rl. Between  t,-1   and  4  the  risk  set
Ri consists of n-i t l subjects, as i-1 subjects have died up to and including time
ti-i·
The likelihood based on (2.4) equals
n
Li = II p(tilz,(ti)) = I-10(ti)A(tilz,(ti))
i€Rl ;1
so that the log likelihood becomes
n                   n   rti
inLi =Iln A(tilz,(ti))-      
A(u)du. (2.6)
i=l
Using the observations 4(u), 0 S u<t„ available from all subjects i i n Ri, A(t) can be
calculated as the average of A(t z(t)) among the subjects in the cohort that still survives
just before time t, implying
t f             *   r
.
A(u)dit =    A(ulzi(u))du. (2.7)
This can be shown by using
n  tti          n           rt,
X .111 A(u) du= X(n-it 1)   A(u) du2-1 i=] Jt,-1
with to = 0 and
A(u) = (n-1+ 1)-1 Z A(ulzj(u)),      t,-1 <u< ti,
j€R,
from which equality (2.7) readily follows. Substituting (2.7) in (2.6) gives the log like-
lihood function as it is usually specified throughout this book and also, for example,
in [3}. However, in case of internal time-dependent covariables, the right-hand side of
(2.7) formally may not be thought of as being the negative logarithm of a product of
individual survivor functions.
We may also derive another likelihood based on (2.5), yielding
·rr A(t |z,·(t,·))L2 = 11 5        · h(z,(t,)It,)
i€Rl A(ti)
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Of all observations z,(u),0 f u< 4, available from all subjects i i n R l,w e only use
part of these, viz., only zj(ti), i = 1,...,j, for all j in Rl, in order to calculate the
averages A(ti) among the subjects in  Ri just before  time ti, yielding
T™    A(414(4))     TTL 2- " | „  0 11(n-it 1)h(z,(ti)Iti),its-1 EjER, A(tilzj(t"I)  i€Ri
where zj(t,)  is an observation in subject  j just before  time  t i,i s j.  The  first  part  of
this likelihood that uses only part of the observations on z(t) is known as the partial
likelihood  [1]; the second  part  is no longer relevant. Although  only  part  of the observa-
tions on z(t) is used, the partial likelihood has been shown to be an ordinary likelihood,
see [2].
2.5_Ageing  for Tracking   and   Diffiiginn)
So far we did not yet involve any tracking in the covariable Z(t). Tracking in its extreme
form is constancy of z(t): z(t) = z for all 12 0. In a clinical study z may also denote
a baseline value z(0) of a prognostic variable of which only the value at time t=O
is of interest for making a prognosis. In this latter case the time dependency of the
mortality rate that otherwise would have been accounted for by z(t) then becomes part
of its dependency on time t; the remaining variability in Z(t) that is left unexplained by
z = z(0) or by time t then becomes unobserved heterogeneity in the mortality rate. In
either case  the pdf h(z t) is completely determined by its starting value  h(40)  and the
mortality rate A(t lz):
/t
h(z 10)exp  - j, A(ulz)du 
h(zlt) = 0(t)
with the normalizing constant being equal to the mean survivor function (2(t).  The
proof follows from equation (2.8) below for z(t) a constant in time. It follows from here
that the joint pdf (2.2) then reduces to the traditional form in which the conditional
survivor function exists:
C ft
p(t, z) = h(zIO) exp  - /  A(ulz) du  A(tiz).Jo
When we are dealing in general with an internal time-dependent covariable, we
are interested in the explanatory effect of its evolution (possibly including a stochastic
element) on the survival of a cohort. We then have to involve tracking in a more general
form as follows:
dz(t) = a(z(t)) dt + dE,
where the change in z(t) is some tracking-function a(·) of the level Z(t) plus some
diffusion (or random walk) term d€, which is Brownian motion with E(dg) = 0 and
E(d62) = 02 dt. This model, which is also called "ageing process" [61, and the mortality
rate  A(tlz(t)) completely determine the forward time path  of the pdf h(z(t)  t) through
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the extended Kolmogorov-Fokker-Planck (KFP) forward partial differential equation
[5]:
dh(z(t)It) dh(z(t)It)0(z(t))   1 9  d2h(z(t)It)  (2.8)dt dz(t) + 2'; '    dz(t)2
- {A(liz(t)) - 1(t)} h(z(t)It),
which also provides the forward time path for A(t) and so for the mean survivor function
Q(t) as will be demonstrated in Chapter 7 under certain model assumptions.
Using the equality
C rt
h(z(t) t) = h(z(0) 0) exp      (h(z(u)Itt))-1 dh(z(u)Itt)7 ,
Jo
substituting herein dh(z(u) u) by the KFP equation (2.8) and substituting the result in
(2.2) yields
p(t, z(t))   =   h(z(0)IO) · exp (- f ,(,(.)I.) dh(z(u)lu)a(z(u)) du  xdz(u)
(1 1, 02 dvh(z(u)lu) du  xx exp , 2 Jo  h(z(u)lu)      dz(u)2        J
C ft
x exp t-  /  A(ulz(u)) du  A(21z(t)),
Jo
clearly showing  that the ageing process, represented  by the tracking-function  ot( ·)  and
the diffusion-parameter ces,  and the mortality process, represented by the function A( · ),
are in separate terms in which the joint pdf p(t, z(t)) factorizes. Hence, these processes
can be separately estimated with maximum likelihood technique.
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Chapter 3
The Relative Risk in a Cohort
Study with Poisson Cases'
Paul G.H. Mulder
Abstract
This paper deals with making statistical inference about the relative risk (or risk
ratio) in a cohort (or prospective) study with dichotomous exposure when the number
of cases is a Poisson distributed variable. The exact procedure for testing the null
hypothesis for the relative risk and the exact computation of its confidence interval for
a single 2 x 2 table is presented. Maximum likelihood methods and the homogeneity
test are presented for the common risk ratio when data is stratified in several 2 x 2
tables. These methods are based upon a sufficient statistic and therefore are considered
proper statistical alternatives to the more descriptive epidemiological measures such as
(in)directly standardized mortality (morbidity) ratios. All computations can be done
on a programmable pocket calculator. With the HP-41 CV more than 70 strata can be
distinguished.
1 Published in  Computer Methods  and Programs in Biomedicine, 27 (1988) 103-109.
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3.1 Introduction
A well-known elegant and exact way of making statistical inference about the relative
risk in a cohort (or prospective) study with dichotomous exposure for a single 2 x 2
table is based upon the assumption of a Poisson distributed number of mortality or
(new) disease cases in the exposed and non-exposed cohort and thus in the total cohort.
The statistical methodology for a single 2 x 2 table has been derived by Bross [21 and
Klerk-Grobben and Prins [5} and was later mentioned by Ederer and Mantel  [3]
Gart [4] developed maximum likelihood methods for the common relative risk when
data is stratified in several 2 x 2 tables. Breslow [l] continues along this line and compares
the Mantel-Haenszel method with the maximum likelihood method. In this paper we
further deal with maximum likelihood estimation, without avoiding the use of iterative
computational procedures. The purpose is to develop a tool useful for epidemiologists
and biostatisticians using programmable calculators such as the HP-41 CV.
In Section 3.2 the exact method of making statistical inference about the relative risk
in a single 2 x 2 table under the above-mentioned conditions is reviewed. In Section 3.3
asymptotic maximum likelihood methods are presented for the combination of several
2 x 2 tables. A standard iterative root-finding procedure, which is available for the
HP-41 CV pocket calculator, is used in an example in Section 3.4. In Section 3.5 some
interesting points are discussed.
3.2 Exact Statistical Inference  in  a 2 x 2 Table
Two cohorts are considered: a cohort which is exposed to a certain factor of interest and
a cohort which is not exposed to this factor. In each cohort a relatively small number
of new cases is observed and the relative risk (or risk ratio) e is defined as the ratio of
the true probability of an individual in the exposed cohort being a case to that of an
individual in the non-exposed cohort being a case:2
Pr(caselexposed)e =                                                     (3.1)
Pr(caselnon-exposed)
Further,  let s denote the given ratio  of the  size (e.g., expressed in person-years)  of tlie
non-exposed cohort to that of the exposed cohort:
size of non-exposed cohortS- (3.2)size of exposed cohort
and let n denote the observed total number of cases in the exposed and non-exposed
cohort:
n = total number of cases in both cohorts. (3.3)
Assuming Poisson distributed numbers of cases iii both cohorts and here using the
quantities defined  by  expressions  ( 3.1)  to  ( 3.3)  it  has been derived by Bross  [21  and
Klerk-Grobben and Prins [5} that, for a given total number of cases n, the number of
2 Actually, e is a rate ratio, which under the rare disease assumption approximately equals a proba-
bility ratio (this note was not mentioned in the originally published paper).
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cases k in the exposed coliort is a binomially distributed variable in n "trials" with
probability paraineter T given by:
Q
T = -.                                    (3.4)
Q+S
Note that n and s are given quantities, k is a random variable and er and e are unknown
parameters, with the relative risk e the parameter of interest. Statistical inference about
the relative risk e can be made through the binomial parameter r as follows from (3.4),
representing a monotonically increasing relationship between the unknown parameters
e and r.
For an observed number of cases x in the exposed cohort, the 100(1 - a)% confi-
dence interval (71·L, 7ru)  for the binomial parameter  ,r  can be obtained from the binomial
probability density function b(·) as
n
  b(k In, 7rL)   =   0/2
k=r
r
 b(kin,Tu) = O/2, (3.5)
k=0
which interval can be easily converted into the 100(1- a)% confidence interval (eL,QU)
for the relative risk e:
SIL
QL =  -1- fL
(3.6)
S'IT U
QU             -1 - iru
as follows from (3.4).
The p-value of testing the null hypothesis e=1 against e>l i s computed as
p  =  Pr(k 2 xle = 1)
n






The maximum likelihood estimate   of e equals
SZ
e =-,                                          (3.8)n-x
which a.o. will be shown in the next section.
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3.3 Maximum Likelihood Methods for the Combi-
nation of Several 2 x 2 Tables
Often the explanatory exposure factor of interest is confounded with other explanatory
factors such as age and sex. In order to be able to make proper statistical infereiice
about the relative risk e, representing the multiplicative effect of the exposure factor
of interest, given the other explanatory factors, the data are broken down into m 2 x 2
subtables (or strata) j=1, . . . ,m, each 2 x 2 subtable for a subcohort representing e.g.
a particular age-sex combination.    In  each of these subtables (or strata)  j,  the  same
quantities are relevant as in the single 2 x 2 table:
xi: the observed number of cases  in the exposed jth subcohort,
nj: the given total observed number of cases in the exposed and non-exposed
jth subcohort;
7rj: an unknown binomial parameter, representing the probability  of  a  case
in the jth subcohort being exposed,
sj: the given ratio  of the  size  of the non-exposed jth subcohort  to  that  of
the exposed jth subcohort;
e: the relative risk, which is the unknown parameter of interest.
The assumption is made that the relative risk Q i s constant across the m 2 x 2 subta-
bles; this assumption is often called the homogeneity assumption, although it actually
expresses a certain model specification, viz., a multiplicative model without interaction
terms. Note that the need to split up a single 2 x 2 table into several 2 x 2 subtables
arises  from  the  fact  that the ratios  sj  (and  thus the probabilities  7rj)  may  vary  over
the subtables for common e. From the ni 2 x 2 tables simultaneous statistical inference
about the relative risk e can be made as follows. First the maximum likelihood estimate
of e is computed and the homogeneity assumption is tested (see also [1,4]). Again the
observation z j is, for given nj. the realization of a binoinially distributed variable with
probability paraineter
Q
:rj=-, 1-1,...,m. (3.9)9+ Si
Assuming the zj to be mutually independent realizations for j =1, . . . ,m, the likelihood
function of the parameters 7rj (and thus, by (3.9), of the single parameter e) for the
observations x, can be written as the product of m binomial distributions
L(elzi,...,Im)       =        11A (n,j (    e     4  <    ,   '\ "'-41      (4)   (2 + 4) ke + sj jj=1
772 771 / j7-r    /  71 j   \      ..1 -i, (3.10)=      W H(e t s, ))-n, 11 Cgi) s
j=1 J=1
for  given  nj  and  s,   and  with  z  =  Ej xi, the total number of cases  over all exposed
strata. It follows from here that I is a sufficient statistic for the relative risk e. Setting
the score O ln L/De at zero results in the following equation:
7,
  <_njQ_j _g= O. (3.11)
j=1 (etsj)
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The  first  term  in  the  left-hand  side  of  (3.11)  is,  for  e  >  O, a monotonically increasing
function of e; equation (3.11) thus has a unique positive root D which is the maximum
likelihood estimate of e and which is a function of the sufficient statistic z = E j z j for
given  nj   and  sj. An iterative procedure for solving  (3.11) is known  as "root finding"
and is available as a standard program for some programmable pocket calculators. Note
that (3.11) reduces to (3.8) for m = 1.
Given the homogeneity  assumption (i.e., constancy of e for j=1, . . . ,m)a n asymp-
totically chi-square distributed variable with m-1 d.f. is defined in a usual way as
)(2(m - 1) = E 4 + 47 (nj - xj)2 - En), (3.12)j=t nitri    f=-1, nj(1 - iii) j=1
where *j = 0/(Otsj) with & the maximum likelihood estimate as the solution of (3.11).
The homogeneity assumption can be tested by the chi-square statistic (3.12), for which
theseparateobservations KJ are needed. Proxided -that_the-homogeneity assurnptionis_  _        _    _
not rejected, it is now necessary to derive an approximate confidence interval for the
relative risk.
From the theory of maximum likelihood estimation it is well-known that the score
aln L/ae is asymptotically normally distributed with variance  -E [02 ln L/822]   and
mean zero. An asymptotically standard normal variable z thus can be defined as
Bln L/De (3.13)Z=
4-E [B, ln L/002] '
which can be computed from the likelihood function (3.10) as
I-9




FY     n joIM=  2   - =X 7154 (3.15)
1=1  9  + Si j=1
and
m m
a2=X njsje =Inj,ri(1-7rj), (3.16)
j=  (e + Sj)2 j=1
(see also (3.9)). The asymptotically standard normal variable z defined in (3.13) thus
equals the standardized sum of m binomially distributed variables zj with parameters
nj and 7rj = 2/(2 + s j), j =1,...,m Hence, asymptotic normality of z follows from
the central limit theorem applied to  z/ Z j nj.
By denoting za/2 as the 100(a/2) upper percentage point of the standard normal
variable z and for an observed total number z of exposed cases, the 100(1 - a)% con-
fldence interval  for the relative  risk e should comply  with the interval  (-za/2, tza/2 )
for z through (3.14). Although in general z in (3.14) is not a monotonic function of e
through equations (3.15) and (3.16), it will be possible under moderately large sample
conditions to obtain unique roots  OL  and eu corresponding with  +2(/2  and  -zo/2,  re-
spectively. These conditions are: (i) the total number of cases Z j nj is not too small;
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(ii) the sj ratios are not too variable over the strata j; (iii) the a-value is not extremely
small. For the solution of the asymptotic confidence limits OL and eu from (3.14) an
iterative root-finding procedure has to be used. A continuity correction can be made
by  adding  -    or  +    to the numerator of (3.14)  for  et;  and Ou, respectively.
The approximate p-value of testing the null hypothesis is e = eo = 1 against e > 20
is computed from the value zo of a standard normal variable z as





with Bo and 00 given by equations (3.15) and (3.16) for e = 20 = 1. Gart [41 proposes a
continuity correction here by subtracting 1 from the numerator in the right hand side
of (3.18).
Another interval estimation method uses the asymptotic normality of a maximum
likelihood estimator. Breslow [ll proposes " ... to develop the normal approximation
on the log scale, since b is constrained to be positive and has a rather skew distribution
...".   The asymptotic variance of the maximum likelihood estimator for  In e follows from
the likelihood function (3.10) as
( -E [82 ln L/(Bln e)21 }-1 - 1 02 (3.19)
with 02 defined in (3.16).  As e is a monotonic function of ln e, the asymptotic confi-
dence limits  of the  100(1  -  a)% confidence interval  for 2 itself  can be computed  from
transforming the asymptotic confidence limits of ln 2, resulting iii:
91. = b expt-zot218)
eu = 8 - expl.+za . f&j, (3.20)
where the replacement  of  a  by 8, following  from   (3.16)  for   e   =   b, is asymptotically
justified.
For an exact calculation of the confidence limits and the significance of the rela-
tive risk from m 2 x 2 subtables one has to evaluate tail probabilities from the exact
probability distribution of the sufficient statistic .r, the total number of cases over all
exposed subcohorts. This exact probability is the sum of the exact probabilities of all
possible combinations (Il,·.., xm) subject to Zj zj = x and xi S nj for j = 1,-..,m.
The exact probability of each combination (xl,···,Zm ) is computed from the product
of m binomial probability functions as in (3.10). This would be a very time-consuming
procedure even for computers.
3.4  An Example
5-year mortality data of two small municipalities near Rotterdam is compared, with
both municipalities broken down into 22 age-sex strata. The parameter of interest is
the assumedly constant mortality ratio e of municipality 1 with respect to niunicipality
0, adjusted for age and sex. The data is presented in Table 3.1.
21
Sex Age   j    31         zi         ni
Female 0-4 1  .15937        19          20
5-9 2  .21144         1           1
10-14 3  .21157          2           2
15-24 4  .16016         2           2
25-34 5  .11488          6           6
-  35-44 -6 .16083  -    18         18 -
45-54 7  .14834        36          39
55-64 8  .15313        51          54
65-74 9 .12141 129 139
75-84  10 .11335 246 256
285 11 .05785 151 154
Male 0-4  12  .14749        15          17
5-9  13  .23056         5           5
10-14  14  .21071         3           3
15-24  15  .18896         7           8
25-34  16  .10961         11          11
35-44  17  .17431        23          24
45-54  18  .15018        62          68
55-64  19 .16563 106 117
65-74  20 .12848 175 200
75-84  21 .17127 190 217
>85  22  .12000        90          97
Totals x = 1348 n = 1458
sj = the ratio of the size of the population
in municipality 0 to  that in municipality  1.
ZJ  = the number of mortality cases in municipality  1
nj = the total number of mortality cases in both municipalities.
Table 3.1: 5-year mortality in two small municipalities near Rotterdam
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The maximum likelihood estimate i of the mortality ratio follows from solving (3.11)
to 2
D = 1.60439
The homogeneity assumption (e is constant across strata) is tested by the chi-square
statistic (3.12) with 21 d.f.:
X2(21) = 20.53,
implying that this assumption can be accepted.
The asymptotic 90% confidence interval for e is given by the roots eL and Qu of
(3.14) for z = +1.6449 and z = -1.6449 respectively:
eL = 1.363
QU = 1.889.
The approximate p-value of testing e=1 against e>l i s obtained from computing zo
as in (3.18):
zo = 4.80
from which it follows that
p  =  Pr(z > 4.80) = 7.90 x 10-:
With a continuity correction one has zo = 4.76.
The computations of the maximum likelihood estimate b and the confidence limits
eL and eu have been done on the HP-41 CV programmable pocket calculator where
use  has  been  made  of the general application program "root finder". A large number
of strata can be taken into account with the HP-41 CV calculator.
It is interesting to also compute the asymptotic confidence limits of the mortality
ratio e with the non-iterative formula (3.20) in the data set at hand.  Fore= # = 1.60439
the standard deviation a (3.16) becomes a = ao = 10.06031. Taking z = 1.6449, the
90% confidence limits QL and gu are computed from (3.20) as
e L = 1.363
eu = 1.889.
Hence, in this example no difference up to the third decimal place is found between
the iterative solution of (3.14) and the non-iterative application of (3.20). Although a
confirmative example may not serve as a proof, it appears that (3.20) might be a good
non-iterative alternative for the iterative solution of (3.14) in large samples.
In a single stratum of Table 1, say stratum 10 (females aged 75-84), exact statistical
inference about the mortality ratio can be made. The maximum likelihood estimate
of the mortality ratio in stratum 10 follows from (3.8) with s = 0.11335, z = 246 and
n = 256:
0.11335 x 246
2% = 2.79.256 - 246
For the exact 90% confidence interval of the mortality ratio in stratum 10 first the
exact lower and upper limits of a binomial parameter are solved from (3.5) for z = 246,
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n = 256 and a = 0.10:
7T L =  0.93464
TrU = 0.97866.
For these solutions of (3.5) use has been macie again of the getieral apl,licatioti program
"root finder" for the HP-41 CV. The exact lower and upper confidence limits of the
mortality ratio in stratum 10 then follow from (3.7):
0.93464 x 0.11335
QL = 1.62091 - 0.93464
0.97866 x 0.11335
QU .I = 5.1983.1 - 0.97866
The exact p-value of testing the null hypothesis e=1 against e>l i n stratum 10 is
computed as in-(37) for To - 1/(1 + 0.11335):
p = 0.00017.
3.5 Discussion
In this paper it is shown that in a cohort study with Poisson cases the given ratios sj
sufficiently represent the structure of the confounding factors.  In a cohort study the
ratios sj are fixed and non-stochastic numbers, which is true as a cohort forms the
total population at risk from which the observed cases derive. Therefore, the interval-
estimation methods presented in this paper are inappropriate for a case-referent study.
In a case-referent study, when carried out correctly, the referents are sampled from the
total population at risk (persons x time) from which the cases derive over time. Due
to this sampling of referents, an additional stochastic eleinent has to be introduced,
as in a case-referent study only sample statistics of the (unknown) odds parameters s j
are available. The relative risk e = irs/(1 - Tr) is then determined by two unknown
parameters T and s simultaneously, whereas in a cohort study this is only by ir as s is
a known fixed ratio.
In the case of a common (homogeneous) risk ratio e across the strata formed by the
confounding factors, it is shown in this paper that the total number z = Ej zj of cases
over all exposed strata j is a sufilcient statistir for e.  Of cozirse. f,ir testing homogeneity
of e with the heterogeneity chi-square statistic the separate exposed case numbers I J
are needed.  In the presence of heterogeneity (=interaction), i.e., the risk ratio varies
over the strata  j, one might estimate a separate  risk  in each stratuin j, which would
mean that 7n parameters ej, j =1, . . . ,m, have to be estimated. Of course, it is more
efficient  to  model the interaction as a siniple aiid appropriate function  of the index j,
e.g·,  6  =  exp(Bo + dij) with j denoting classes of one confounding variable, where only
two parameters, viz., Bo and 81, have to be estimated. Maximuni likelihood estimation
of Bo and Bl from the likelihood function (3.10) with exp(Bo + Blj) substituted for
2 in stratum j is straightforward, but is considered beyond the scope of this paper.
However, interaction may also result as an artefact wheii a contiIiuous confounding
factor (e.g., age) is too broadly grouped. Mantel [7] warns for this possibility. It is
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therefore recommended to make the stratification as fine as data and the memory size
of the calculator allow.
In order to compute an exact confidence interval for a binomial proportion, an
iterative root-finding procedure is applied to (3.5) in order to solve the exact confidence
limits. A non-iterative exact method is provided by a mathematical relationship between
the binomial and the F-distribution. Exact confidence limits can be easily calculated by
hand from the relevant tabulated F-values. F-values corresponding with not tabulated
numbers of degrees of freedom can be accurately found by double-linear interpolation
with harmonic arguments as shown by Liddel   [6]. In regular empirical  data  sets   the
iterative solution  of the confidence limits   OL   and  eu   from  (3.14)   has  so  far  given  no
serious problems. Problems arose only in artificial data sets with characteristics opposite
to the three conditions mentioned in Section 3.3 above equation (3.17).
All computations dealt with in this paper can be made by consecutively running a
series of programs made for the HP-41 CV pocket calculator.  Up to 74 strata of the
confounding factors can be taken into account with the HP-41 CV. Program listings and
illustrative applications with the instructions have been reported and can be obtained
from the author.
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Multiple Failure Causes and Observations of
Time Dependent Covariables
by A.L. Hempenius and P.G.H. Mulder
Abstract.  In this paper firstly a summary of the theory of competing risks is presented; it shows how
cause specific failure time distributions, failure probabilities and failure rate functions relate to the joint
survivor function in the presence of various competing failure causes. This first part of the paper gives
the insight useful for the second part, which concerns the way in which the dependency of the failure
process on given time-dependent observations of covariables is specified and estimated. An application
is presented briefly.
Key Words & Phrases: competing risks,  mortality,  multiple failures, survival analysis.
1 Introduction
In this paper a method is presented to analyse, for censored failure time data, the
relation between: (1) failure rates of a number of mutually exclusive and simultane-
ously acting (so-called "competing") failure causes and (2) values of time dependent
covariables, including possibly the covariable "time" itself. These covariables are
supposedly measured at predetermined time points.
Some examples from epidemiology, medicine and economics are:
(i)    The development over time of cardiovascular disease in an originally disease-
free cohort of persons in relation to annual values of blood pressure,
cholesterol level, ECG-anomalies, smoking, sex and age, taking into account
the two other (competing) failure causes: mortality from other causes and
disease-free withdrawal from the cohort.
(ii) The survival prognosis after operation on a certain type of cancer, in the
presence of various competing mortality causes (including the given kind of
cancer) of patients discharged from hospital, in relation to various medical
therapies, the time since the operation, age, and socio-demographic charac-
teristics.
(iii) The termination of the duration of unemployment, firstly of course by finding
a job and secondly by other causes, such as transfer to some social security
scheme (say a disability scheme), other than the unemployment scheme, or
mortality. Possibly time-dependent covariables are educational and/or pro-
fessional status, age, the duration of unemployment and the acquisition of
new skills.  See, for example, LANCASTER and NICKEL (1980).
In Section 2 a review of the relevant theory of competing risks is presented, as
this theory may be used to describe the distributions generating type and time Of
failure  for a given "subject':  The  parameters of these distributions depend  on  the
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values of a number of explanatory variables characteristic for this subject. This
dependency is also modelled in Section 2. In Section 3 the likelihood function suit-
able for estimating the relevant parameters of the model is presented. An applica-
tion is presented in Section 4.
2 Elements of the theory of competing risks* 
2.1 Theoretical and Observed Failure Times
A given subject, free from any "failures" at time point zero, is in the course of time
subject to K (mutually exclusive) simultaneously acting failure causes or so-called
competing risks.  At some point in time, and by one of the K failure causes, the
subject considered is supposed to actually experience "failure". This may be for-
malized as follows.
Let the observed random variable (r.v.) X denote the time offailure (from one
of the K risk causes) and let the unobserved theoretical random variable
X 200 =1,  · · · 'K) be the time of failure if risk j were the only risk present.   Then
X is assumed to be equal to the smallest of these K theoretical failure times
Xi, **· ,XK:
X= min(Xl,    - * ,Xk)                                                                          (1)
These theoretical failure times have a joint distribution defined by the so-called
(supposedly continuous and differentiable)joint survivorfunction S:
Socl,   ,)CK) - Pr(Xl >Xl,···,XK>XK).              (2
The (observable) probability of still being fulure-free at time x (i.e. of surviving
after time x) is a value of the survivorfunction F(x) defined for the r.v. X of (1):
F(x) = Pr(X > x).                                                          (3)
As each 6 exceeds X, according to (1), F(x) may be expressed as follows:
F(x) = Pr(Xi >X,'-,Xk >x) = S(x, · · · ,x).                    (4)
The probability density function (p.d.f.) of X,f(x), is therefore:
f(x, -                                                     (5)-djr(x) =  -dS(x, · · ·x)dx            dx
The (observable) probability of failure, at some time, from risk cause j is
· See also DAVID and MOESCHBERGER (1978).
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denoted by gj(j =1,  · · · AD:
erj  = Pr[min(Xt,·*   ,XK) =  Xj]  =                                                     (6)
=  -[-LS(X l,  "' .Xj, ·,XK)lx,= =   XK   -   xdx6   exj
with Ev  - 1
The(conditional) probability L(.x)dx of failure  in  the  interval  (x,x + dx)  from
risk cause j given failure from cause j, is:
S(x, ···,x)-S(x, ···,xtdx, ···,x)
.,6(x)dx i                                                (7)
7Tj
-sethat the ,(conditionalkp. df.  of»lure  time  given failurefrom causel,  is:     -    ---     ----
8-[-S(X 1,  I      ,Xj,  · · · iXK)1*1 = -4-xaxj
fj(x)  =                                                                                                              (8)
1Tj
The  (unconditional)  probability   of failure  in   the  interval   (x,x + dx)  from  cause   j   is
therefore 91 jfjix)dx,
The following relation between foe), «6(x)  and  erjq -1, ···,K) follows  from
the above definitions:
K
foc, =  E 5·,6(x)                                                           (9)
1-1
2.2 Failure rates
By  means of F(x)  and f(x) one defines  the well-known failure rate function  X(x) of
X as follows:
ACK)  =  tfxl  =  - -ilnp(x). (10)
F<x)         dx
The failure rate (function) defines the following probability: A(x)dx is the (condi-
tional) probability that a subject, failure-free at time x, will experience failure in the
interval (x,x +dx), from any of the K risk causes.
The marginal failure rate function for cause jil=1,· · · .K), in the presence of
all K risks, is denoted by Xj(x), so that Aj(x)dx is the (conditional) probability of
failure  from risk cause j  in the interval  (x, x + dx),  for a subject failure-free  at  time
X:
- S(x, ···,x)-S(x, ···,x+dx, ···,x)
A/(x)dx -                                               (11)S(X, . . . 'X)
By letting dx approach 0, one has:
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8
-[--- S(Xt, ···,Xj, ·   ,XK)lx,= ··· =Xi=x
BxjXj(X) =                                                 (12)
S(X, ...,X)
From (8) and (12) the following relation follows:
5.,6(x) = Aj(x)17(x) (13)
The probability  of failure in  the  interval  (x.x + dx) from  cause  j  may  thus  also  be  writ-
ten as Xj(x)F(x)dx.
The failure rate function X(x) of the observed failure time X can be expressed in
the failure rates Xj(x):
K
A(x) = E Aj(x), (14)
j-1
which follows from
A(x) = f(x)/7(x) = -[-ts(x,···,x)]/s(x, ···,x), (15)dx
and from (12).
A special case of the marginal failure rate functions Xj(x), viz. proportionality
between failure causes for all x:
Aj(x) = cjX(x)    0 =1, · · · ,K) , (16)
defines the so-called proportional hazardw model; see also footnote p.52.  For the cj
one can easily prove from (13), (16) and (15):
9   =   5          0. =1,... 'K) (17)
From (13), (16), (17) and (15) it follows that in this case
«6(x,=f(x)    0 =1, · · · ,J O, (18)
so that in the proportional hazards model (16) all cause-specific failure time distri-
butions (x) are equal to the overall failure time distribution f(x). Hence the pro-
portional hazards model implies independency of time and cause of failure.
In contrast to Xj(x), which is defined in the presence of all risks, a theoretical
marginal failure rate function in the absence of all other risks, rj(x), is defined
analogous to (10) as:
pi«)
rt(x) = -5--- , (19)
pjcx')
with pj(x) the p.d.f. of the unobserved r.v.  AJ and Pj its "decumulative" distribu-
tion function Pr(Xj>x)=SCO, ···,x, · · · ,0).
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as may be proved directly from (12). Result (20) implies that
K
X(x) = 22 rj<x), (21)
J-1
if the unobservable r.v.'s Xii  · · · ,X K are independent.
Some rele'gnt probabilities can be expressed in terms of the Xj(x) and X(x).
For example, F(x), the probability of failure later than x, is according to (10):
X
F(x) = exp[- f X(t)dt] . (22)
0
The so-called crude probability of failure (i.e.  in the presence of all risks) from
cause j in the interval (a, b), given survival until  time a, Qj(a,b), is equal  to
Q#ah) -  -1     -.,IC»'1 - f-'»»I# -) '1 , 1  d.            (23)F(a) a
as follows from (13) and (22).
*
2.3 Modelling the dependency of the failure process on the covariables  
In this subsection the covariables enter the failure process.  As will be seen in Sec-
tion 3, the likelihood function may be expressed in terms of F(x) and the
Aj(x)(1 -1, · · · K), with F(x) the (overall) survivor function (3) and Xj(x) the mar-
ginal failure rate function for cause j, in the presence of all risks. As F(x) can be
expressed in the Xj(x), see (14) and (22), it is sufficient to describe the dependency
of the Aj(x)4 =1,  ·  ·  · K)  on the covariables, which will be assembled in the vector
z. In the context of the competing risks theory of Section 2.2, which uses the
theoretical    r.v.'s    X i, · · · ,X K,    it is natural to specify first the dependency    of
S(Xl, ...,XK'Z) onzand then to derive the Aj(xlz)(/=1, · · · 'AD.
As directly modelling the dependency  of  the  Xj(x  z) also seems very natural,  it
will first be checked whether both ways, modelling the dependency of the joint sur-vivor function and modelling the marginal failure rates, are equivalent ways. For
the most general survivor function this is not the case:
-I-Q  S(x 1, · · · ,xj, · · · ,XK)lx, = ·· · =xx=x
axjXj(x) =                                                   (24)
F(x)
so that knowledge of the Aj(x)F(x)  does not allow for a solution of S(x 1,          ,XK).
This is just an expression of the non-identifiability of S from data on failure time
and failure cause; see DAvID and MOESCHBERGER (1978, Chapter 4) on this
* See also PRENTICE, KALBFLEISCH et.al ( 1978) and KALBFLEISCH and PRENTICE
(1980).
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phenomenon.  If  the  Xi,  '    ,XK are assumed  to be independent  r.v.'s,  then  both
ways are equivalent:
-ip (x)dx JAjoc) = rj(x) =                                            (25)
4(X)
whicll for givgn Xj(x) may be solved for Pj(X)(1 '=1, · · · ,K), specifying
S=P l x· · ·X P K·   TSIATIS (1975) formally proved   that the theoretical marginal
failure rate functions rj(x)  are in general non-identifiable from observations on time
and cause of failure and BERMAN (1963) formally proved that, in cise of indepen-
dent  r.v:s Xi,  o o    iXK' the theoretical marginal survivor functions Pj are uniquely
determined by the observable joint distribution of time and cause of failure.
Without assuming an untestable parametric specification of the joint survivor
function S, which also parametrizes the interdependency among the failure types,
there remain two practical ways of introducing the dependency on the covariables
z.   The  first  way  is  to make assumptions about the Aj·(x z)(/=1,···.AD, without
assuming anything about the S-function or even mentioning it. The second way is
to   assume   S=P i X   ·  ·  ·   X PK, i.e. independent   r.v.'s   Xi, o ,XK' and subse-
quently also to asiume something about the marginal failure rates
r (xlz)=Aj(xlz)=  -[d4(xlz)/dx]/Pj(xlz).  For the resulting likelihood function,
which will be expressed into the failure rate functions Aj(xiz), these two ways of
introducing z are therefore indifferent. As in the previous section the theoretical
r.v.'S  XI,  0    0  iXK  have  been used model the competing risks problem, the second
way is in this paper the consistent one, and will be used here. It has to be men-
tioned, however, that the same (time-dependent) covariables might explain the vari-
ous failure causes.  So, the assumption of independent failure causes is made condi-
tionally upon the covariables and therefore is a serious assumption only to the
extent that the interdependency is not taken account of by the explanatory covari-
ables.
Assuming independent r.v.'s Xi, , XK' the dependency  on the covariables  z
will be modelled as follows:
Aj(xM) = exp(Bjz)Aoj(x), (26)
where    the   #jU -1,  ·  ··,K) are column vectors of cause specific regression
coefficients and Xoj(x) is the failure  rate  for z = 0.
A special case of (26) is
Aj(x z) = exp(g·z)eY'Ao(x), (27)
* Model (26) is often called a proportional hazards model too, because of the propor-
tionality of a particular failure rate with between-subject differences in the covari-
ables z.
33
Statistica Neerlandica 40 (1986), nr. 1
in which case the marginal failure rates 4 are proportional to each other. For a
subject, with given z, the ratios of the Xj are independent of x, which defines the
proportional hazards model.  The probability 5 that a subject with covariables z
ever fails of cause j, then becomes a logistic function in z:
Aj                experj + Bi'z)
*j =  K   =  K                                    (28)
E X, E exp(y, + Biz)
i=l i-1
with Ao(x) cancelled out.
3 The Likelihood Function
-311 bitrodii tion
In this section, the likelihood function, initially for a cohort of subjects followed for
some period of time, will be developed.
In Section 3.2. this is done for the case that failure rates and covariables
influencing the failure rates may change continuously with time.
In Section 3.3, this same case is treated by means of Cox' partial likelihood
approach. Finally, in Section 3.4, the practical case of failure rates and covariables
being constant within time intervals is considered. Section 3.4 forms the core of this
paper.
3.2  The  likelihood for  continuously  changing rates  and covariables
Subject i of the failure-free cohort H is followed during the time interval [0,4].  BY
"time" is meant follow-up or study time rather than calendar time, so that although
different subjects enter the follow-up study at the same study time 0, the calendar
times of entering the study may be different.  The only type of censoring present is
of type I, i.e., the total follow-up time ti of subject i is either predetermined or sto-
chastic   and   it is stochastic   only   if   one   of   the K failure causes produces   time   ti.
Correspondingly, two types of events are defined for each subject i eH:
(i)     event Mo, occurring if the follow-up end without failure at predetermined time
tl,
(ii)   event  Mj(j =1, ···,K), occurring if the follow-up  ends at stochastic  time  4,
produced by failure cause jq=  1,   ·   ·   ·, K).
The set H i s partitioned into the sets Mo,Ml,          ,MK. Each subject i€H belongs
to exactly one of these sets. This is also denoted by the zero-one indicators
60, 6li, - ,6Ki, which are defined as 6ji=1 if i€M:(  =0,1, · · · ,K) and as Bj,=0
otherwise.
The likelihood function Li for subject i eH can now be written as:
4    -   [F, (t,)f'    f[   [rj,  f;,(t,)18' , (29)
j -1
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as follows from (3) and (8).  In (29) Fi(4) denotes, for-subject i, the survival proba-
bility for predetermined  time  4   and   DifB (ti )dt,  = Aj,(t,)F, (ti)dti denotes the probabil-
ity of failure from cause j at stochastic time t,. The likelihood function for all sub-
jects in H is, because of independence:
K
L = 1-I 4 = II F,(4) II II Xj,(t,)F,(4)· (30)
ieH ieM' j=lieM,
This  can be expressed  into the rates  Xj,, as follows:
K                               t,
L = Il {II exp[-f Aj,(x)dx] II Aj,(4)} , (31)
1-1 isH   0     ieM,
which follows from (14) and (22). This implies that lnL is additively separable with
respect to the causes j=1, . . . .K:
K                                                 1,
lnL = E { 52 lnIAj,(4)]- E f A··(x)dx} (32)JI
j =l iEM: i€HO
A separate maximization for each failure cause j maximizes the log likelihood (32).
By   introducing the dependency model   (26)   for   the   AB,   with time dependent
covariables zi(x), one introduces cause-specific coefficients #j. Assuming knowledge
of the z, (x), these #j can then be estimated by maximizing (32) with respect to the
4.    Of  course,  the  Xoj  have  to be specified.    The  Xoj  need  not  be made dependent
on the subjects i, as this dependency is accomplished by means of the (subject
dependent) vector of covariables zi.
In Section 3.4 the assumption of knowing the z, (x) functions is replaced by the
assumption of knowing values of Zi(x) at (predetermined) points in time, say
Xl'X2, ,Xp. Another, somewhat more "heroic", assumption is to suppose that
the Xji depend  on one measurement  of  the  z,(x),  say  at  time   x i. Of course,  for
some covariables this is justified. For example, a subject's sex does not change that
easily.
3.3 Cox's partial likelihood approach
But first, for more insight, it is instructive to use a partial likelihood for estimating
the  4. The partial likelihood approach considers the complete likelihood  as  fac-
tored into parts which are relevant to the estimation problem at hand and other
parts; see Cox ((1972), (1975)), PRENTICE and KALBFLEISCH (1979) and
KALBFLEISCH and PRENTICE (1980).
A partial likelihood is found by conditioning on certain relevant events. Sup-
pose,  there  are mj failures from cause j, assembled  in  the  set  Mjq - 1, . . . 'A b
The times of failure corresponding to these assumedly untied failures are such that
0<4 <          tm .   (For ease of notation, a second index, indicating cause of failure,
is suppressed.) Denoting by Hi the set of persons free from failure just before time
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4(i =1,···,mi),  the probability that subject i fails from cause j a t time ti, condi-
tional on the set Hi, is
Aj,(4)L = (33)
p       E Aj,(t,)
r. H,
Introducing the dependency model (26), the log partial likelihood for all subjects of
Mj becomes:
mj
Ind (Bj) = E 1«(Bj) (34)
i./1
5           4
=  0,1   E  z,(4)- E  ln[ 61   exp(Fjz,(4))1.
7-= 1 -7 -1      rEH,
The notation lnLj(Bj) stresses that (34) [and also (33)] only depends on Bj and not
on  Xoj.    This in contrast  to  the log likelihood  (32).
Cox's partial likelihood approach is dealt with by many authors. For instance,
GILL (1984) provides a firm mathematical basis to Cox's regression model by show-
ing its consistency with the statistical theory of counting processes developed by
AALEN ( 1976)), ( 1978)) and its connection with martingale and stochastic integral
theory. Goodness-of-fit-tests for Cox's regression model are proposed by e.g. KAY
(1977) and ANDERSEN (1982).
The relation of (34) to (32) - actually its j-th sum - is, that (34) may be con-
sidered as a special "maximized" case of (32); see BRESLOW (1974). In order to
show this, the total follow-up time is divided into mj intervals
(4 -1,41 (i= 1, ···,mj;to=0). Considering only failure cause j within interval
(4 -1,4] and considering (not quite correctly)  the  "risk"  set  Hi as defined above,  the
log likelihood for each interval follows from (32) with only its j-th sum considered.
Considering all the intervals, gives:
4                     m           1,
ln,Lj = E ln[Ap(t,)]- E  E fAj,(x)dx. (35)
i=1 i=1 rEH, t,_,
Now, introduce the dependency (26) and consider the 4 as constant within the
intervals (4 - 1,4]· Writing these constants as exp(a  ), (35) must then be maximizedJ1
with   respect   to  the  aj,   and  #j.     The  aji   may be solved  from the first order condi-
tions as:
exp(ap) - [(4-4-1) E exp(B'jzr(4))]-1 (36)
reH,
Substituting (36) into (35) gives, apart from a constant, the log partial likelihood
(34).
When the number of subjects mi is large, giving rise to many constants aji, this
approach of using the log likelihood (34) for estimating the Bj and (36) for also
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estimating the Xoj as a step function of time, may not be so efficient. By
sufficiently parameterizing the functions Aoj(x) and treating them as continuous
functions of time, one may increase the efficiency of the ML estimates by using the
log likelihood (32). Two other arguments are in favour of the approach leading to
(32). Firstly, this approach copes more easily with dependency models other than
(26). And, secondly, it copes more easily with a subdivision of total follow-up time
as determined, for instance, by the measurement times of the covariables, which is
the subject of the next section.
3.4  Rates and covariables constant within time intervals b
Although rates and covariables, when they change with time, in most cases change
continuously, there will be little or no harm in supposing constancy in predetermined
time intervals. This complies with the actual practice of follow-up studies in which
the total follow-up time is divided into predetermined intervals, at the start of
which a number of covariables is measured in subjects of the remaining failure-free
cohort. This division of total follow-up time may be, and ideally is, done in such a
way as to practically ensure the above mentioned constancy within intervals.
A reformulation of the log likelihood (32), incorporating the information from
several observation points, requires double sums over subjects and time intervals. A
simpler notation is achieved in the following way.  The time intervals during which
a given subject of the cohort is followed, are called subject-intervals. The set of
subject-intervals for all subjects of H is denoted by H'.  It is assumed that the
indices i, denoting subject-intervals for the same subject, form a set of consecutive
integers.    A  subject-interval  i eH'  is  denoted by (t'i't' i +Wi'), with t'' the starting
point and w, the width of the interval. The widths of the subject-intervals are either
predetermined or stochastic.  They are predetermined, possibly different, numbers if
they are determined by the observation points t'i  of the covariables or by fixed cen-
soring of a subject's last time interval.  Only if the subject-interval considered is the
last time interval for this subject and if failure occurs by one of the K failure
causes, then the interval width is stochastic. Accordingly, the set H' is partitioned
as follows:
M'o:the set of subject-intervals with wi predetermined;
M'j·(/ -1,  ···,K):  the set of subject-intervals with wi the stochastic time of failure,
as measured from the start of the interval.
As an example, let there be three subjects, two observations points at times 0
and   1, two failure causes and total follow-up interval [0,2]. Values  of the covari-
ables are observed at predetermined times 0 and  1;  the end of the follow-up study
is at predetermined time 2. Subject 1 remains failure-free during [O,21. Subject 3
* See also HOLFORD (1976).
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experience failure cause 2 sometime in interval (0,1].  The set H' is then as follows;
intervals  1  and 2, being  [0,1]  and  (1,2], for failure-free subject 1, hence W l=W 2=1
(predetermined); intervals  3  and 4, being  [0,1]  and  (1,1 + w4] for subject 2 failing
from  cause 1, hence  w 3 = 1  (predetermined)  and  w4 is stochastic; interval 5, being
[o, w 5 ] for subject 3 failing from cause 2, hence w 5 is stochastic. The set M'o then
consists  of the subject-intervals  1,2  and  3,  the  set  M'i of subject-interval  4  and  the
set M'2 of subject-interval 5.
Assuming   constancy   of  the  failure   rates   Aji,   with   index  j   denoting   cause   j   and
index i subject-interval i, within the time-intervals of the follow-up study, the log
likelihood becomes:
K
_101« -X {-I  lnX   -  9  w·X ·1 (37)-   -p--T   -4  P-'--I  -   -    ---   -   -    -     --    -
j -1 EM'J iEH'
For the proof of (37) the same steps as the ones leading from (29) to (32) may be
followed.  So, let the index i in (29) now represent a subject-interval from H'.
Further, let all probabilities (and rates) in (29) now be conditional upon survival
until the start of interval i.  Time is measured from the start of the intervals.  The
likelihood  for all subject-intervals  i EH'  is the product  of  the  Li,  with the added
motivation that for the same subject the likelihoods Li of different intervals may be
multiplied because 4 specifies a likelihood conditional upon survival until the start
of the intervals. This leads to (32), with Mj and H replaced by M'j and H; respec-
tively,  and with the integral having lower bound fi and upper bound  t'i + wi.   Tak-
ing natural logarithms gives (37).
The log likelihood (37) is not unique: there are other assumptions, then the one
used in deriving it, that lead to this form.  In the above a cohort is followed in time
and each subject of the cohort contributes a number of intervals to If. By, for
example, following a cohort of subjects initially of age forty one observes the
development of the relevant covariables and rates over time ( =  age).
The same log likelihood is obtained if one samples the subjects by age and
measures the relevant covariables just once. Each person contributes one interval,
with its covariables, including possibly "age", to H'. What matters are the "infor-
mation sets", the subject-intervals with their covariables and their type of endpoint,
characterized by one of the failure causes or by no failure. (Of course, as is well
known, this does not necessarily mean that the conclusions drawn within one con-
text may be transplanted to another context.)
Assuming that to each subject-interval i EH' there belongs a value of zi, the vec-
tor of covariables measured at the start of this interval for the relevant subject, the
rates Xji, which are supposedly constant within the intervals,  may  be made depen-
dent on zi, e. g. by means of the dependency model (26). In the previous subsection
it was concluded that the time dependence of the Xoj may be satisfactorily modelled
by sufficiently parameterizing the Xoj as functions of time. This may be accom-
plished by incorporating "time" as one of the covariables in the zi vectors. Doing
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this, the dependency model (26) for subject-interval i is reformulated as:
Al,(zi) = exp(Bjo + B'jz,), (38)
where, moreover, one of the covariables has been explicitly started as the constant
1.
Substituting (38) into (37) gives:
K
lnL = E {mj#jo + E B&  - exp(BA)   22 wiexp(B'jzi)}, (39)
3-1 ie M'J ieH'
where m/ is again the number of subjects failing from cause j. This likelihood is to
be maximized with respect to 40 and 11'j,j =1,... 'K. Details may be found in
the appendix.
In a recent paper, LARSON (1984) starts from the same likelihood function (31)
and specifies a discrete log-linear model for the failure rate functions with the total
cohort broken down in strata formed by a discrete categorization of the joint distri-
bution of failure cause, time and covariables.  In each stratum the observed number
of failures (the numerator) and the given observed total failure-free exposure
experience of the cohort (the denominator) serve as suflicient statistics for estimat-
ing the coefficients of a (saturated) discrete log-linear model for the assumedly con-
stant (homogeneous) stratum-specific failure rate, which equals the ratio of the
expected numerator to the given denominator in each stratum.
4 An application* 
Table   1   gives   a  list of variables measured in 1972-73   at a screening examination  in
a representative sample of 3,284 Rotterdam men aged 45-59. This data has been
taken from the Kaunas-Rotterdam Intervention Study; see GLASUNOW, DOWD et
al. (1981).
In this section these covariables and time measured in years will be used to esti-
mate a simple model of mortality (from all causes). Specifically, model (38) for one
failure cause, and the following failure rate, which is constant within each year t
following the screening examination, is assumed:
A(t1z) = exp(Bot#*AGE+B,t+B'zz+B'z,zt) (t=l,2, · · · ) (40)
where AGE specifies age measured in 1972-73   and the other covariables measured
in   1972-73 are assembled  in the column vector  z.
In  order to select the significant covariables  from   the  list in Table   1,   (40)  has
been  estimated  for  Pt -0  and #St -0'· This computationally much simpler  one-
period problem has been estimated, with as resulting significant variables the ones
in Table 1 with an explicitly mentioned symbol.  So the vector z now contains these
• For details see MULDER and HEMPENIUS (1984).
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Table  1.  List of covariables
variable definition symbol
Systolic blood pressure mm Hg SBP
Diastolic blood pressure mm Hg
Cholesterol mg/100 ml plasma CH
Age years AGE
ECG anomaly 1 = 1 for Minnesota codes I-1,2 ECG1
= 0 elsewhere
ECG anomaly 2 = 1 for Minnesota codes I-3, ECG2
IV-1,2,3, V-1,2,3 or VII-1
- = 0 elsewhere
Angina pectoris =  1 for a positive ROSE questionaire
(ROSE and BLACKBURN (1968))
= 0 elsewhere
Cigarette smoking = 1 yes SMOK
= 0 no
Number of cigarettes smoked = 0 for none
= 1 for 1-9 cigarettes/day
= 2 for 10-19 cigarettes/day
= 3 for 2 20 cigarettes/day
Diabetes mellitus = 1 yes
= 0 no
Alcohol use = 1 for no use or less than once
a month
= 2 for regularly or daily a
moderate amount
= 3 for regularly or daily a
large amount
QUETELET index weight/height 2 (kg/m2)
Education ordered categories from primary
education (1) to university (9)
covariables only.
Next (40) is estimated, resulting in Table 2. Note that also B':t=0, which
hypothesis could not be rejected. The difference between the one-period and the
multi-period model thus is only the variable t. As may be seen from Table 2 this
variable is combined    with AGE, because the hypothesis    BA  = Bt could   not   be
rejected.
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Statistica Neerlandica 40 (1986), nr.1
Table 2. Maximum likelihood estimates for model  (40)  with  /1,t  = #t   and
F.,=0' (29,398 subject-years).
variable est.coeff. est.SE t-ratio
0. constant -6.48486 1.74746 -3.711
1. SBP/10 -0.32722 0.18484 -1.770
2. SBP2/1000 0.12186 0.06008 2.028
3. CH/10 -0.17561 0.07629 -2.302
4. CH2/1000 0.04231 0.01666 2.540
5.  AGE + t 0.09492 0.01140 8.326
6. SMOK 0.47293 0.12028 3.932
7. ECG1 0.74920 0.22702 3.300
8. ECG2 0.83022 0.14628 5.676
9. AP 0.74590 0.16402 4.548
likelihood ratio 2 (9) = 195.299
correlation matrix of estimated coeflicients
0 1 2 3 4 5 6 7 8     9
0. 1.00
1. -0.79 1.00
2. 0.78 -0.99 1.00
3. -0.45 -0.03 0.02 1.00
4. 0.43 0.02 -0.01 -0.98 1.00
5. -0.38 0.02 -0.03 -0.03 0.04 1.00
6. -0.11 0.03 -0.02 0.03 -0.03 0.05 1.00
7. 0.06 -0.04 0.04 -0.05 0.05 0.00 0.00 LOO
8. 0.01 0.04 -0.07 -0.03 0.02 -0.07 0.05 -0.28 1.00
9. -0.07 0.04 -0.02 0.10 -0.13 -0.02 0.02 -0.17 -0.09 1.00
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Appendix
Maximizing the log likelihood (39)
Thels log likelihood function (39) has to be maximized with respect to the vec-
tors of coefficients (Bjo,#'j), for given mj,w, and zi(/=1, · · · ,K;i E H'). As the log
likelihood function is separable with respect to j, its maximization can be per-
formed separately and analogously  for each failure cause jo -1, ···,K). There-
fore, the index j in (B  0, B'j ), mj   and   M'j is suppressed  in the following.
The ML-estimators for (po,B') follow from the condition of zero first order par-
tial derivatives of (39) with respect to (Bo,B'):
81nL
- = m -Bexp(Bo) =0, (A.1)
BBO
81nL                    BB
-33   =,3'. 4--BBexp(Be) =O, (A.2)
where
B= 2 w,exp(B'zi), (A.3)
ieH'
8B-  =   E ziwiexp(B'Zi) (A.4)
BB   'sH'
Solving exp(Bo) from (A. 1) as
exp(#0)   = - (A.5)
and substituting this into (A.2) yields
1 BB
z   B   B
-0' (A.6)
where
I  =   .;1.  ,   z                                                                                                                    (A.D
The estimate for /3 follows from numerically solving (A.6) with respect to B,
whereafter the estimate for Bo directly follows from (A.5). An accurate solution of
(A.6) with respect to B is easily obtained in less than ten iterations with the
NEWTON-RAPHSON procedure  with B= 0 as starting value.
The estimated (asymptotic) covariance matrix of the ML-estimators for (Bo,B')
is the inverse of FISHER's information matrix:
-      221nL      - 821nL - -1 --1
BBO             0#0 8/3' 1  P
1
= -                                                                  (A.8)m
821nL 821nL - 1 828
BBOBB a BBB' f   B aBBB'_
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where
82 B- =  z ziz'iwiexpurz,) . (A.9)
aBBB, teH'
Hence, the estimated (co))variances are inversely proportional to m, and systemati-
cally insensitive  to the total number of subject-intervals  i E H'.  From  (A.6) it follows
that the estimated B-vectors are systematically insensitive to m and also to the total
number of subject-intervals  i EH', while the estimated Bo directly varies  with  the
ratio of these numbers, see (A.5).
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Chapter 5
Analysis of Total Mortality in the Rotterdam
Sample of the Kaunas-Rotterdam Intervention
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SUMMARY
In 3284 middle-aged Rotterdam men, the dependency of 9-year survival on a number of cardiovascular risk
factors is analysed. The purpose of this analysis is twofold. First, there is interest in the relationship betweentotal mortality and the continuous variables blood pressure and plasma cholesterol. in accordance with other
studies, the results provide further evidence for a U-shaped relationship. The second purpose is to compare
three models theoretically as well as empirically: a piecewise exponential distribution of survival time, Cox'sproportional hazards model (both with a log-linear dependency specification of the mortality rate), and a
logistic model. The disadvantage of a logistic model is that it is theoretically not appropriate in longitudinal(prospective) epidemiologic studies. The theoretical advantage of the piecewise exponential distribution toCox's model is that longitudinal (time) effects on the mortality rate can be specified and estimated directly.Empirically, with 342 deaths all three methods yield quite similar estimates and therefore are almost equallycapable of detecting relationships between mortality and the risk factors in the data set at hand.
KEY WORDS Epidemiology Mortality Cardiovascular disease Risk factors Logistic regressionCox regression Rate ratio Ageing
INTRODUCTION
In 1972 a representative sample of approximately 4000 men was drawn from the Rotterdam male
population aged 45 to 59. These men were invited to participate in the Kaunas-Rotterdam
Intervention Study (KRIS), a small-scale study aimed at testing the feasibility of carrying out a
double-blind randomized drug intervention trial in cardiovascular diseases in men, with special
interest in operational and behavioural aspects. This study was initiated by the World Health
Organization and consisted of two parallel studies carried out simultaneously in two different
health care systems: in Kaunas (Lithuanian SSR, USSR) and in Rotterdam (The Netherlands); see
Glasunow  et  at. 1
The purpose of this paper is twofold. First, the relationship between a number of explanatory
variables measured at entry in the study and the subsequent incidence of death during
approximately 9 years of follow-up of the Rotterdam sample is studied. The explanatory variables
used for the analysis may be characterized as somatic cardiovascular risk factors. Special interest
lies in a quadratic (U-shaped) relationship of the continuous variables with total mortality which,
02774715/87/040501-16$08.00 Received 24 February 1986
© 1987 by John Wiley & Sons, Ltd. Reuised  18  Nouember  1986
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according to Woodbury and Manton,2 should follow from the principle of homeostasis. Feinleib3
also mentioned the appropriateness ofa U-shaped relationship with total morbidity, and Tyroler et
al.4 observed such relationships in the Evans County study. Socio-demographic and psychological
risk factors for cardiovascular disease and their confounding with the somatic risk factors in the
Rotterdam study are dealt with elsewhere; see Appels and Mulder.5
The second purpose of this paper isan application and comparison ofvarious statistical methods
for analysing the data. Two different models will be used: a log-linear model for the mortality rate
and a logistic model for the mortality probability. For the log-linear rate model two estimation
methods are used: (i) a method based upon the (piecewise) exponential distribution ofsurvival time
(see  David and Moeschberger,6  Holford,7  and  Kalbfleisch  and  Prentice8);  and  (ii) Cox's
proportional hazards model.9·10 A rate model is theoretically more appropriate for analysing
survival data than a (logistic) probability model; however, the latter is often applied for this purpose
and is therefore also dealt with here. In this paper only mortality from all causes is considered an
endpoint. Subsequent analyses are now being performed for separate causes of mortality.
MATERIAL
The sample
From September 1972 until the end of 1973, 3365 Rotterdam men participated in an initial
screening examination of the KRIS which was the first of several selection stages for entry to the
intervention trial. This initial screening is the only extensive examination common to all 3365
participants. At the time of this examination a flagging procedure was started so that each subject
was followed through the population registers of Rotterdam and other Dutch municipalities, to
register one of two endpoints: emigration or death. Causes of death were obtained from the Dutch
Ministry of Health. A third endpoint is study termination on 1 March, 1982; this applies to all
subjects alive at that time in The Netherlands.
Of the 3365 participants, 3284 had complete observations on all the variables considered in this
paper. Of these, 342 died and 44 emigrated between the initial screening examination and the
censoring date of 1 March, 1982 Total follow-up amounts to 29,398 subject-years.
The sample does not represent a purely observational data set. Inevitably, participants as well as
their family doctors were informed of pathological findings and disorders and advice has been
given to change unhealthy habits. Such interventions are inevitable in observational studies when
subjects are aware of the results of medical examination. Also a group of approximately 600
subjects was randomized and 'treated' (either with placebos or with drugs) for several years in a
double-blind drug intervention trial for mild hypertension, hypercholesterolaemia or mild glucose
intolerance. This point will be discussed further.
The data
The explanatory variables measured at the initial screening examination and chosen as potential
prognostic factors in the mortality analyses are defined in Table I. The blood pressure
measurements are averages oftwo consecutive measurements. Cholesterol was measured in plasma
and  not in serum; the average ratio of serum to plasma cholesterol is  1 ·17. Age denotes age at entry,
that is, at the time of the initial screening examination. ECG anomaly 1 denotes (almost) certain
occurrence of previous myocardial infarction, while ECG anomaly 2 denotes probable occurrence.
Pipe and cigar smokers are considered non-cigarette smokers and no distinction is made between
ex-smokers and those who have never smoked, because almost all non-smokers were ex-smokers.
Table  1.   Selected variables measured in 3284 subjects participating in the initial screcningexamination of the Rotterdam sample in the Kaunas-Rotterdam Intervention study.
Variable Symbol Definition Frequency Minimum Maximum Mean Standard
deviation                K0
Systolic blood pressure SBP mmHg                                                                   84 246 138.1 20.2  Diastolic blood pressure DBP mmHg                                                                   26 164 80.0 121
Cholesterol CH mg/100 mi plasma 91 428
201.7           34.0               Age AGE years 44 ' 60 52.5 4.3
ECG anomaly  1 * ECGi 0 anomaly absent 3213                                                              2
1 anomaly present                              71                                                                              >
ECG anomaly 2 t ECG2 0 anomaly absent 3019
1 anomaly present 265
ECG anomalies  1*  and  2 t ECG 12 0 for both anomalies absent
2982                                                                
1 for only one anomaly present 268
2 for both anomalies present                     34                                                                                     kyAngina pectoris AP 0 for a non-positive Rose questionnaire 3094
1 for a positive Rose questionnaire (Rose                                                                                              @and Blackburn23) 190
Cigarette smoking SMOK       0 no
1200                                                               I yes 2084
Number of cigarettes smoked CIG 0 for none 12001 for 1-9 cigareues/day                          396                     1                                                                C2 for 10-19 cigarettes/day 836
3 for ) 20 cigarettes/day 852                                                                   ylDiabetes mellitus                    DM           0 no                                              3225                                                                                     M1 yes                                    59Alcohol use ALC 1 for no use or less than once a month 951
2 for a moderate amount regularly or daily     1825                                                                                                                                       H
3 for a large amount regularly or daily 508
Quetelet index Ql weight/height' (kg/m') 16·7 47·9 25 5 30           Education EDUC 1 primary 1294
2 primary + parttime
courses                           348                                                                                                                      3 lower vocational 349
4 lower vocational +
supplementary                                                                                                                                                                courses 352
5 advanced primary 119
6 advanced primary +
supplementary                                                                                                                                           courses 197
7 secondary 20
8 higher vocational 199
9 university
156                                                              SFollow-up time TIME years 002 9·46 8·46 1·57
.* Minnesota codes I- 1,2 t Minnesota codes 1-3, IV-1,2,3 V-1,2,3 and VII-1. -1
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The alcohol consumption variable is considered of little value a priori, as it is necessarily a poor
summarization of scores on a questionnaire which was too complicated for simple analysis. The
Quetelet Index is a measure of body fatness. The variable for education, defined by distinguishing
nine ordered categories typical for the Netherlands, is considered a proxy for socio-economic
status. Glucose tolerance, which was tested only in non-diabetic subjects, is not included as an
explanatory variable, because prior analyses indicated that it was unreliable due to the necessarily
far from ideal circumstances under which it was tested at the initial screening examination. Table I
also gives the frequencies for the categorical variables and the ranges, means and standard
deviations for continuous variables in the group of 3284 subjects. Besides the explanatory
variables above, the following two variables are also necessary for survival analysis:
(i)  the follow-up time, in years and also given in Table I;
(ii)  a 'failure' indicator, defined here as 0 for non-failure that is, true censoring (2898 subjects), 1
for failure due to death (342 subjects) and 2 for'failure' due to emigration (44 subjects). Here
emigration is considered a failure because an emigrant by definition no longer belongs to the
'population at risk', which is the above mentioned male population, alive in The Netherlands.




The purpose ofsurvival analysis is to examine the dependency ofa subject's stochastic survival time
on a number of explanatory variables. Survival time is defined as the time elapsed since the start of
follow-up (here the date of the initial screening examination) until either the occurrence of a
number of mutually exclusive, independent and competing 'failure' causes (here death and
emigration) or the occurrence of independent termination of a subject's follow-up, so-called
'censoring' (here the predetermined and fixed censoring date of 1  March,  1982, if a subject is still
alive in The Netherlands at that time). Separability of the likelihood function justifies failures from
causes other than the one of interest being placed in the censored group (see the Appendix). This
will indeed be done: mortality from all causes is the failure of interest and emigration is treated as
censoring. It is well-known from the theory ofcompeting risks that inter-dependency among some
failure rates is non-identifiable (see Tsiatist 1 ) unless it can be attributed to a number of measured
variables explaining these failure rates. For instance, a possible interdependency of mortality from
lung cancer and mortality from cardiovascular disease may (partly) be attributed to smoking as an
explanatory variable for both mortality rates.
The piecewise exponential distribution
The log likelihood function for the follow-up times ofall subjects is derived in the Appendix for the
case of multiple causes of failure. It is shown that for the failure of interest (here death) one may
maximize:
et,
In Li = I ln[.1,(ti)] - I 1 1,(x) dx,                     (1)
i in M wn H JO
where t, is the follow-up time (in years) of subject  i and 4 (t) is the mortality rate of subject i as a
function of time t. M is the set of subjects who died and H is the set of all subjects.
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At first the only simplifying assumption is that the mortality rate Ai (t) is a constant A'. Assuming
that A; is a log-linear function of age a, at the initial screening examination and of a vector of
covariables z, as measured in all subjects i at the initial screening examination:
A;  =  exp (/10 + B. a,+B'zi),                                                                                     (2)
the log likelihood function (1) reduces to
in Li =m/10+B. I a,+B' I zi-exp(Bo) I tiexp(#„a,+B'zi),         (3)
i in M i In M i in H
where m equals the number of subjects who died. This log likelihood is maximized with respect to
the coeflicients Bo, B. and B', with F a row vector o f coefficients belonging to the covariables in z.
Note that assuming a constant mortality rate A, implies an exponential distribution of survival time
for subject i.
The above assgmptions of constaot mortality Eates 4 and_dependincy on thecross-sectional age
structure at the initial screening examination theoretically allow only the coellicient B„ to be
interpreted as some autonomous birth cohort effect. This does not seem a very realistic assumption,
particularly since the obvious presence of ageing and, possibly, other time effects are disregarded.
To extract this longitudinal information we partition the total follow-up interval of a subject into a
number ofsubject-years and define a time variable t = 0,1,2, . . . for, the tst, 2nd, 3rd,. . . year of
follow-up, respectively; see also Holford.7 Next we model the possible behaviour of the
explanatory variables in time as follows.
The time dependency  of A, (t) is defined  as:
A,(t) = exp{yoty„(a; + t) ty'z,(t) ty,t}                                             (4)
with the variable a; + t denoting age at time t, the variable t an autonomous time trend and 4 (t) a
time-dependent vector o f other explanatory variables. A remaining dependency of.1, (t) on  age at
may be interpreted as a cohort effect. Time-dependent (for example, yearly) observations could be
used for z, (t) ifavailable. In the present study, only an initial measurement z, = z, (0) is available for
all subjects. Therefore, the vector z, (t) needs to be specified as some vector valued function of time t.
Considering only the set of linear functions of time  t,  z, (t) has the form:
z, (t) = zi + bt + Cz, t                                               (5)
where b is a column vector and C a matrix. Substitution  of z, (t) into A, (t) gives:
A,(t) -exp{yo + y.a; + ft + y'zi + y;zit}                                             (6)
with 9 = 7. + 7, +7'b and y; = y'C
The first hypothesis one might want to test is y*  = 0 (that is, C = 0, assuming y 0 0), implying no
interaction effects with time in zi (t). Another interesting hypothesis is 9  = y« (that is, y'b + 7,  =  0),
implying  that the combined  pure time effects  of the covariables  in  z; (t)  plus the effect  of  an
autonomous time trend are zero. If one accepts both hypotheses then:
A;(t)=exp{yoty„(a,+0+7'zi}.                                (7)
Note that for this specification the survival time distribution for subject i is a Gompertz-like
piecewise exponential distribution. Empirically, the estimated model (2) might approximate the
estimated model (7) very well. Model (7) uses an evaluation of the second summation term of the
log likelihood over the set of subject-years (see the Appendix); this set is approximately 9 times as
large as the set H of subjects needed for the estimation procedure with model (2). Model (2)
therefore requires much less CPU-time for the maximization of the log likelihood (1)and, ifindeed
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the estimates of models (2) and (7) compare very well, the simpler model (2) can be used for the
selection of explanatory variables. The maximization has been done by means of the
Newton-Raphson method using a FORTRAN program.
Cox's proportional hazards model
The partial likelihood as derived  by  Cox9·' o  is:
L2 =
H   <'1, (ti)     I    A, (ti)                                                                                    (8)
i in M C 1 r'nH.                              3
with H, the set of subjects r surviving just before the mortality time t, of subject i in set M and with
A, (t) specified as
A; (t)= 10(t) exp(8„a, + 8'z,),                                                       (9)
with  Ao (t) an unspecified time-dependent hazard function, which allows  one to argue  that  no
additional information about the coefficients 4 and 8' is obtained between any two adjacent
mortality times. The partial likelihood  (8) is only a function of 8. and 8', leaving the purely time-
dependent  part  Ao (t) as arbitrary and irrelevant  for the estimation  of 8. and  5'.  Note that  the
baseline hazard function.10 (t) is factored out from the partial likelihood function (8). Also note that
the values of the variables a, and z, in model (9) are those of one measurement point only (the initial
screening examination) and that longitudinal characteristics of the mortality rate can only be
estimated from (8) by the introduction of subject-dependent terms such as z, t in (9), as purely time-
dependent terms are factored out.
The log partial likelihood without interaction terms follows from expressions (8) and (9):
In Ll =8„ I a, to' I z,- I In< I exp(8„a,+3'z,) ,             (10)
i in M imM imM l r in H,
and is maximized with respect to 4 and J'. For this purpose program 2L of the BMDP-packagen
has been used.
LOGISTIC ANALYSIS
With logistic analysis the probability of death or survival (as a binary outcome) within some
specified time period of follow-up of a subject i, who participated in the initial screening
examination at the start of this period, is specified as a logistic function of age a, and covariable
vector  zi:
Pr[death lai, zi] = {1 + exp (- Co - Ga; - 6'z,)}-1 (11)
where Co, C. and row vector <' are estimated. However, logistic analysis does not utilize all the
information contained in the data of a prospective (incidence) study, see Green and Symons. 13
More specifically, logistic analysis does not take the actual follow-up times into account.
Consequently, only those subjects should be counted in the population at risk who (potentially)
have been followed for the whole predetermined time interval to which the logistic probability is
assumed to apply; see also Hauck:4 Moreover, when considering a long follow-up time interval in
which death is no longer a rare event, the time of death within the interval becomes a source of
information which cannot be neglected. One way of partly using this information is to partition a
subject's follow-up time into a number of fixed subject intervals, as in the section on piecewise
exponential distribution, and to apply a logistic analysis using binary outcomes observed in subject
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intervals; see Abbott. 15  As the overall survival probability of a subject over a long follow-up time
interval can be computed from multiplying the interval-specific survival probabilities over the
adjacent subject intervals constituting the total follow-up time interval, the simple logistic form
(11) is inconsistent with such a multiplication rule. These are a number of reasons why a logistic
analysis is theoretically less appropriate for modelling risk in a prospective (incidence) study. It is
more appropriate for cross-sectional (prevalence) studies, where follow-up time is not relevant.
Substituting Co + Gai + C'zi - y;  in the logistic function   (11) the likelihood function  is
proportional to
Lj= 1-1 {ltexp(-Yi)}-1 62 exp(-yi){1+exp(-yi)}-1 (12)
iin M i in H-M
= 11 exp(yi) 11 {1+exp(yi)}-1,
imM i in H
-   from- which-thefollowirrgloglikelihood-carrbe-deiived: -  -   -    -    -    -    -        -   -    -    -   - - - -     -   -
In L3 = I Yi- I ln{1+exp(y,)} (13)
i in M i in H
=m<o+C. I at+C' I z,- S ln{l+exp(Co+C„at+C'zi)}
i in M i in M i in H
This log likelihood is maximized with respect to Co, & and 6'. For this purpose program LR of the
BMDP   package12   has   been   used. For relatively rare events the functions   in   (2)   and   (11)
approximate each other very well if the #-coefficients are equal to the <-coefficients, and so the
estimated A-coefficients will approximate closely the estimated B-coefficients.
ESTIMATION RESULTS
Introduction
The major emphasis is on an application of the piecewise exponential survival time distribution
with a log-linear dependency model of the mortality rate, the results of which are compared with
those from Cox's proportional hazards model and from a logistic model of the mortality
probability. A criterion helpful for these comparisons, but used mainly for selection ofcovariables,
is the large-sample chi-square likelihood ratio statistic, defined as
X2LR(v) = 2(in Lf- ln Lr) (14)
with L fthe likelihood of the relevant full model and Lrthe likelihood ofa restricted (nested) model.
The number ofdegrees of freedom, v, is the difference between the number ofcovariables in the two
models.
Exponential distribution: covariable selection
For computational simplicity model (2), where the mortality rate is constant in time, is used to
select the set of covariables relevant for total mortality. The potential set of explanatory variables
are all covariables in Table I and their relevant squares. This potential set did not include
interaction terms other than those mentioned below in this section. The selection process was by
backwards elimination using judgement about the intercorrelations of the covariables, the
likelihood ratio chi-square statistic and the significance of the estimated coefficients. The set of
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covariables eventually selected was confirmed as the best set by an SPSS/PC16 stepwise regression
analysis with binary mortality outcome as the dependent variable and with the set of explanatory
variables entered initially into the regression model as independent variables. In the following
section it is checked whether the results with the selected set ofcovariables remain similar when the
computationally more complicated models (6) and (7) are assumed, that is, with longitudinal
information included in the mortality rate as described in the section on piecewise exponential
distribution. The set ofcovariables eventually selected, with their estimated coefficients (including
standard errors) and the likelihood ratio chi-square statistic for including all covariables listed in
addition to the constant, are presented as analysis (i) in Table II.
A remarkable result is that for systolic blood pressure, as well as for cholesterol, significant
effects on mortality rate are found only when both linear and quadratic terms are included in the
model despite the very high collinearity between the terms. This strongly confirms a U-shaped
relationship between mortality and these explanatory variables. This was tested with the likelihood
ratio test with a full model containing the 8 covariables listed in Table II. Significance levels (in the
individual tests) of 5 per cent  have been used throughout. Diastolic  (when used instead of systolic)
blood pressure had no significant effects on the mortality rate. As the separately estimated
coefficients ofthe ECG1 and ECG2 anomalies did not differ significantly from each other (0·73 and
0·82, respectively, with standard error of the difference equal to 0·30), both anomalies can be
combined into their sum ECG12; this has indeed been done for the reason of reaching convergence
in the numerical maximum likelihood procedure for all analyses performed in this paper.
Adding diabetes mellitus to the model containing the 8 covariables listed in Table II does not
give a significant improvement. Also no significant improvement results from adding education,
alcohol, Quetelet Index and their quadratic terms. With respect to smoking, the binary variable
'cigarette smoking' appears the only variable of interest; adding the number of cigarettes smoked
does not yield a significant improvement. This representation of smoking by two variables is made
because  it is hypothesized  that the effect of smoking  one  unit of cigarettes  (code 1) versus  non-
smoking (code 0) is different from that ofsmoking an additional unit ofcigarettes. Garrison et a/.17
found from the Framingham Heart Study data that 'lean smokers' demonstrate an excessive
mortality risk. This hypothesis has been tested here by adding the Quetelet Index, its quadratic
term and the interaction of both these terms with 'cigarette smoking' to the model; however these
terms did not yield a significant improvement. Finally, the interaction of age, as measured at the
initial screening, with the other 7 covariables listed in Table II has been investigated by adding 7
interaction terms to the model; this also does not yield a significant improvement. The likelihood
ratio tests used in this paragraph have been computed with a restricted model containing the 8
covariables listed in Table II.
Piecewise exponential distribution: variable rates
In models (6) and (7) follow-up time is included, together with the 8 covariables listed in Table II as
the discrete variable t = 0,1,2,..., measuring the (t + 1)th follow-up year ofa subject. The second
term of the log likelihood (1), where the summation is over subjects i in set H, is therefore evaluated
over the set of subject-years; this set is approximately 9 times as large as the set H of subjects. Of
course, computing time increases almost correspondingly.
In the first analysis the follow-up year t is simply added: this is model (6) without the interaction
variables z, t,  with  z, the vector of covariables of Table II, except  AGE. This already produces  a
substantial improvement in terms of the likelihood ratio test: Z&(1) = 21·762. In a second analysis
the interaction terms  zit  are also added,  so  as  to  test  y* = 0 in model  (6). No significant
improvement results from adding these 7 interaction terms, so that the hypothesis y* = 0 in model
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Table II Maximum likelihood estimates for four mortality analyses.
Analysis (i) Analysis (ii) Analysis (iii) Analysis (iv)
exponential piecewise exponential
distribution with distribution With
rate model (2) rate model (7) Cox's proportional logistic
(3284 subjects) (29,398 subject-years) hazards model (9) regression model (11)
Variable Coefficient (SE) Coefficient (SE) Coefficient (SE) Coefficient (SE)
Constant - 5·959 (1·764) -6-468  (1-746)                            -                - 2·757  (2-131)
SBP/10 - 0-325 (0·184) - 0-330 (0·184) -0·333 (0·185) - 0·441  (0-221)
SBP2/1000 0· 121 (0·060) 0-123 (0·060) 0·124 (0-060) 0·163 (0-073)
CH/10 -0·176 (0·077) - 0·176 (0·076) - 0-177 (0·076) - 0·237  (0·106)
CH2/1000 0·042 (0·017) 0·042 (0·017) 0·042 (0·017) 0·057 (0·024)
AGE* 0·093 (0·013) 0·095 (0·011) 0-094 (0·013) 0·100 (0-015)
SMOK  -   -  -  0464-(0120)-    --   - 0·472-(0·1203  -  -  -0·471- (0 120)  -  -  -0·518-(0131)
ECG12 0·785 (0·105) 0·803 (0·105) 0·803 (0·105) 0-909 (0·130)
AP 0-727 (0·164) 0-742 (0·164) 0·743 (0·164) 0·864 (0·193)
%6(8) 173·49 195·23 177·55 177·18
* AGE = age in year t in analysis (ii), age at initial screening (t = 0) in other analyses
(6) cannot be rejected. Going back to the first analysis, one may now test the equality of the
coefficients y« for age at and 9 for follow-up year t, assuming y* = 0. The estimated coefficients
equal 0·094 and 0·098 respectively; the estimated difference has a standard error ofO·025 and thus is
not significantly different from zero. This implies that age a, and follow-up year t can be combined
into age in year t as in model (7), which is a simple and appealing way to extract the longitudinal
information contained in the dataset at hand. Model (7) complies with the assumption that, for
given explanatory variables zi,longitudinal effects in the mortality rate only arise because o fageing,
there being no remaining dependency, as a cohort effect, on age a'.
The results of the analysis with model (7) are presented as analysis (ii) in Table  II. The estimates
are quite similar to those of analysis (i) in Table II, computed with model (2). Table III and
Figures 1 and 2 give an interpretation of the estimates with analysis (ii) in terms of the mortality
rate ratio. The minimum mortality points for systolic blood pressure and plasma cholesterol are
estimated from analysis (ii) as 134·1  mmHg and as 207·7 mg/100 mI, respectively. It is worth noting
that these estimated minimum mortality points are  near the sample means  of  138·l  mmHg  and
201·7 mg/100 ml for systolic blood pressure and plasma cholesterol, respectively; see Table I. The
estimated standard errors for the minimum mortality points are 13·3 mmHg and 5·7 mg/100 mi for
systolic blood pressure and plasma cholesterol, respectively; these have been calculated using a
theorem in Rao18 on the distribution of a function of statistics; the functions concerned have an
asymptotically normal distribution.
In Table IV 8-year observed and expected proportions of deaths among 3250 non-emigrant
subjects are broken down by classes of relevant covariables such as quintiles for the continuous
variables systolic blood pressure and cholesterol. The expected proportion of deaths in a class is
computed by averaging the following predicted 8-year mortality probabilities P; over the subjects i
in that class:
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Table Ill Effects of covariables on the mortality rate in terms of
the rate ratio (RR); interpretation of the estimated model (7).
Variable RR (SE 18)
AGE (1 year increase) 1·10 (0·013)
SMOK 1-60 (0·193)
ECG12 one anomaly present 2·23 (0·234)
both anomalies present 4-98 (1·046)
AP 2·10 (0·344)
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Figure 1. The predicted mortality rate ratio as a function of systolic blood pressure from the estimated model (7); the
minimum mortality point  is at  134·1  mmHg where the rate ratio equals  1  by definition
7
p,-1 -exp<-exp(yo+Y'z,+y«a,) I exp(y.t)                 (15)
'-0
exp (87.)-11
= 1-exp<-exp(yo + y'z,+yea,) exp(y.)- t f'
where the estimated coefficients are taken from analysis (ii) (Table II) so that the constant
{exp(87„)-  1}/{exp (y„) -1} equals  11·42. The observed and expected numbers (percentages) of 8-
year deaths equal 296 (9· 1 per cent) and 294· 1 (9· 1 per cent), respectively. The observed distributions
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Figure  2. The predicted mortality rate ratio as a function of plasma cholesterol from the estimated model (7); the minimum
mortality point is at 207·7 mg/100 ml where the rate ratio equals 1 by definition
of survivors and deaths over the classes do not differ significantly from the expected distributions.
Considering the distribution over the three age classes, representing three birth cohorts, there
seems to be no evidence for the presence of a cohort effect.
Comparison with Cox's proportional hazards model and logistic regression
In Table II the results of four analyses are presented together:
(i) exponential survival time distribution with rate model (2);
(ii) piecewise exponential (Gompertz-like) survival time distribution with rate model (7);
(iii) Cox's proportional hazards model;
(iv) logistic probability model.
For an interpretation of the estimated coefficients of all four analyses in Table II it must be noted
that in analyses (i) to (iii) logarithms of rate ratios are estimated and that in analysis (iv) logarithms
of probability odds ratios are estimated. As the logarithm of a rate ratio At /Ao is in an absolute
sense smaller than the logarithm of a corresponding 9-year probability odds ratio  {exp C - 9Ao) [l
-exp( - 9Al)]}/{exp(- 9.11) [1 -exp(- 910)] },it is expected that the estimated coefficients from
analysis (iv) are in an absolute sense larger than those from analyses (i) to (iii).
It is interesting to compare the chi-square likelihood ratio statistics for including all 8 covariables
in addition to the constant for these four analyses. It appears that analysis (ii) yields a substantially
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Table IV Comparison of observed and expected 8-year mortality (from the
estimated model (7)) in classes of relevant covariables.
Covariable Class Frequency Mortality percentage
observed expected
SBP 4 121 636 10·2 85
122-130 644 6·7               7·9
131-140 668 7·6 8·4
141-153 662 8·5 8·5
3 154 640 12·7 12·0
CH 4173 646 9·9               9·1
174-192 650 8·5 8·6
193-208 658 8·8               8·5
209-226 636 7·2 8·7
3 227 660 11·1 10·3
ECG12                         0 2951 7·7 7·6
1 265 20·0 20·3
2                      34 50·0 448
AP                                0 3061 8·3 8·3
1 189 21·7 22· 1
SMOK                       0                1184                   7·1                  7·2
1 2066 10·3 10·1
AGE 449 941                5·1               4·9
50-54 1157 7·4 7·6
3 55 1152 14· 1 13·9
total 3250                     9·1                    9-1
higher chi-square statistic than the other analyses, which results from the fact that the explanatory
variable AGE in analysis (ii) not only represents the cross-sectional age structure at the initial
screening examination, but, AGE being the sum of initial age and follow-up year t, also represents
the effect of (longitudinal) ageing, complying with a Gompertz survival time distribution. It further
appears that analyses (i), (iii) and (iv) yield approximately the same chi-square statistic where
particularly the logistic analysis (iv) merits some attention. As mentioned in the previous section,
logistic analysis does not utilize all the information from the data as the stochastic mortality
process is simply represented by a random binary outcome, whereas in the other analyses this
process is represented by the continuous random variable time to death. Hence, one would expect,
as  in  Green and Symons,13  the logistic analysis  (iv) to yield a markedly lower chi-square  than
analyses (i) and (iii), considering the long follow-up time interval of approximately 9 years. The
reason why not much information is lost by considering the stochastic mortality process only as a
simple random binary outcome, is the relatively small number of mortality cases despite the long
follow-up interval.
The empirical conclusions from the comparisons made in this section are that in the dataset at
hand all four analyses are almost equally capable of detecting relationships between mortality and
the explanatory variables and that the estimated coefficients of all four analyses are quite similar.
DISCUSSION
The variables considered in this paper (Table I) characteristically are the somatic cardiovascular
risk factors. Education is included as a proxy for socio-economic status, recently receiving
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attention in The Netherlands as a possible health indicator. lt appears to have no significant effect
on mortality in this study. As mentioned in the section 'Data', alcohol consumption had been
anticipated a poor variable in this study and, not surprisingly, appears to have no significant effect
on mortality. It is surprising that the Quetelet Index, considered a reliable measurement, has no
significant (quadratic) effect on mortality, which is in contrast to Tyroler et al.4 The number of
cigarettes smoked by a cigarette smoker has no significant effect on mortality in this study,
additionally to the significant effect of being a cigarette smoker. This might (partly) be a matter of
unreliability in the stated number of cigarettes smoked. The reason why smoking is represented by
these two variables is mentioned in the section on exponential distribution and covariable selection
What remains here as an explanatory set of variables for total mortality (Table 11) are the
traditional somatic cardiovascular risk factors. For the continuous variables systolic blood
pressure and plasma cholesterol, significant effects on mortality are found only when including
both the (almost perfectly collinear) linear and quadratic terms This strongly confirms the presence
of a U-shaped relationship. As indicated in the section on the sample, this relationship must be
-    -   -interpreted- under--the- conditions  of the -study  which include -a  drug-- intervention-trial  for         -    -   -
hypercholesterolaemia and mild hypertension. Of the total number of almost 30,000 subject-years,
only 1 per cent has been spent in the intervention trial for mild hypertension (initial levels between
160 and  190 mmHg systolic) and 5 per cent in the intervention trial for hypercholesterolaemia
(initial levels above 216 mg/100 ml plasma), including overlap. Considering that only half of these
numbers relate to drug treatment because of the randomization, and considering the observed
small effects of drugs on these covariables, 19 it seems reasonable to assume that there is at most a
very minor effect on the observational relationship studied.
From a competitive evaluation Brenn and Arnesen20 advocated stepwise discriminant analysis
as a preliminary for the CPU-time consuming stepwise analyses with logistic and Cox's regression.
In the previous section it was found that the set o f explanatory variables selected eventually with
model (2) was confirmed as a best set by a stepwise ordinary linear regression analysis with
SPSS/PC,16 which therefore also might be helpful as a preliminary stepwise variable selection tool.
In this paper two mathematical descriptions of the stochastic mortality process are considered: a
crude description in terms of probabilities of death during specified time intervals of follow-up
conditional upon being alive at the start of these intervals, and a more sophisticated description in
terms of mortality rates .1, with Adt the probability o f death during an infinitely small time interval
(t, t + dt), given alive at time t. When measuring the incidence of a relatively rare event, such as
mortality observed in a cohort over a small time interval, the distinction between a rate and a
probability may seem somewhat academic. However, a description in terms of rates is
mathematically much more convenient as a rate is related directly to the probability density
function of the continuous random variable time to death. This facilitates the generalization in
various directions, such as longer follow-up intervals where death becomes a much less rare event
and the presence of competing risks. when the total death rate is the sum of a number of cause
specific death rates. When using probabilities of binary outcomes in these more general
circumstances one may run into problems. since the information provided by a binary mortality
outcome gives too crude a description of the mortality process. If everyone has died, a binary
mortality outcome would give no information whatsoever, so that time to death remains the only
relevant outcome. Moreover, the simple logistic form of a survival probability is inconsistent with
the multiplication rule for such probabilities over adjacent time intervals: the probability of
surviving over two or more adjacent time intervals is obtained as the product o f the interval-specific
iurvival probabilities, which product has no longer the same simple logistic form as the interval-
specific probabilities. In describing the mortality process in terms of rates. two specifications have
been considered: a piecewise exponential survival time distribution and Cox's proportional hazards
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model. The advantage of the piecewise exponential distribution is that longitudinal time (age)
effects in the mortality rate can be specified and estimated. In this paper a Gompertz survival time
distribution (often considered appropriate for middle-aged human populations) and its de-
pendency on a number ofcovariables has been estimated. With the partial likelihood function used
for estimating Cox's proportional hazards model, an autonomous time dependency of the baseline
hazard function cannot be directly specified and estimated.
Another interesting point to discuss is the dependency specification. In this paper a log-linear
dependency model is chosen for rates, see expressions (2) and (9), and a logistic dependency model
is chosen for probabilities, see expression (11). The reasons for these choices are epidemiological
tradition and computational simplicity. Traditionally coefficients of the log-linear dependency
model represent logarithms of rate ratios and the coefficients of the logistic dependency model
represent logarithms of probability odds ratios, both ratios being well-known measures of
association in epidemiology. Computationally a log-linear function is always positive, as a rate
should be, and a logistic function is always in the interval (0,1), as a probability should be, without
the need to make any restrictions on the coefficients in either dependency model. It has to be
mentioned, however, that no clear biological mechanism leads to these dependency models and
that the mortality process is looked at in an isolated way.
Recent developments in this area (Woodbury et al.21 - 22) consider the total life trajectory of a
longitudinally followed cohort in the presence of the simultaneous processes of ageing and
mortality selection. Woodbury et al. postulate a fully saturated quadratic model (convexly shaped)
of the mortality rate, which they justify physiologically by the principle of homeostasis built into
their analytically tractable simultaneous equations model. The empirical results in this paper
confirm the U-shaped relationship as postulated by Woodbury et al. between the mortality rate and
the continuous explanatory covariables systolic blood pressure and plasma cholesterol, although
here as a quadratic function in the exponent, for ease of estimation. Also Tyroler et al.4 reported a
U-shaped relationship for the covariables cholesterol and Quetelet Index and Feinleib3 mentioned
the appropriateness of such a relationship for total morbidity risk. Ofcourse, one should be careful
when interpreting the increasing mortality rate associated with decreasing systolic blood pressure
or plasma cholesterol in terms of cause and effect.
APPENDIX: LOG LIKELIHOOD (1)
Subject i of the total cohort H is followed during the time interval [0, ti]. The only type ofcensoring
present is independent non-informative censoring, that is, censoring occurs independently of the
failure times and is non-informative about the parameters estimated. Two types of events are
defined for each subject i in H, the set of all subjects:
(i)    event Mo, occurring if the follow-up ends without failure  at a censored failure  time  ti;
(ii)  event Mju =1, . . . ,K) , occurring if the follow-up ends at stochastic time 4, produced by
failure cause j(j  =  1,  .      .,  K)
The set H i s partitioned into the sets M o,M t, · · · , Mk. Each subject i i n H belongs to exactly one
ofthese sets. This is also denoted by the zero-one indicators ti, 31 1,··  · ,8 Ki, which are defined as
3.· = 1 ifi belongs to Mj(j=0,1,.  .,K) and Oj, = 0 otherwise.B
The likelihood function L; for subject i in H can now be written as:
K
Li=[F.(t,)]4 11 [Aj,(ti)F(ti)]4                            (16)
j=l
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where Aj, (t,) is the failure rate at time t, from failure cause j (j  = 1, , K) and F, (t,) is the survival
function at time t, of subject i given by:
K        1 14*,-"p[-f {,il, i.tx,kdx]              (1, 
Expression (16) is equal to F, (t,) for subject i in Mo: this is the survival probability for
predetermined  time  t,   For a subject  i  in  Mi (j =1, .   . ,K) , the expression is equal  to
A" (t,)F, (t,)dt,;  this  is  the  probability  of failure from cause j at stochastic  time t, Because of
independence between subjects. the likelihood function for all subjects in H is
K
L = Il L, =  11  Fi  i, 11  I] Aj,(t,)F,(t,) (18)
in H i in Mo 1=1   l i n M,
This can be expressed in terms of the rates A ·· as follows:
J,
6=-A 1 n 4,(#, 11 exp[-fl,(x,dxll.               (19,
1 = I    lim M, i in H
which follows from the survival function (17) This implies that In L is additively separable with
respect  to the causes j =  1.  .    . ,K:
K(in L=  I i  I  in[Aj, (t,)]- I   ' Aj, (x) dx                                                 (20)
j -  1    1 i in M, i in H
A separate maximization for each failure cause j maximizes the log likelihood (20). Suppressing the
index j for a particular failure cause, one may maximize:
rt,
I  ln[i,(t,)] -  I   I   '1,(x) dx, (21)
In M i in H JO
which equals the log likelihood (1).
The extension to subject-years, assuming constancy of the failure rates .1„ in each year of the
follow-up interval, and with i now denoting subject-year i and w, the duration of subject-year i, is as
follows:
int=  I  4  I  In 4- I W. 6, 2 (22)j =  1     l lin M, i in H'               3
with Mjand H' now sets of subject-years The extension is useful when the A depend on time-
J1
dependent covariables measured at yearly time intervals, for example.
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Chapter 6
A FORTRAN Program for




In this paper a FORTRAN program is presented for multivariate survival or life
table regression analysis in a competing risks' situation. The relevant failure rate (for
example, a particular disease or mortality rate) is modelled as a log-linear function of
a vector of (possibly time-dependent) explanatory variables. The explanatory variables
may also include the variable time itself, which is useful for parameterizing piecewise
exponential time-to-failure distributions in a Gompertz like or Weibull like way as a
more efficient alternative to Cox's proportional hazards model. Maximum likelihood
estimates of the coefficients of the log-linear relationship are obtained from the iterative
Newton Raphson method. The program   runs   on a personal computer under   DOS ,
running time is quite acceptable, even for large samples.
1 Published in  Computer Methods and Programs in Biomedicine, 27 (1988) 175-188.
62
6.1 Introduction
In a prospective epidemiological or clinical study a population of subjects, iIiitially in a
failure-free ("healthy") state H, is followed in time. When subjects enter into the study
at study time t=0 they are characterized by the value z o f a vector of explanatory
variables. First, for simplicity's sake, it is assumed that t=O i s the only measurement
point  for  z. This assumption  can be relaxed easily  as  will be shown later-on. During
follow-up one of a number of mutually exclusive and competing failure types j  =1, . . . ,k
may occur to a subject, so that at the end of the follow-up study each subject belongs




The set Mo is the set of subjects who at the end of follow-up are still in state H.  The
follow-up of these subjects ends by a censoring process wliich is assumed to be inde-
pendent of the failure types and non-informative about the parameters to be estimated.
Sets  M j,j=1, . . . ,k,  are sets of subjects for whom follow-up ends with the occurrence
(incidence) of failure type j. The study time at which follow-up of subject i ends, either
by  censoring or  by  one  of the failure types, is denoted  by wi. Hence, each subject  i  and
his follow-up is characterized by the following set:
{Zi,j, Wi  ' j    =    0,1,...,k,            wi    2 0, (6.1)
with zi the vector of explanatory variables measured at entry into the study (at t = 0),
j a failure type indicator (with j=0 for non-failure or censoring) and wi denoting the
width of the follow-up interval ending with failure  type j.
In the set (6.1) j and w are simultaneous outcomes of random variables which are
dependent on the given vector z of explanatory variables. This dependency is specified
by  means  of a log-linear dependency model  for the failure rates  on  z, iii which  the
coefficients are estimated by the maximum likelihood method.
6.2 The Likelihood Function
In  order to formulate the likelihood function, first a failure rate function   A j, (t) >0
is defined, where A · (t)dt equals the (approximate) probability that subject  i. who isJ,
in  state  H at study  time  t  <   wi,   will experience failure  type  j   (j   = 1, . . . ,k)i n  a n
infinitesimally small time interval  (t, 1  + dt) while the subject  is  also  at  risk  of all other
failure types. Assuming independency between subjects, the likelihood function L for
all subjects' follow-up durations w, ending by failure cause j (Mj,j = 1,. . ., k) or by
non-failure (Mo)  can be formulated now as
1       [wiL=
H exp t- 1,  E A.,Ct) d,j x
t€Mo j=1




C r Wi C              fwi=  II i H exp t- 1    Aj,(t) dt   I-I Aji(wi) exp <- /    Aj,(t) dt   
1=1 li€Mo i€MlJo                              Jo
=   11 4 II A'.(w,) II exp (- /   At,(t) dt)   ,
1-1 l,EM, i€H             Jo
so that the log likelihood is additively separable with respect to the failure types j =
1,...,k:
lnL= El X ln(Aj,(wi)) - Z /  Aj,(t) dt  .         (6.2)
j= i     l  ie Mi i€HJO
Therefore, for each failure type a separate maximization procedure can be performed in
order to estimate coefficients characterizing the dependency (yet to be specified) of the
-failure-rates-on  tlie  vectoi  of explatiatory  variables (for  details see I4,  2  5]1.    -   -   -   -    -    -   - -
It is now supposed that the widths w, of the follow-up intervals are short enough (or
the time-behavior of the rates Xii (t) is slow enough) to justify the assumption that the
failure rates are constant in time and dependent on a vector of explanatory variables zi
as only measured at the start of the follow-up interval. Later-on it will be shown that
the approach for wider follow-up intervals and time-dependent explanatory variables is
not essentially different. Constancy in time of the failure rates reduces the log likelihood
(6.2) to:
lnL -E<Zln(Ai,)- S w,Ai,           (6.3)j-1  l i€Mi i€H j
Note that this log likelihood complies with an exponential time-to-failure distribution
for  j   and  i.
As a failure rate is positive it is mathematically convenient to specify a log-linear
dependency model for it, so that its coefficients can be estimated unrestrictedly:
Ali = Aj(zi) = exp(001 + /Izi), (6.4)
with scalar Boj and row vector 13)T the coefficients to be estimated. After substituting
the dependency model (6.4) into the log likelihood (6.3), choosing a particular failure
type j and suppressing the corresponding index j in the sequel. the log likelihood (6.3)
reduces to
tn L = m/90 + E BTzi -exp(Bo) X wiexp(BTzi), (6.5)
i€M ie H
with m the number of failing subjects in M.  This log likelihood has to be maximized
with respect to the constant Bo and the row vector  T.
6.3 Maximum Likelihood (ML) Estimation
The ML-estimator for the row vector of coefficients (Bo, FT) in model (6.4) follows from




BB-    = m -  B exp(Bo) =0 (6.6)
aln L r-. BB
-7-- = L zi - -exp(Bo) = 0, (6.7)BBi€M
where
B = E wi exp(BTzi), (6.8)
i€H
BB  '-
- = 2.i ziwi exp<BTzi). (6.9)BB i€H
Solving exp(Bo) from condition  (6.6)  as
exp(Bo)  =  (6.10)
and substituting this into condition (6.7) yields:
maB=o (6.11)
't Zi - 8 33-
The ML-estimate for B follows from numerically solving equation (6.11) with respect
to B, whereafter the estimate for Bo follows from equation (6.10).
Before dealing  with the Newton Raphson procedure for solving equation  (6.11)  for
0, let f denote the column vector of first partial derivatives as given in the left hand
side of equation (6.11) and S the matrix of second partial derivatives obtained from
differentiating the column vector f with respect to the row vector  T:
f=  Zi- -- (6.12)
m OB
B BBi€Af
s =BL  = m f  1  88 OB 1        B     )




808#T = L zizTwi
exp(BTz,) (6.14)
i€H
With the Newton Raphson procedure the equation (6.11) is iteratively solved for the
vector B. The value 3(n) for the estimate of B after the nth iteration is given by the
following recursive formula:
 (n) =  (,1 - 1) + h(n - 1), n=1,2,.... (6.15)
The change vector h(n - 1) is given by:
h(n -1)= -S-'f, (6.16)
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with S and f given in expressions (6.13) and (6.12), respectively, and evaluated for
0 =  (n - 1).  The starting value  (0) is the zero-vector. The value of the log likelihood
is obtained from substituting equation (6.10) into the log likelihood (6.5) and evaluating
it for B = B(n) after the nth iteration:
ln L= m ln(m) + E BTz, -mln(B) (6.17)
KM
The iterative procedure stops for such a value K#(n) that all elenients of the correspondiIlg
vector f of first partial derivatives are smaller than 0.001; usually this occurs after less
than 10 iterations.
The resulting stopping value  (n) is the maximum likelihood estimate of B with
which the maximum likelihood estimate of Bo is obtained from equation (6.10).  The
asymptotic covariance matrix of the ML-estimators for  (Bo, BT) is equal  to
/_ ln L      -aln L \ -1 /1    ET -1
 8 1 0130*,T 1    1 1
1   -02 ln L      -02 ln L j
= m  <
2
1 828 (6.18)
\    0/30 OB OBBPr 1 B 813813T j
evaluated at the stopping value 3(n) and with
2=l z z im
i€M
The corresponding value h(n - 1) equals the last change from 23(n - 1) to the stopping
value &(n).
6.4  Time-Dependency and Multiple Measurements
In practice the follow-up time intervals may be too wide to justify the assumption of
constant failure rates, or time-dependent variables z explaining the failure rates may
have been measured at several (more or less equidistant) time points for a subject.
In  either  case the solution is essentially  the same: partition each subject's follow-up
time interval into a number of subject-intervals (see also   [4]) and assume constancy
in these subject-intervals. This complies with a piecewise exponential time-to-failure
distribution.
An example will make this clear. Suppose a subject, initially at age 40, is followed for
3.5 years. His or her blood pressure has been measured four times: at entry (t = 0), after
the 1st year (t = 1), after the 2nd year (t = 2) and after the 3rd year (t = 3). Half-way
between the 3rd and 4th year the subject involved experiences a myocardial infarction
being the failure type of interest.  This one subject offers four subject-intervals, each
characterized by a set  {z, j, w} as defined in (6.1) and containing:
- the vector z denoting age, study time (t) and blood pressure at each measurement
point marking the lower limits of the four adjacent subject-intervals;
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- the indicator j denoting non-failure at the end of each of the first three subject-
intervals and the relevant failure (myocardial infarction) at the end of the fourth
subject-interval;
- the width w which equals 1 in the first three subject-intervals and 0.5 in the fourth.
In this case of multiple measurements of time-dependent explanatory variables a
number of re-arrangements of the data set and re-definitions is necessary in order to
being able to use the same log likelihood function (6.5):
(i)  records of the data set have to be defined as subject-intervals rather than as subjects;
(ii)  a time variable denoting study time can be included in each record of the data set
as one of the explanatory variables (the study time variable expresses how long a
subject has already been followed when entering a subject-interval) i
(iii)  the set M in the log likelihood (6.5) now has to be defined as the set of m subject-
intervals ending by the failure type of interest and the corresponding z, values are
those measured at the start of these m subject-intervals (of course, the number m
itself does not change);
(iv)  the set H now consists of all subject-intervals ending with or without the relevant
failure type and the corresponding z, values are those measured at the start of
these subject-intervals (of course, the number of subject-intervals is a multiple of
the number of subjects).
If there is only one measurement point of the explanatory variables at the start
of one whole (wide) follow-up interval, time-dependency can be taken into account by
manipulating the study time variable, possibly in combination with the once-measured
explanatory variables. It is not necessary in this case to actually re-arrange the data set
from subjects to subject-intervals. Instead, partition of the whole follow-up interval into
a number of smaller subject-intervals and definition of a discrete study time variable t
are done within the program itself rather than in the data set. The interpretation of the
sets M and II remains as defined above in (iii) and (iv), respectively. Using the study
time variable t directly as one of the explanatory variables in the dependency model
(6.4)  complies  with a Gompertz time-to-failure distribution, while using  ln t complies
with a Weibull time-to-failure distribution. This might be more efficient than using




The computer program is written in Olivetti MS-Fortran  (V3.13  Rl.0)  and runs under
MS-DOS (version 2.11) on an Olivetti M24 personal computer with 8087 coprocessor
and hard disk. The program reads and processes one record at a time and makes
several reading passes through the data. The advantage of this approach is that the
amount of addressable internal memory cannot become a limitation with increasing
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number of records in the data file. The disadvantage might be that data access causes
delay. However, running time appears to be quite acceptable when the data is made
directly accessible by recording it in an unformatted and binary way.  As a further
(marginal) improvement the data can be temporarily loaded internally on a virtual disk
(the RAMDISK facility in MS-DOS 2 which also operates in extended non-addressable
internal memory beyond the 640 Kb limit).
All real variables, except the data, are in double precision and use is made of a
subroutine DSYMINV, which  is the double precision version of algorithm   AS7    11,   for
inverting positive definite symmetric matrices by the Choleski decomposition method
CHOL, which is algorithm AS6 [1] in double precision.
The main program includes the above mentioned matrix subroutines and can be
used in its compiled form (object code). The setting of program parameters, opening of
input and output files and transformation of explanatory variables is done by means of
a series of subroutines which has to be compiled and linked to the main program before
exicutioil
6.5.2 Two Program Versions
As mentioned in Section 6.4 there are two versions (versions 1 and 2) of the program,
depending on the width of the follow-up interval.
Version 1 is used if follow-up intervals are small enough to justify the assumption
of constant failure rates in time.  In this case either there is a single measurement
of the explanatory variables or there are multiple measurements.  In case of a single
measurement each subject is represented by only one record (one follow-up interval) in
the data file, whereas in case of multiple measurements each subject is represented by a
corresponding number of subject-intervals as separate records in the data file. A study
time variable may be defined as one of the explanatory variables in the data set for each
subject-interval of a subject, expressing how long a subject has already been followed
when entering a subject-interval.
Version 2 is used if follow-up intervals are too wide to justify the assumption of
constant failure rates in time and if there is only a single measurement of the explanatory
variables at entry.  In this version a discrete variable study time (TI =0,1,2, . . . , INT(W))
is automatically created within the program in the same time units as in which the width
W is measured; hence, this has to be taken into account when defining W in the data file.
The study time variable TI expresses how long a subject has already been followed and
can be used as an explanatory variable along with the explanatory variables from the
data file measured once at entry.
6.5.3 Input Subroutines
As mentioned in Subsection 6.5.1 the input subroutines have to be specified, compiled
and linked to the main program before execution. These subroutines are listed in
Appendices A.1 and A.2 for versions 1 and 2, respectively.
The following input parameters have to be specified:
NVAR2 5 20: number of explanatory variables in the analysis,
K = 1,2,. . .:  failure type of interest,
68
NVARl 5 30. number of explanatory variables in the data set,
NITER: maximum number of iterations;
BMAX: maximum absolute value allowed for all coefficients in the vector   so
as to prevent under- or overflow during the iteration process.
The input and output files have to be specified. The input file is a binary data file
containing the following variables, analogously to expression (6.1):
ZR( 1),..., ZR(NVARl), XJ, W. These variables are defined as follows  in this order:
ZR(1),..., ZR(NVARl): the vector of explanatory variables as measured at the
start of a follow-up interval;
XJ: failure type indicator denoting one of the mutually exclusive failure types
(including non-failure) by which the follow-up interval ends;
W: width of the follow-up interval defined in the appropriate time unit.
For an actual analysis one may wish to recode the ZR variables, to use a subset of the
ZR variables or to use newly created explanatory variables out of the ZR variables. This is
also specified in the input subroutines, as a new vector Z( 1),..., Z(NVAR2) of explanatory
variables  has  to be created  from  the data vector  ZR( 1),..., ZR(NVARl )a s input vector
into the analysis. In version 2 also the automatically generated time variable TI is
involved here.
As an option a number of failure causes J can be combined into the one (K) of
interest.
6.5.4 Main Program Structure
The main program (here excluding the subroutines DSYMINV and CHOL, see Subsection
6.5.1) is listed in Appendices A.3 and A.4 for versions 1 and 2, respectively.
In the first reading pass through the data (version 1: lines 20 to 30) the relevant
parameters in the failing subset M are evaluated, such as the number of failing subjects
(m) and the sum of their zi values (see Section 6.3). Moreover, in version 2 (line 30)
the study time variable TI is created which can be used as an explanatory variable.
Second and further reading passes through  the data (version 1: lines  52  to  65)  are
made in order to evaluate the parameters which include the vector B of coefiicients: one
pass through the total set II for each iteration (version 1: lines 43 to 105). In each such
iteration pass the following parameters are calculated:
the vector (6.12) of first partial derivatives (version 1: line 74),
the matrix (6.13) of second partial derivatives (version 1: line 83),
the vector h of expression (6.16) (version 1:  line 99);
the resulting new vector B of expression (6.15) (version  1:  line  105);
the log likelihood (6.17) (version 1: line 66).
Moreover, in version  2 an additional DO-loop (version 2:  line  61) is inserted in order  to
create the study time variable TI which can be used as an explanatory variable.
When all first partial derivatives are smaller than 0.001, the asymptotic covariance
matrix (6.18), the corresponding correlation matrix and standard errors of estimate,
and the constant Bo of expression (6.10) are calculated (version 1:  as of line 106).
Table 6.1 is an alphabetical list of the relevant program parameters with reference
to their algebraic counterparts in the text.
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Program s=scalar Algebraic Reference to text
parameter v=vector counterpart
m matrix
B            v            B              (6.4)
BO             s               Bo                (6.4)
BMAX s Subsection 6.5.3
BZ       s BTZ (6.4)
COV m (6.18)
COVI m inverse of (6.18)
FPD            v               f                 (6.12)
H               v               h                 (6.16)
IPI  _     _    _s subject-interval counter
ITER s iteration counter
J             s             j               failure type
K                s                                    failure type of interest
M             s n (6.5)
NITER s Subsection 6.5.3
NPERS s number of subjects
NREC s number of subject-intervals
NVARl s Subsection 6.5.3
NVAR2 s Subsection 6.5.3
NVAR3 s NVAR2 + 1
RLNL              s                     ln L (6.17)
RM                    s m (6.5)
RML                s                     ln m (6.17)
SBZ         s            ,EM BTZ,   (6.17)
SEB              v standard error of estimated B
SPD m -S (6.13)
SPDI m -S-' (6.16)
SWE           s               B                 (6.8)
SZ             V               ZieM Zi (6.7)
SZWE v DBIBB (6.9)
SZZWE m   828/8#OBT (6.14)
TI            s                                Subsection 6.5.2
W            s            w              (6.1)
XJ            s              j                 (6.1)
Z              v              z                Subsection 6.5.3
ZR           v             z               Subsection 6.5.3




Output is written to a file (and also partly to screen) opened by means of the input
subroutines of Subsection 6.5.3. It is presented in Appendices A.5 and A.6 for versions
1  and  2  of the program, respectively. First the number of subjects ("PERSONS"),  the
number of subject-intervals ("RECORDS")  and the number of failure cases of the relevant
failure type are written. Further output contains for each iteration the value of the log
likelihood (6.17), the value of the vector # resulting from the previous iteration and the
corresponding values  of the first partial derivatives  (6.12). The value  of the vector  B
for which all first partial derivatives are smaller than 0.001 is considered the maximum
likelihood estimate for B. This value is also given together with its last change and the
estimated vector of standard errors. Also the estimated constant Bo with its standard
error is given. Finally, the estimated asymptotic covariance and correlation matrices
are written.
6.6  An Application
Table 6.2 gives a list of variables measured in 1972/73 at a screening examination in a
representative sample of 3,284 Rotterdam men aged 45-59. This data has been taken
from the Kaunas-Rotterdam Intervention Study,  see [3}. During approximately 9 years
of follow-up 342 mortality cases were observed in 29,398 subject-years; for details see
[6].
In this section these covariables and time measured in years will be used to estimate
a simple model of mortality (from all causes). The following failure rate, which is
constant within each year t following the screening examination, is assumed:
A(tlz) = exp(Bo + BA · AGE + Mt + BI,z),         t = 0,1,2 1•••' (6.19)
where AGE specifies age measured in 1972/73 and the other covariables measured in
1972/73 are assembled in the column vector z.  Note that this specification complies with
a Gompertz-like piecewise exponential survival time distribution as is often appropriate
in middle-aged human populations.
The significant covariables from the list in Table 6.2 are those with an explicitly
mentioned symbol. So the vector z now contains these covariables only. Version 2 of
the program is used in which the study time variable t is generated. The estimates are
taken from Appendix A.6 and presented in Table 6.3. As may be seen from Table 6.3
the variable t is combined with AGE, because the hypothesis BA = Bt could not be
rejected. The chi-square likelihood ratio test score is computed from Appendix A.6 as
2(1846.12256 - 1748.47308) = 195.299, which is twice the difference between the initial
(when all B coefficients are zero) and the final value of the log likelihood.
A same analysis is performed without the study time variable t by using version 1
of the program, the results of which are given in Appendix A.5.
Running times are approximately 8 and 35 minutes for version 1 and 2 respectively,
given the hardware conditions mentioned in Subsection 6.5.1 and the data set.
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Variable Definition Symbol
Systolic blood pressure mm Hg SBP
Diastolic blood pressure mm  Hg
Cholesterol mg/100 ml plasma CH
Age years AGE
Education ordered categories from
primary education (1)
to university (9)
ECG ano »ly- 1
-
= l for Minnesota_co%es ECG 1
I-1,2
= 0 elsewhere




Angina pectoris = 1 for a positive Rose AP
questionnaire [7]
= 0 elsewhere
Cigarette smoking = 1 yes SMOK
= 0 no
Number of cigarettes smoked   = 0 for none
= 1 for 1-9 per day
= 2 for 10-19 per day= 3 for 2 20 per day
Alcohol use = 1 for no use or less
than once a month
= 2 for regularly or daily
a moderate amount
= 3 for regularly or daily
a large amount
Quetelet index weight/height2  (kg/m2 )
Diabetes mellitus = 1 yes
= 0 no
Table 6.2: List of covariables.
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Variable Est. coeff. Est. SE t-ratio
0. constant -6.48486 1.74746 -3.711
1. SBP/10 -0.32722 0.18484 -1.770
2. SBP2/1000 0.12186 0.06008 2.028
3. CH/10 -0.17561 0.07629 -2.302
4. CH2/1000 0.04231 0.01666 2.540
5. AGE + t 0.09492 0.01140 8.326
6. ECG1 0.74920 0.22702 3.300
7. ECG2 0.83022 0.14628 5.676
8. AP 0.74590 0.16402 4.458
9. SMOK 0.47293 0.12028 3.932
likelihood ratiO XiR(9) = 195.299
Correlation matrix of estimated coefficients
0 1 2 3 4 56 78
0. 1.00
1. -0.79 1.00
2. 0.78 -0.99 1.00
3. -0.45 -0.03 0.02 1.00
4. 0.43 0.02 -0.01 -0.98 1.00
5. -0.38 0.02 -0.03 -0.03 0.04 1.00
6. 0.06 -0.04 0.04 -0.05 0.05 0.00 1.00
7. 0.01 0.04 -0.07 -0.03 0.02 -0.07 -0.28 1.00
8. -0.07 0.04 -0.03 0.10 -0.13 -0.02 -0.17 -0.09 1.00
9. -0.11 0.03 -0.02 0.03 -0.03 0.05 0.00 0.05 0.02
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Appendix A






C  SPECIFY PARAMETERS:
C  NVAR2 = NUMBER OF Z-VARIABLES IN MODEL;
C K = FAILURE TYPE OF INTEREST;
C  NVARl = NUMBER OF ZR-VARIABLES IN DATA SET;
C  NITER = MAXIMUM NUMBER OF ITERATIONS;
C  BMAX  = MAXIMUM VALUE ALLOWED FOR ABS(B).







C  OPEN DATAFILE (UNIT=1) AND OUTPUTFILE (UNIT=2); THE DATA FILE
C  MUST CONTAIN NVARl + 2 REALS PER RECORD IN THE FOLLOWING ORDER:
C  ZR(1),...,ZR(NVARl) = COVARIABLES;
C  XJ = FAILURE TYPE INDICATOR;













































C  SPECIFY PARAMETERS:
C  NVAR2 = NUMBER OF Z-VARIABLES IN MODEL (NVAR2 <= 20);
C K = FAILURE TYPE OF INTEREST;
C  NVARl = NUMBER OF ZR-VARIABLES IN DATA SET (NVARl <= 30);
C  NITER = MAXIMUM NUMBER OF ITERATIONS;








C  OPEN DATAFILE (UNIT=1) AND OUTPUTFILE (UNIT=2); THE BINARY DATA
C  FILE CONTAINS NVARl + 2 REALS PER RECORD IN THE FOLLOWING ORDER:
C  ZR(1),...,ZR(NVARl) = COVARIABLES;
C  XJ = FAILURE TYPE INDICATOR;
C  W = WIDTH OF FOLLOW-UP INTERVAL.


















































A.3    Listing of Program Version 1
1 C .1.  ...11111111111/11.  1..   111111111111/11111
2 C LIFE TABLE REGRESSION                     *
3 C VERSION 1:                          *
4 C CONSTANT FAILURE RATES                    *
5 C************************************************************
6       REAL Z(20),ZR(30),XJ,W
7       DOUBLE PRECISION BZ,RM,RML,TRM,RLNL,BO,WE,SWE,ZWE,SBZ,
8      *SF,TN 1N2,BN,BMAX,SZ(20),B(20),SZWE(20),H(20),FPD(20),
9      *SZZWE(20,20),SPD(20,20),SPDI(20,20),
10      *WKSPCE(21),SEB(21),
11      *COVI(21,21),COV(21,21),
12      *TEMP(231),TEMPI(231)
13       COMMON Z,ZR,NVAR2,NVARl,NITER,BMAX,J,K
14       CALL PAROPEN
15       NVAR3=NVAR2+1
16       DO 789 N=l,NVAR2
17   789 SZ(N)=0.
18       M=0
19       NREC=0
20 DO 20 NPERS=1,999999
21       READ(l,END=99)(ZR(N),N=l,NVARl),XJ,W
22 J=XJ+.5
23       CALL GROUPJ
24 NREC=NREC+1
25       IF(J.NE.K)GOTO 20
26       M=M+1
27       CALL ZZR
28       DO 5 I=l,NVAR2
29 5 SZ(I)=SZ(I)+Z(I)
30    20 CONTINUE
31    99 NPERS=NPERS-1
32 WRITE(2,104)NPERS
33       WRITE(2,105)NREC
34 WRITE(2,106)K,M
35       WRITE(*,104)NPERS
36       WRITE(*,105)NREC
37       WRITE(*,106)K,M
38 DO 55 N=l,NVAR2
39    55 B(N)=0.
40 RM=M
41       RML=DLOG(RM)
42       TRM=(RML-1.)*RM
43       DO 6 ITER=l,NITER
44 SBZ=0.
45 SWE=0.
46 DO 7 Nl=l,NVAR2
47 SZWE(Nl)=0.
48 SBZ=SBZ+B(Nl)*SZ(Nl)
49 DO 7 N2=l,NVAR2
50 7 SZZWE(N2,Nl)=0.
51       REWIND 1
52 DO 8 I=l,NPERS
53       READ(1)(ZR(N),N=l,NVARl),XJ,W
54 CALL ZZR
55       BZ=O.
56       DO 9 N=l,NVAR2
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57     9 BZ=BZ+Z(N)*B(N)
58       WE=W*DEXP(BZ)
59       SWE=SWE+WE
60 DO 10 Nl=l,NVAR2
61       ZWE=Z(Nl)*WE
62 SZWE(Nl)=SZWE(Nl)+ZWE





68       WRITE(2,109)RLNL
69 WRITE(2,110)
70       WRITE(*,108)ITER
71       WRITE(*,109)RLNL
72       WRITE(*,110)
73       DO 11 N=l,NVAR2
74 FPD(N)=SZ(N)-RM*SZWE(N)/SWE
75       WRITE(*,111)B(N),FPD(N)
76    11 WRITE(2,111)8(N),FPD(N)
77       DO 12 N=l,NVAR2
78       IF(DABS(FPD(N)).GT..001)GOTO 13
79    12 CONTINUE
80       GOTO 14
81    13 DO 15 Nl.1,NVAR2
82 DO 15 N2=1,NVAR2
83 15 SPD(N2,Nl)=RM*(SZZWE(N2,Nl)/SWE-SZWE(Nl)*SZWE(N2)/SWE**2)
84 DO 300 N2=l,NVAR2
85 DO 300 Nl=l,N2
86 NlN2=N2*(N2-1)/2+Nl
87   300 TEMP(NlN2)=SPD(Nl,N2)
88 CALL DSYMINV(TEMP,NVAR2,TEMPI,WKSPCE,NULLTY,IFAULT)
89 DO 310 N2=l,NVAR2
90 DO 310 Nl=l,N2




95       DO 200 N2=l,NVAR2
96 SF=0.
97       DO 210 Nl=l,NVAR2
98   210 SF=SF+SPDI(Nl,N2)*FPD(Nl)
99 200 H(N2)=SF







107 DO 16 Nl=2,NVAR3
108 COVI(Nl,1)=SZ(Nl-1)
109 COVI(l,Nl)=SZ(Nt-1)
110 DO 16 N2=2,NVAR3
111 16 COVI(N2,Nl)=RM*SZZWE(N2-1,Nl-1)/SWE
112 DO 400 N2=l,NVAR3





117 DO 410 N2=l,NVAR3















133   -    -DO-171- I=-1 ,NVAR3-   -   -   -    -   -    -           -   -   -    -    -  -    -    -   -        -    -  -     -        -
134 171 WRITE(2,116)(COV(J,I),J=l,NVAR3)
135 DO 18 Nl=l,NVAR3
136 DO 18 N2=l,NVAR3
137 18 COV(N2,Nl)=COV(N2,Nl)/(SEB(N2)*SEB(Nl))
138 WRITE(2,117)
139 DO 181 I=l,NVAR3
140 181 WRITE(2,118)(COV(J,I),J=l,NVAR3)
141 104 FORMAT(///,1H ,' TOTAL PERSONS',Ill)
142 105 FORMAT(1H ; TOTAL RECORDS',Ill)
143 106 FORMAT(1H ,' CASES TYPE',I3,Ill)
144 108 FORMAT(///,1H ,' ITERATION',I3)
145 109 FORMAT(1H ,' LOGLIK',F15.5)
146 110 FORMAT(1H ,; COEFFICIENT PART DER LOGLIK')
147 111 FORMAT(1H ,F20.5,E14.2)
148 112 FORMAT(///,1H ,' COEFF CONST',F 10.5,' (SE',F10.5,')')
149 113 FORMAT(/,1H ,' LST CHG COEFF SE')
150 114 FORMAT(1H ,E20.2,2F10.5)
151 115 FORMAT(///,1H ; COVARIANCE MATRIX')
152 116 FORMAT(/,1H ,1£13.4,6£11.4,2(lE14.4,6Ell.4))
153 117 FORMAT(///,1H ,' CORRELATION MATRIX')
154 118 FORMAT(/,1H ,1F7.4,20F8.4)
155 END
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A.4   Listing of Program Version 2
1 C************************************************************
2 C LIFE TABLE REGRESSION                     *
3 C VERSION 2:                         *
4 C TIME-DEPENDENT FAILURE RATES                 *
5 0 STUDY TIME TI = 0,1,2,...,INT[W]               *
6 C************************************************************
7       REAL Z(20),ZR(30),XJ,W,TI
8       DOUBLE PRECISION BZ,RM,RML,TRM,RLNL,BO,WE,SWE,ZWE,SBZ,
9      *SF,TN1N2,BN,BMAX,SZ(20),B(20),SZWE(20),H(20),FPD(20),
10      *SZZWE(20,20),SPD(20,20),SPDI(20,20),
11      *WKSPCE(21),SEB(21),
12      *COVI(21,21),COV(21,21),
13      *TEMP(231),TEMPI(231)
14       COMMON Z,ZR,NVAR2,NVARl,NITER,BMAX,J,K,TI
15       CALL PAROPEN
16       NVAR3=NVAR2+1
17       DO 789 N=l,NVAR2
18   789 SZ(N)=0.
19       M=0
20       NREC=0




25       IW=W
26 NREC=NREC+1+IW
27       IF(J.NE.K)GOTO 20
28       M=M+1
29       CALL ZZR
30 TI=IW
31       CALL ZZRTI
32       DO 5 I=l,NVAR2




37       WRITE(2,105)NREC
38 WRITE(2,106)K,M
39       WRITE(*,104)NPERS
40 WRITE(*,105)NREC
41       WRITE(*,106)K,M





47       DO 6 ITER=l,NITER
48 SBZ=0.
49 SWE=0.
50 DO 7 Nl=l,NVAR2
51       SZWE(Nl)=0.
52 SBZ=SBZ+B(Nl)*SZ(Nl)
53       DO 7 N2=l,NVAR2
54 7 SZZWE(N2,Nl)=0.
55       REWIND 1
56       DO 8 I=l,NPERS
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61       DO 8 IPI=l,IW
62       TI=IPI-1




67       DO 9 N=l,NVAR2
68 9 BZ=BZ+Z(N)*B(N)
69 WE=W*DEXP(BZ)
70       SWE=SWE+WE
71       DO 10 Nl=l,NVAR2
72       ZWE=Z(Nl)*WE
73       SZWE(Nl)=SZWE(Nl)+ZWE
74 DO 10 N2=l,NVAR2
75    - 10-SZZWE<N2,-Nl )=SZZWE(Ne,Nl)+2(N27*ZWE
76     8 CONTINUE
77       RLNL=TRM+SBZ-RM*DLOG(SWE)
78 WRITE(2,108)ITER
79 WRITE(2,109)RLNL
80       WRITE(2,110)
81       WRITE(*,108)ITER
82 WRITE(*,109)RLNL
83 WRITE(*,110)
84 DO 11 N=l,NVAR2
85       FPD(N)=SZ(N)-RM*SZWE(N)/SWE
86 WRITE(*,111)8(N),FPD(N)
87    11 WRITE(2,111)8(N),FPD(N)
88 DO 12 N=l,NVAR2
89 IF(DABS(FPD(N)).GT..001)GOTO 13
90 12 CONTINUE
91       GOTO 14
92 13 DO 15 Nl=l,NVAR2
93       DO 15 N2=l,NVAR2
94 15 SPD(N2,Nl)=RM*(SZZWE(N2,Nl)/SWE-SZWE(Nl)*SZWE(N2)/SWE**2)
95       DO 300 N2=l,NVAR2
96 DO 300 Nl=l,N2
97       NlN2=N2*(N2-1)/2+Nl
98 300 TEMP(NlN2)=SPD(Nl,N2)
99       CALL DSYMINV(TEMP,NVAR2,TEMPI,WKSPCE,NULLTY,IFAULT)
100 DO 310 N2=l,NVAR2





106 DO 200 N2=l,NVAR2
107 SF=0.
108 DO 210 Nl=l,NVAR2
109 210 SF=SF+SPDI(Nl,N2)*FPD(Nl)
110 200 H(N2)=SF








118 DO 16 Nl=2,NVAR3
119 COVI(Nl,1)=SZ(Nl-1)
120 COVI(1,Nl)=SZ(Nl-1)
121 DO 16 N2=2,NVAR3
122 16 COVI(N2,Nl)=RM*SZZWE(N2-1,Nl-1)/SWE
123 DO 400 N2=l,NVAR3




128 DO 410 N2=l,NVAR3















144 DO 171 I=l,NVAR3
145 171 WRITE(2,116)(COV(J,I),J=l,NVAR3)
146 DO 18 Nl=l,NVAR3
147 DO 18 N2=l,NVAR3
148 18 COV(N2,Nt)=COV(N2,Nl)/(SEB(N2)*SEB(Nl))
149 WRITE(2,117)
150 DO 181 I=l,NVAR3
151 181 WRITE(2,118)(COV(J,I),J=l,NVAR3)
152 104 FORMAT(///,1H ,' TOTAL PERSONS',Ill)
153 105 FORMAT(1H ,' TOTAL RECORDS',Ill)
154 106 FORMAT(1H ,' CASES TYPE',I3,Ill)
155 108 FORMAT(///,1H ,' ITERATION',I3)
156 109 FORMAT(1H ,' LOGLIK',F15.5)
157 110 FORMAT(1H ,' COEFFICIENT PART DER LOGLIK')
158 111 FORMAT(IH ,F20.5,E14.2)
159 112 FORMAT(///,1H ,' COEFF CONST',F 10.5,' (SE',F10.5,')')
160 113 FORMAT(/,1H ,' LST CHG COEFF SE')
161 114 FORMAT(1H ,E20.2,2F10.5)
162 115 FORMAT(///,1H ,' COVARIANCE MATRIX')
163 116 FORMAT(/,1H ,lE13.4,6Ell.4,2(lE14.4,6Ell.4))
164 117 FORMAT(///,1H ,' CORRELATION MATRIX')
165 118 FORMAT(/,1H ,1F7.4,20F8.4)
166 END
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A.5   Output of Program Version 1
TOTAL PERSONS 3284
TOTAL RECORDS 3284
CASES TYPE 1 342
ITERATION 1 ITERATION  5
LOGLIK -1846.12256 LOGLIK -1759.33644
COEFFICIENT PART DER LOGLIK COEFFICIENT PART DER LOGLIK
.00000 .13E+03 -.32225 -.46E-01
.00000 .42E+03 .12012 -.18E+00
.00000 .89E+02 -.17714 -.14E+01
.00000 .49E+03 .04256 -.81E+01
.00000 .66E+03 .09234 .22E+00
.00000 .18E+02 .72885 -.SlE-01
.00000 .46E+02 .81519 -.29£-01
.00000 .3OE+02 .73122 -.7OE-01
.00000 .27E+02 .46522 -.14E-01
ITERATION 2 ITERATION  6
LOGLIK -1825.78594 LOGLIK -1759.33572
COEFFICIENT PART DER LOGLIK COEFFICIENT PART DER LOGLIK
-.68253 -.23E+03 -.32186 .54£-03
.25192 -.76E+03 .11998 .15£-02
-.30936 -.45E+03 -.17508 -.llE-01
.07616 -.23E+04 .04205 -.65E-01
.08568 -.57E+02 .09235 .21E-02
1.50000 -.51£+02 .72672 -.48E-04
1.44017 -.75E+02 .81527 .3OE-05
1.26770 -.58E+02 .73095 -.41E-03
.42492 .71E+01 .46515 -.12E-03
ITERATION 3 ITERATION  7
LOGLIK -1764.26981 LOGLIK -1759.33572
COEFFICIENT PART DER LOGLIK COEFFICIENT PART DER LOGLIK
-.43102 -.SlE+02 -.32186 .49E-07
.16219 -.17E+03 .11998 .14E-06
-.22678 -.13£+03 -.17506 -.8OE-06
.05635 -.65E+03 .04204 -.49E-05
.08598 .19E+02 .09235 .15E-06
1.08082 -.12E+02 .72672 .38E-09
.86084 -.llE+02 .81527 .29E-08
.85829 -.12E+02 .73095 -.29£-07
.48458 -.81E+00 .46515 -.8SE-08
ITERATION 4 COEFF CONST -5.97819 (SE 1.76629)
LOGLIK -1759.49467
COEFFICIENT PART DER LOGLIK LST CHG COEFF SE
-.33835 -.49E+01 .12£-05 -.32186 .18410
.12611 -.17£+02 -.37E-06 .11998 .05983
-.19638 -.2OE+02 .18E-04 -.17506 .07692
.04739 -.11E+03 -.46E-05 .04204 .01683
.09184 .2OE+01 .28E-07 .09235 .01334
.79268 -.17E+01 -.17£-05 .72672 .22765
.81722 -.12E+01 .llE-05 .81527 .14702
.74413 -.16£+01 -.41E-06 .73095 .16460
.46846 -.22£+00 -.42E-07 .46515 .12024
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COVARIANCE MATRIX
.312OE+01 -.2527E+00 .8157£-01 -.6030E-01 .1256E-01 -.9526E-02
.2615E-01 .6996E-02 -.1644E-01 -.2233E-01
-.2527E+00 .3389£-01 -.10922-01 -.3972£-03 .6495E-04 .5059E-04
-.1775£-02 .1162E-02 .993OE-03 .50652-03
.8157E-01 -.1092E-01 .358OE-02 .8329E-04 -.1338£-04 -.3047E-04
.606OE-03 -.619OE-03 -.2609E-03 -.9993E-04
-.603OE-01 -.3972E-03 .8329E-04 .5916E-02 -.1272E-02 -.3508E-04
-.9898E-03 -.2534E-03 .1275E-02 .2799E-03
.1256£-01 .6495£-04 -.1338£-04 -.1272£-02 .2833E-03 .1116E-04
.1903E-03 .3528E-04 -.3725E-03 -.7019E-04
-.9526E-02 .5059E-04 -.3047E-04 -.3508£-04 .1116E-04 .178OE-03
-.4287E-04 -.2045E-03 -.9801E-04 .741 OE-04
.261 SE-01 -.1775£-02 .606OE-03 -.9898E-03 .1903E-03 -.4287E-04
.5183E-01 -.9343£-02 -.6598£-02 .4876E-04
.6996E-02 .1162E-02 -.6190E-03 -.2534E-03 .3528£-04 -.2045£-03
-.9343E-02 .2161E-01 -.2296E-02 .8197E-03
-.1644E-01 .993OE-03 -.2609E-03 .1275E-02 -.3725E-03 -.9801£-04
-.6598E-02 -.2296E-02 .2709E-01 .4085E-03
-.2233E-01 .5065E-03 -.9993E-04 .2799E-03 -.7019E-04 .741OE-04
.4876E-04 .8197E-03 .4085E-03 .1446£-01
CORRELATION MATRIX
1.0000 -.7770 .7718 -.4439 .4226 -.4042 .0650 .0269 -.0566 -.1051
-.7770 1.0000 -.9917 -.0281 .0210 .0206 -.0424 .0429 .0328 .0229
.7718 -.9917 1.0000 .0181 -.0133 -.0382 .0445 -.0704 -.0265 -.0139
-.4439 -.0281 .0181 1.0000 -.9824 -.0342 -.0565 -.0224 .1007 .0303
.4226 .0210 -.0133 -.9824 1.0000 .0497 .0497 .0143 -.1345 -.0347
-.4042 .0206 -.0382 -.0342 .0497 1.0000 -.0141 -.1042 -.0446 .0462
.0650 -.0424 .0445 -.0565 .0497 -.0141 1.0000 -.2792 -.1761 .0018
.0269 .0429 -.0704 -.0224 .0143 -.1042 -.2792 1.0000 -.0949 .0464
-.0566 .0328 -.0265 .1007 -.1345 -.0446 -.1761 -.0949 1.0000 .0206
-.1051 .0229 -.0139 .0303 -.0347 .0462 .0018 .0464 .0206 1.0000
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A.6    Output of Program Version 2
TOTAL PERSONS 3284
TOTAL RECORDS 29398
CASES TYPE 1 342
ITERATION 1 ITERATION  5
LOGLIK -1846.12256 LOGLIK -1748.47443
COEFFICIENT PART DER LOGLIK COEFFICIENT PART DER LOGLIK
.00000 .13E+03 -.32744 -.15E+00
.00000 .42E+03 .12194 -.46E+00
.00000 .89E+02 -.17754 -.16E+01
.00000 .49E+03 .04279 -.9OE+01
.00000 .8SE+03 .09489 .27E+00
.00000 .18E+02 .75691 -.18E+00
.00000 .46E+02 .83021 -.96E-01
.00000 .3OE+02 .74648 -.12E+00
.00000 .27E+02 .47311 -.13E-01
ITERATION 2 ITERATION  6
LOGLIK -1841.77663 LOGLIK -1748.47308
COEFFICIENT PART DER LOGLIK COEFFICIENT PART DER LOGLIK
-.68918 -.25E+03 -.32722 -.49£-04
.25405 -.82E+03 .12186 -.22E-03
-.31179 -.SlE+03 -.17563 -.12£-01
.07680 -.26E+04 .04231 -.68E-01
.08900 .19E+02 .09491 .22E-02
1.95876 -.79E+02 .74922 -.62E-03
1.44778 -.88E+02 .83021 -.3OE-03
1.27220 -.67E+02 .74590 -.6OE-03
.43035 .65E+01 .47293 -.llE-03
ITERATION 3 ITERATION  7
LOGLIK -1756.39007 LOGLIK -1748.47308
COEFFICIENT PART DER LOGLIK COEFFICIENT PART DER LOGLIK
-.39005 -.57E+02 -.32722 .33E-07
.14965 -.18E+03 .12186 .94E-07
-.21643 -.14E+03 -.17561 -.75E-06
.05449 -.73E+03 .04231 -.45E-05
.08728 .53E+02 .09492 .1SE-06
1.29821 -.18E+02 .74920 -.72E-08
.85980 -.13E+02 .83022 -.15E-08
.87650 -.14E+02 .74590 -.29E-07
.51971 -.26E+01 .47293 -.llE-07
ITERATION 4 COEFF CONST -6.48486 (SE 1.74746)
LOGLIK -1748.79611
COEFFICIENT PART DER LOGLIK LST CHG COEFF SE
-.33739 -.58E+01 .95£-06 -.32722 .18484
.12589 -.19E+02 -.32E-06 .12186 .06008
-.19527 -.23E+02 .17E-04 -.17561 .07629
.04728 -.12E+03 -.42E-05 .04231 .01666
.09430 .45E+01 .65E-07 .09492 .01140
.87908 -.33E+01 -.27E-04 .74920 .22702
.83339 -.21E+01 .6OE-06 .83022 .14628
.76470 -.22E+01 -.16£-05 .74590 .16402
.47920 -.33E+00 -.54E-06 .47293 .12028
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COVARIANCE MATRIX
.3054E+01 -.2539£+00 .8183£-01 -.5974E-01 .1244E-01 -.7539E-02
.2237E-01 .340OE-02 -.2022E-01 -.2268E-01
-.2539E+00 .3416E-01 -.1101E-01 -.3921E-03 .6379E-04 .3284E-04
-.1692E-02 .1181E-02 .1151£-02 .57282-03
.8183E-01 -.1101E-01 .361OE-02 .8009E-04 -.1267E-04 -.2039E-04
.5724E-03 -.6293£-03 -.32052-03 -.1191 E-03
-.5974E-01 -.3921E-03 .8009E-04 .582OE-02 -.1248E-02 -.2603E-04
-.9336E-03 -.2971E-03 .1250£-02 .2739E-03
.1244E-01 .6379E-04 -.1267E-04 -.1248E-02 .2774E-03 .8464E-05
.1770£-03 .4789E-04 -.364OE-03 -.6851E-04
-.7539E-02 .3284£-04 -.2039£-04 -.2603E-04 .8464E-05 .1299E-03
.6012E-05 -.1226E-03 -.4217£-04 .6579E-04
.2237E-01 -.1692E-02 .5724E-03 -. 9336E-03 .17702-03 .6012E-05
.5154E-01 -.9297E-02 -.632OE-02 .7158E-04
.340OE-02 .1181E-02 -.6293E-03 -.2971£-03 .4789E-04 -.1226E-03
-.9297E-02 .214OE-01 -.2248E-02 .8502E-03
-.2022E-01 .1151E-02 -.3205£-03 .125OE-02 -.364OE-03 -.4217E-04
-.632OE-02 -.2248E-02 .269OE-01 .4775E-03
-.2268E-01 .5728E-03 -.1191E-03 .2739E-03 -.6851 E-04 .6579E-04
.7158E-04 .8502E-03 .4775E-03 .1447E-01
CORRELATION MATRIX
1.0000 -.7862 .7795 -.4481 .4273 -.3785 .0564 .0133 -.0705 -.1079
-.7862 1.0000 -.9918 -.0278 .0207 .0156 -.0403 .0437 .0380 .0258
.7795 -.9918 1.0000 .0175 -.0127 -.0298 .0420 -.0716 -.0325 -.0165
-.4481 -.0278 .0175 1.0000 -.9822 -.0299 -.0539 -.0266 .0999 .0298
.4273 .0207 -.0127 -.9822 1.0000 .0446 .0468 .0197 -.1332 -.0342
-.3785 .0156 -.0298 -.0299 .0446 1.0000 .0023 -.0735 -.0226 .0480
.0564 -.0403 .0420 -.0539 .0468 .0023 1.0000 -.2800 -.1697 .0026
.0133 .0437 -.0716 -.0266 .0197 -.0735 -.2800 1.0000 -.0937 .0483
-.0705 .0380 -.0325 .0999 -.1332 -.0226 -.1697 -.0937 1.0000 .0242
-.1079 .0258 -.0165 .0298 -.0342 .0480 .0026 .0483 .0242 1.0000
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Chapter 7
The Simultaneous Processes of
Ageing and Mortality'
Paul G. H. Mulder
Abstract
When studying the stochastic process of mortality related to observed covariables in
a cohort of subjects followed in time, it is usually assumed that the observed covariables
are given, non-stochastic quantities.  In this way one can predict only a subject's survivor
function, given certain values of the covariables at baseline. Continuous covariables are
assumed to have (approximately) a multivariate Gaussian distribution in a cohort and
to evolve with random fluctuation in subjects as a consequence of ageing. Woodbury et
al. elaborated a model where this evolution-diffusion process (called ageing process) can
be incorporated and kept in balance by an appropriately modelled mortality selection
process, so that the distribution of the covariables in the cohort remains (approximately)
Gaussian. The analytical tractability of this model allows one to readily calculate
the cohort survivor function as ultimately being epidemiologically more relevant than
individual survivorship.
i Accepted for publication in Statistica Neeriandica
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7.1 Introduction
In traditional survival analysis interest lies in modelling and estimating the dependency
of mortality on certain non-stochastic explanatory characteristics (covariables).  The
dependency of the distribution of time to death t on (time-dependent) covariables zt is
specified through the hazard rate. Often  the most natural  (or at least most convenient)
specification chosen for the hazard rate A(tlzt)  is Cox's proportional hazards model  [l]
A(tlzt) = Ao(t) · exp(BTzt)
with  Ao(t) an arbitrary baseline hazard function and BT  a row vector of coefficients
which, by this specification, can be estimated in an unrestricted parameter space (see
KALBFLEISCH and PRENTICE  [4,  p  31]).    In  this  (more  or less freely chosen)  de-
pendency specification of the hazard rate, the values of the time-dependent covariables
observed in surviving subjects are considered non-stochastic. However, epidemiologic
relevance lies eventually in the population (cohort) life time distribution, rather than in
individual survivorship. Knowing the distribution of the covariables in a certain pop-
ulation allows one to calculate the mean hazard rate with respect to this distribution
as an epidemiologically relevant characteristic of the population. Of course, this dis-
tribution is not stable in time, in the first place because of survival selection. Second,
there is also the evolution in time of the time-dependent covariables within surviving
subjects. Once a certain functional form for this distribution at a certain time point is
established, consistency considerations should let this functional form be preserved in
time under these both simultaneously acting stochastic processes. Hence, the time path
of the directly observable distribution of the covariables is determined by the stochastic
mortality process as well as by the stochastic evolution (including random walk) of the
covariables within survivors. This distribution and its time path are needed to derive
the macro relationship between the evolution of the covariables and the population life
time distribution. The ultimate epidemiologic relevance of population based health in-
tervention measures lies in their effect on this evolution and so on the population life
time distribution.
Therefore, a macro oriented approach may be more promising for modelling mortal-
ity in a coliort. It is dealt with in this paper and it starts from the distribution of the
covariables in a surviving cohort. This distribution is influenced by the mortality selec-
tion process as well as the stochastic evolution of the covariables in surviving subjects,
which is called the ageing process. In this macro approach, initiated by WOODBURY
and MANTON  [8} and developed further by YASHIN et  al. [12], primary interest lies in
the evolution in time of the distribution of a vector of covariables in a surviving cohort
as the result of two simultaneously operating stochastic processes: ageing and mortality
selection. This evolution in continuous time is governed by the Kolmogorov-Fokker-
Planck (KFP) forward partial differential equation.
The mortality selection process involves the operation of a mortality rate depending
on the covariables. This mortality rate is considered a stochastic non-viability measure
associated with each point in the space of the covariables. In this space each subject has
a stochastic trajectory (including  "random walk")  as  long  as  he or she survives.   This
latter process is called ageing and it involves the evolution of the covariables with time
(=age) in surviving subjects of the cohort.
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These two simultaneously acting stochastic processes should keep each other in bal-
ance and, for reasons of consisteiicy, preserve a certain functional form (once estab-
lished) for the distribution of the covariables in the surviving cohort in the course of
time. WOODBURY and MANTON [8]have shown that the assumption of a Gaussian
distribution of the covariables in the surviving cohort allows one to find an analytical
expression for the evolution in tinie of its mean vector and covariance matrix, given
certain specifications for the ageing process and the mortality selection process.
The relevant specification for the mortality rate (from all causes) is a U-shaped
quadratic function of the covariables, meaning that the more extreme areas of the co-
variables space are associated with increasing mortality. Theoretical arguments for this
come from the biological principle of homeostasis, according to which there is a biologi-
cally determined viable range of covariate values outside of which non-viability rapidly
increases. As for the ageing process, the relevant specification is a first order autore-
gressive structure in the covariables, plus a random error term (random walk). These
two simultaneously acting processes let the form of the distribution of the covariables
in the surviving cohort remain Gaussian. These model specifications are realistic. In
various epidenziological studies a U-(or J-)shaped relation of certain Continuous covari-
ables with total mortality is found. For example, in the Kaunas-Rotterdam Intervention
Study (GLASUNOW et al. [2]), MULDER and HEMPENIUS  [6] found substantial ev-
idence for such a relationship between total mortality and the covariates systolic blood
pressure and cholesterol content: significance was obtained only after adding quadratic
terms of these covariates to a log-linear model for the mortality rate that was not
significant when containing linear terms. TYROLER et al. [7] observed such relation-
ships in the Evans County study. Continuous covariables (possibly after an appropriate
transformation) often have (approximately) a multivariate Gaussian distribution and
their evolution in time is almost always well represented by a first order autoregressive
structure.
The theoretical approach in continuous time with both processes acting truly si-
multaneously is dealt with in Section 7.4. Also in this section the complete continuous
likelihood function is derived. But first, for more insight, an intuitively clear and di-
rectly applicable formulation for discrete time is given in Section 7.2, with the complete
discrete likelihood function worked out in Section 7.3. It appears from this, as a general
result, that the ageing process and the mortality process can be estimated separately.
The formulas resulting from the continuous time model can also be obtained as a liin-
iting case of the formulas restilting from the discrete time model, which will be dealt
with at the end of Section 7.4. Section 7.5 shows how the life time distribution and life
expectancy of the cohort can be calculated, of which an illustration is giveii in Section
7.6.
7.2  Discrete Time
A cohort is followed in time. Time is considered a discrete variable by distinguishing
adjacent time intervals t = [t, t + 1) of unit length for t = 0,1,2,...  In each such
time interval two processes apply: mortality selection and ageing. WOODBURY and
MANTON [9} assume that these two processes operate consecutively within each time-
interval: first the mortality selection and, next, the ageing process.
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At the start of time interval t the distribution of the n vector of explanatory char-
acteristics (covariables) z in the surviving cohort is given by the multivariate normal
probability density function  h,(z)  with mean vector Ft and covariance matrix  Vt.  Dur-
ing time interval t the vector z is assumed to be constant so that during this interval
there is a mortality selection process with constant rate A(z) specified as a positive-
definite quadratic function of the covariables z:
A(z) = Bo + BTz +  zTBz, (7.1)
with Bo a constant scalar, B an n vector of coefficients for the linear effects of z on A and
B a symmetric n x n matrix of coefficients for the quadratic (and cross-product) effects
of z on A. The probability of surviving till the end of time interval t for given z and
conditional on being alive  at the start  of time interval t therefore equals  exp ( -A(z))
Just at the moment of entering period t+1 the ageing effect applies for survivors so as
to generate a new value of z from its previous value.
As a consequence of mortality selection during time interval t the density of the
covariables z in the cohort remaining at the end of time interval t becomes
ht(z)exp(-A(z))
h;(z) = _ (7.2)
qt
which, because of normality of hi  and the quadratic dependency specification (7.1) for
A(z), can be verified to be a multivariate normal density with mean vector B; and
covariance matrix It* as specified below in (7.4) and (7.5). The denominator 4-t is the
normalizing constant given by
t.  -   .1-1·   f_-  hiC,)"p (-'Cz))  dz                                            (703)
which is the proportion surviving during period t of the cohort entering period t alive.
Normality  of  h;(z)  in  (7.2) is easily verified with: the parameters  Fi,  VZ   and  0
expressible into the parameters  Ft  and  1/1  of h,(z)  with  Bo,  B  and  B  of A(z) as coeffi-
cients:
V,*  =  Di 14 (7.4)
B; = Dt (Ft - 1/t#) (7.5)
0 = ID,11/2 exp <-,90 - BTD:Bl +  BTD,VtB -  #zi'BD£#11           (7.6)
with the matrix Dt given by
Dt - (I + ViB)-' (7.7)
with I the identity matrix. Results (7.4) to (7.6) only represent the effect of mortality
selection during interval t = [t, t + 1), assuming constancy of z.
Ageing from period t t o period t+1 occurs only at  time t+1, the moment of entering
period t + 1, in the cohort remaining at time t + l. Just before that moment the normal
distribution of the covariables  z  is  h;(z)  in the surviving cohort with niean vector  p;
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and covariance matrix Vt* as derived above. The ageing process is represented by a first
order autoregressive structure
zi+, - zt = ao + Azt + 4 (7.8)
where ao is a column vector of n coefficients and A a n n x n matrix of coefficients.
The disturbance vector €t has a multivariate normal distribution with mean vector zero
and covariance niatrix E, independent  of zt · The right  hand  side of (7.8)  is  the sum of
three terms:  a term ao representing "drift",  a term Azi representing "regression"  and
a term Et representing "diffusion".
The ageing process (7.8) preserves normality and causes the normal distribution
h;(z) to be updated in time towards ht+1(z) in the cohort entering period t + 1 alive
with mean vector Fit+. and covariance matrix 14+1 given by
Ft+1 = B; + ao + Afi (7.9)
Vt+' = Vt* + Et Vt*AT-+ A'5* +AVt'AT.- - (7.10)
Consecutive application of, firstly, (7.4) and (7.5) and, secondly, (7.9) and (7.10) mimics
in discrete time the simultaneous processes in continuous time of mortality selection and
ageing during period t. The continuous time version will be dealt with in Section 7.4.
Constancy in time of the coefficients a.  and A in expression (7.8) and Bo, 0 and B
in expression (7.1) is not necessary for the derivation of the formulas (7.4) to (7.7), (7.9)
and (7.10); so the effect of time (= age) itself can be incorporated througli time-varying
coefficients.
7.3 The Complete Likelihood Function
The parameters ao, A and E of the autoregressive structure (7.8) aiid the parameters
Bo,  B  and  B  of  the  mortality  rate  (7.1)  can be estimated separately by maximum
likelihood methods. A sufficient condition for this is multiplicative separability of the
complete likelihood into parts with each set of parameters belonging to exactly one
such part. In this section it is shown that the complete likelihood function can be
multiplicatively separated into two parts: one part representing the ageing process
and the other part representing the mortality process. The latter part can again be
multiplicatively separated into various parts, each representing a certain death cause,
provided that t.he r.a.iise anrl t.he precise time of death are known. This information is
usually available in follow-up studies. Applications are given in WOODBURY et al.
[10, 11} although they only consider the binary mortality outcome (and not the precise
mortality time) in a discrete time interval.
As in Section 7.2, time is considered a discrete variable by distinguishing adjacent
time-intervals (periods)  t= [t, t+1) ,t=0,1,2, . . . . The covariables measured  at
the  start of period  t are denoted  by  zt. The probability density function  of  zo   in
the original cohort  at  time O i s denoted  by  ho(zo);  at the start of periods  1 2 1  the
conditional probability density function  of zt, given  zt-,, is denoted  by  ht(zt Izt-,),
t   =   1,2,...,   in the cohort entering period t alive.     Here  it is assumed   that   only   one
previous measurement zt_, explains the current measurement zt, although  this  is  not
a necessary restriction.
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Let Mt denote the set of subjects dying in period t 2 0.  A subject i in Mt is
assumed to die at the precise moment t + 19„ with 0 5 19, < 1. Within each period t the
mortality rate A(zt) is assumed to be constant in time. The likelihood Lio of subject i
in Mo having covariables zo, and dying in period 0 at time 0, then becomes
Lio = ho(zo,·)exp(-0,·A(zo,))A(zoi), i EMO. (7.11)
The  likelihood  L,1 of subject  i  in Afl having covariables  zoi,  z, i and dying in period  1
at time 1 + 19, becomes
Lit      ho(zoi) exp (-A(zo,)) x
x hi(zii'zoi)exp(-0,A(z,i))A(z,i), i E Afl. (7.12)
The  likelihood  Lit of subject i  i n M i having covariables  z o i,Z„ , . . . , Zt, and dying  iii
period t at time t + di, 1 2 2, equals
Ct-1
Lit      ho(zoi)exp(-A(zo,))1 H hr(zr,|z,--i,i)exp(-A(ZT,)) f x
ir=1
x ht(ztilzt-i,i)exp(-0,(zt,))1(zti), i €Mt,   1 22. (7.13)
The complete likelihood function is obtained from multiplying the above relevant like-
lihood terms (7.11) to (7.13) over all i in Mi and all t 2 0:
L=H H Lzt· (7.14)
1>0 :EM,
Here it is assumed that there is no censoring, although this could have been implemented
straightforwardly. The complete likelihood (7.14) is easily factored out into two parts:
L = L(1)L(2).
The first part L(1) represents the evolution of the covariables z and is given by
L(1) = fH ho(z.,).1 <II II II
h.(z..lz.-,&), 
(7.15)
liEH 3   1 121 ,€M, 7=1
with the set H denoting the total cohort at time 0. This part of the likelihood describes
(i) the covariables generated at the start of period 0 among the total cohort and (ii)
the covariables generated conditionally on one previous measurement among survivors
for further periods. The second part L(2) of the complete likelihood L represents the
survival (mortality) process and is given by
t-1
L(2)  =  H H Hexp(-A(Zr,)) X
t21 IEM, r=0
x  II II exp ( -0, A(zi, )) A(zti)· (7.16)
20 i€Mt
Hence, the evolutioii in time of the covariables among survivors and the dependency
model for the mortality  rate  A(z)  can be estimated separately by niaxiinum likelihood
methods applied to L(1) and L(2) given by (7.15) and (7.16) respectively.
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Cause-specific death rates Aj(z) are introduced now with j=1, . . . ,k indicating k
mutually exclusive death causes, such that the total death rate A(z) equals the sum of
the cause-specific rates  Aj (z). Correspondingly,  the  set  A.'It of subjects dying in period
t is partitioned into k mutually exclusive subsets Mj, with j denoting death cause
j=1, . . . ,k. The likelihood L(2) then becomes:
t-1         k
L(2,   =   II  11  II " p 1-E Aics.,)   *
t21 i€Mt r-0 < 1=1
<    k       k
x   H  H exp t-4 E A,(z'.) 1 H  II  A,(4),            (7.17)t20 i€Mt j=1 )  5-1 i€Mi,
which can be multiplicatively separated with respect to the death causes j=1, . . . ,k:
-   -   -  -  -  -k - -   - -f-+
L(2)  =  HII Il Hexp (-A,(z.,)) x
j=l t21 i€Me r-0
k           Il II < II exp(-0,Aj(z'.)) II Aj(z„) (7.18)j=1 t2O  < i€M, i€Mjt
Hence, the dependency models for the cause-specific death rates  Aj(z)  can be estimated
for each cause j separately by maximum likelihood methods.
7.4  Continuous Time
In the continuous time approach, introduced by WOODBURY and MANTON [81, the
processes of ageing and mortality selection operate simultaneously. In surviving subjects
of a cohort the evolution in continuous time (= age) of an n vector z of time-dependent
covariables is generated by the following Markov process:
dz = a(z)dt + de. (7.19)
In this stochastic differential equation a is an n vector valued function of z and d£
a random walk term which is an n vector Brownian motion with E(d£) = 0 and
E(d£deT)  =  E dt,  an n x n matrix. Equation (7.19) models the ageing process.   It
describes the stochastic time path of z for an arbitrary surviving subject and it influ-
ences the time path of the distribution of z in the surviving cohort. The second process
that also influences this distribution is the stochastic mortality process operating with
rate A(z) depending on z.
The time-behaviour of ht(z), the probability density function of z in the surviving
cohort at time t, is represented by a forward partial differential equation (the extended
KFP-equation, see MANTON et al. [5]) containing the effect of both simultaneous
processes:
aht = -   5(htai)  .  1  02 ht
-37- t; azi -1- 2, 9  aijaziazj·- Ah, + Atht, (7.20)
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with ai the ith element of the vector a, zi the ith element of the vector z, oij the
(i,j)th element of the matrix E and At  the mean mortality rate in the surviving cohort
at time t:
X. - fz 1- 1(z)ht(z) dz. (7.21)
+00
00
The right hand side of the differential equation (7.20) consists of four terms of which
the sum of the first two is called the forward diffusion operator of the process (7.19) (see
for instance JAZWINSKI [3, p 126]), the third term (-Aht) represents the influence of
the mortality selection (see WOODBURY and MANTON [8]) and Atht the normalizing
constant in order to have unit total mass under ht in the surviving cohort (see YASHIN
et al. [12]).
The following model specifications  will  be  made  now. The function  a(z)  in  the
ageing process (7.19) is a linear function of the time-dependent covariables z with
constant coefficients in time:
a(z) = ao + Az, (7.22)
with ao an n vector of constant coefficients representing the drift of z in time and
with A a n n x n matrix of coefficients representing the regression effect of z i n time.
Substituting the linear specification (7.22) into the Markov process (7.19) results in the
continuous representation of the autoregressive structure (7.8). The mortality rate  A(z)
is a positive-definite quadratic function of the covariables z as in expression (7.1).
In Appendix A it is shown that, if a normal probability density function hi and
the specifications (7.22) and (7.1) are substituted in the right-hand side of the KFP-
equation (7.20), the result is the partial derivative of a normal density ht with respect to
time t  if and only if its mean vector  Ft, its covariance matrix  Vt  and the mean mortality
rate At satisfy the following equations in the surviving cohort:
dVi- =E+ VgAT + AVt _ V:BVe (7.23)
dt
dpi
- = (ao - liB) + (A - VtB) Ft (7.24)
dt
4 =Bo + BT#11 +  pi'B/lt +  tr(Bl/t). (7.25)
Equation (7.25) is the mean mortality rate in the surviving cohort at time t which equals
the mathematical expectation  of  A   as  defined in expression  (7.1) with respect   to  any
multivariate density of z with mean vector Ft and covariance matrix Vt at time t.
For the one-dimensional case YASHIN et al. [12] give a formal proof for the preser-
vation of normality  of ht, assuming normality  at the origin  t   =  0. The differential
equations (7.23) and (7.24), which were derived by WOODBURY and MANTON [81,
are the multivariate generalizations of the one-dimensional results formally proved later
by YASHIN et al. [12].
Constancy  in  time  of the coefficients  in  ao  and  A of expression  (7.22)  and  in  Bo,
B  and  B of expression  (7.1)  is not necessary  for the derivation  of the formulas  ( 7.23)
to (7.25); so the effect of time (=age) itself can be incorporated through time-varying
coefficients.
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The complete continuous likelihood L(t) of a subject dying at time t with covariables
z(t) equals
/   It-    \
L(t) = exp <- i  AT d·r h,A(z(t)) (7.26)
JO
with the mean mortality rate AT given by expression (7.21). The covariables history
{1(7-) 0 5 7- <t}i s taken into account by expressing ht - ht (z(t)) in its history as
/ fti  \ht = ho exp l
Cl  r dh.)
Substituting dhr from the KFP-equation (7.20) yields for the likelihood (7.26) of a
subject dying at time t with covariables history {z(T)10 5 7- S t}
L(t) =
_ahrai-- - '1 1 -r" _ _ 02ht - - J exit
(--11,-tf 
-dr +T-  3 0 dr I x
azi(,r)        Jo  2hr 35  'Jazi(T)Bzj(T)     
x exp - A(z(r))dr A(z(t)), (7.27)f 
with ai  the  ith element of the vector a,  a· ·  the  (i, j )th element  of the matrix  E o f the,)
ageing process (7.19) and z,(t) the ith element of the vector z(t). Note again that the
likelihood (7.27) for a subject is factored out into two parts: the first part relating to
the ageing process (7.19) and the second part relating to the mortality process A(z).
For discrete time points t the appropriate difference equations for It and Bi could
be derived from (7.23) and (7.24) as
rt
Vt = Vo + / dV, (7.28)
Jo
it
111= 110 +  1 dp, (7.29)
Jo
However, (7.28) needs to be developed numerically, as equation (7.23) is a matrix Riccati
equation. This is not very practical. Therefore, the direct approach for discrete time as
dealt with in Section 7.2 is more useful.
Of coiirse, the contin110119 time eqtia.t,ions (7.23) t,0 (7.25) shoiild res1112 as limiting
forms of the discrete time equations of Section 7.2. This can be shown by applying the
discrete time approach for a small time interval of width dt.  In such a small interval the
survival probability becomes  exp(- At dt), implying  for the relevant coefficients  to  be-
come: scalar Bo dt, vector B dt and matrix B dt. The ageing process becomes as in (7.19)
and (7.22) with coefficients: vector ao dt and matrices  A dt and E dt. Consequently,
the squared and cross-product terms with B, B and A vanish when dt approaches zero
and the matrix Dt (formula (7.7)) becomes I - 1/tB dt. Recalculating the discrete re-
sults (7.4), (7.5), (7.9) and (7.10) for a small time interval dt, while taking the above
limiting properties into account, leads to the continuous time results (7.23) and (7.24).
Result (7.25) follows from (7.6), since exp(-A, dt) equals 1 - At dt and ln ID,1 equals
-tr(VtB dt), infinitesimally.
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7.5 Life Expectancy of a Cohort
The cohort survivor function Qi equals the proportion of the original cohort that sur-
vives at time t:
C rt
0' = exp l- A lTd, (7.30)
with At the mean mortality rate in the cohort at time t, which is determined by the
time paths of Vt and Ft as follows from equations (7.23) to (7.25). The ultimate effect
of population based health intervention programmes is reflected in the cohort survivor
function (7.30) through intervention-induced changes in the parameter matrix E, vector
ao and matrix A of the ageing process (7.19) specified as in (7.22).
An obvious parameter for characterizing the life time distribution of the cohort is
mean life expectancy LE given by
LE = - i=' t dQ"
Jo
which can be reformulated as
roo
LE =  /    Ot dt (7.31)
JO
as follows from integration by parts and from assuming that
lim 1Qi = 0·1-00
When time t is a discrete variable denoting interval [t, t + 1) as in Section 7.2,  the
cohort survivor function Qt is defined as the proportion of the cohort that enters interval
t alive and equals
41 - ( ,
fort=0
Illo qr   for 12 1. (7.32)
with 4t as in definition (7.3) and expression (7.6). Mean life expectancy LE in discrete
time is approximately given by
00
1
LE=5+Xot,                                  (7.33)
t=l
7.6 Illustrative Application
In 1972/73 a representative sample, drawn from the male population aged 45-59 of
the city of Rotterdam (The Netherlands), was screened for a number of cardiovascu-
lar risk factors because of the Kaunas-Rotterdam Intervention Study (KRIS), initiated
by the World Health Organization ( GLASUNOW  et  al.  [2]).   Part  of this study  was  a
monitoring of time and cause of death during 10 years of follow-up after the screening
examination of 2892 males in whom 206 deaths occurred. These 2892 men have been
selected  as  free of cardiovascular disease ( CVD-free)   from 3284 participants entering
the study with complete observations. For an application of the dynamic process as
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described by the equations (7.4) to (7.6), (7.9) and (7.10), interest lies in the depen-
dency of survival on the cardiovascular risk factors systolic blood pressure (SBP) and
cholesterol content (CH). In a former analysis, where this dependency was specified
as an exponential model for the mortality rate (MULDER and HEMPENIUS [6]), the
evidence for a U-shaped relationship was very strong. Now an additive quadratic rela-
tionship (after logarithmic transformation of SBP and CH) is specified by means of the
proportional hazards model
As (t Zl, 12) -
As(t) I  1 + 191%1 + 132z2 +   11z  +  19224 + 1912zlej , (7.34)
where S denotes two strata (smokers and non-smokers), t is age, zl is ln(SBP) (with
SBP in mm Hg) and z  is ln(CH) (with CH in mg/100 ml plasma). The baseline hazard
function As(t) is specified and estimated in a second stage (after estimation of the B
coefficients in model (134)) as
As(t) = exp (70 + 7sS + 7tt) (7.35)
where S equals 0 for non-smokers and 1 for smokers. Note that this is a Gompertz
function of age (see also MANTON et al. [51). Both expressions (7.34) and (7.35)
constitute the mortality process (7.1) with age-dependent B coefEcients.
The B coefficients in the model (7.34) are estimated under the condition that ex-
pression (7.34) is positive. Age (instead of follow-up time) is used as the time variable
t in the smoking-specific baseline hazard function As(t). In contrast to the capability
of the model to take account of time-dependency (ageing) in the covariables, the KRIS
offers only one measurement wave (viz., the initial screening examination at the start
of the 10 years follow-up period) in the population as a whole for estimating the models
(7.34) and (7.35). Given the estimated B coefficients, the values of the baseline hazard
function AS(t), obtained each time a mortality case occurred in each of both smoking
strata, are summed so as to get yearly rates for each year-of-age available and then, in a
second stage, regressed upon smoking status S and age t according to the model (7.35)
by means of a non-linear regression method with an additive error term. When testing
the goodness-of-fit of the model, this appears to better reproduce the observed age-
dependency and the observed total number of mortality cases in the sample than using
ordinary linear regression of the logarithmically transformed baseline hazard function.
Because of the availability of only one measurement wave of the covariables, part of the
effect of age t in model (7.35) might bc duc to thc agcing process of the covariables.  This
might have harmed somewhat the estimated B and 7 coefficients as they are listed in
Table 7.1, presumably not so much as to become useless for this illustrative application.
The coefficients of the ageing process (7.8) cannot be estimated with only one mea-
surement wave. Using the information available from the KRIS about the correlation
of zl =ln(SBP) with z2=ln(CH) and about the cross-sectional dependency of these vari-
ables on age, the following relationship for the ageing process (7.8) is settled as not too
unrealistically for illustrative purposes only:
Zil    =   0.672 + 0.8011,1-1 + 0·0612,2-1 + El (7.36)











Table 7.1: Estimated B and 7 coefficients of the dependency models (7.34) and (7.35)
for the mortality rate.
The residual terms El and 62 have variances al and a  set at 0.0061 and 0.01, respec-
tively, and are considered to be uncorrelated: 012 = 0. Starting values for the mean
vector Bo and (co)variance matrix Vo of zl and z2 are estimated from the KRIS as
follows: means 4.910 and 5.287, variances 0.019 and 0.029 and covariance 0.00235. The
ageing process is assumed to be independent of smoking in this illustration.
Given the mortality selection process (7.34) and (7.35) with the estimated B and 7
coefficients as in Table 7.1, life expectancy for CVD-free male smokers and non-smokers
of age 50 may now be calculated. This is done by successive application of, firstly, the
mortality process (7.4) and (7.5), and, secondly, the ageing process (7.9) and (7.10) in
each year t. Also the yearly survival probabilities *as in expression (7.6) are calculated
each year, from which the cumulative survival probabilities Qi as in expression (7.32)
and mean life expectancy as in expression (7.33) are calculated. The results show that
the effect of smoking is more than a 5 years decrement of longevity as of age 50: mean
life expectancy is 31.0 years for a 50 years old male CVD-free non-smoker and 25.7 years
for a smoker. In Table 7.2 the projected survivor probabilities and means and variances
of zl and z2 are presented for smokers and non-smokers at the beginning of each five
years age interval. Initially, as of the age of 50, the means of zi and z2 and the variance
of z2 increase with age, apparently due to the ageing process (7.36). As of the age of
75, the mortality selection seems to become more predominant, causing the means and
variances to decrease with age. The respective projected cohort survivor functions are
depicted in Figure 7.1, calculated in each year of age.  Mean life expectancy is simply
the area under the curve of these functions. It should be emphasized that these results
are based upon partly fictitious parameter values and so serve illustrative purposes only.
7.7 Discussion
In the approach dealt with in this paper the mortality process and the evolution of
its explanatory characteristics among survivors of a human cohort followed in time are
considered simultaneous stochastic processes consistent with the distribution of these
characteristics among survivors. Multivariate normality is an obvious choice if one
wishes to parameterize this distribution and it is a key assumption by which an analyt-
ically tractable way for modelling the total life trajectory of a cohort can be reached.
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NON-SMOKERS SMOKERS
age surv. ln(SBP) ln(CH) surv. ln(SBP) ln(CH)
prob. mean var. mean var. prob. mean var. mean var.
50 1.000 4.910 .019 5.287 .029 1.000 4.910 .019 5.287 .029
55 .984 4.935 .019 5.294 .031 .971 4.935 .019 5.294 .031
60 .957 4.944 .019 5.301 .032 .922 4.944 .019 5.301 .032
65 .913 4.949 .019 5.306 .032 .844 4.948 .019 5.306 .032
70 .842 4.950 .019 5.308 .032 .728 4.950 .019 5.307 .032
75 .735 4.951 .019 5.309 .032 .566 4.950 .019 5.308 .031
80 .584 4.950 .019 5.308 .031 .371 4.948 .019 5.307 .030
85 .396 4.949 .019 5.307 .031 .183 4.946 .018 5.305 .029
90 .207 4.947 .018 5.305 .030 .056 4.942 .017 5.302 .028
-95 - 470-  -4-943 -.0117  -5.302 - .028 - -008 -4.938 -  .016 -  5.298-    .-026-   -        -     - -     -
100 .011 4.939 .016 5.299 .026 .000 4.932 .015 5.295 .024
105 .001 4.933 .015 5.296 .024 .000 4.927 .014 5.292 .021
Table 7.2: Projected survivor function and means and variances of ln(SBP) and ln(CH)











so    60    78    80    gb   100
AGE
Figure 7.1: Projected survivor function of a 50 years old CVD-free male cohort of
smokers (lower curve) and non-smokers (upper curve).
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A necessary condition is that the relationship of the explanatory characteristics with
total mortality is positive-definite quadratic. As mentioned before, there are theoretical
(biological) arguments and empirical evidence in favour of this condition. Some binary
explanatory variables used in empirical applications (e.g., smoking, problem drinking)
are in fact dichotomizations of underlying continuous variables which better may be used
as such in the theoretical analysis, provided that they are (approximately) Gaussian.
Certain covariables do not easily obey the model assumptions: categorical variables
generated by some jump process, such as place of residence, marital status, profession.
One might condition on these covariables in the processes of ageing and mortality.
For estimation, only the discrete time approach dealt with in sections 7.2 and 7.3 is
feasible. This is also because of practical reasons: in epidemiological follow-up studies
the continuous covariables are usually measured at regular (equidistant) discrete time
points. The derivation of the complete likelihood function in Section 7.3 is general in
that there are no specific assumptions made about the dependency of the mortality
selection on the covariables or about the dynamics of the covariables. Special attention
is  needed when estimating the quadratic dependency model  (7.1)  for the mortality  rate
A(z). This dependency specification can be reformulated as
,(,)-(,  'T ) (  '   i#„- ) ( : ) . (7.37)
The maximum likelihood procedure has to be performed under the constraint that the
symmetric matrix of B coefficients in the specification (7.37) is positive-definite.  As A(z)
is usually very small, non-standard statistical problems may arise in interval estimation
and testing of the B coefEcients near the boundary of the restricted parameter space.
An advantage of this dependency model is that when k mutually exclusive death causes
j   -   1, . . . ,k   are  considered,  each  with  mortality  rate  Aj(z )  with  own matrix of    B i
coefricients, then the B coefficients of the total (all causes) mortality rate are the siims
over j  of the cause specific  Bj  coefficients. This should  hold  also for their consistent
ML-estimates when using the likelihood (7.18). Another advantage of this dependency
model is that the mean mortality rate does not depend on the functional form of the
pdf  of the covariables  z,  only on their mean vector and covariance matrix, as follows
from (7.25). In the illustration (Section 7.6) only the restriction was made that A(z)
remained positive  over the observed range of values  of z, which suffices  for  the  data  set
at hand to yield estimates satisfying positive-definiteness of the quadratic form.
In Section 7.5 it was shown how mean life expectancy of a cohort can be calculated
from the cohort survivor distribution. The analytical tractability of the approach re-
viewed in this paper allows a quick computation of mean life expectancy as shown in the
illustrative application of Section 7.6. The sensitivity to intervention induced changes
in the dynamics of the covariables can also be quickly analysed. Typical scenarios that
can be evaluated within the framework of this approach are linear transformations of
the covariables. These scenarios can then be mutually compared as for their efTect on
the cohort life time distribution. This is beyond the scope of this paper, however.
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Appendix A
Verification of Equations (7.23) to
(7.25)
The n vector z at time t has a multivariate normal density ht with mean vector Ft and
covariance matrix It both depending on t:
ht(z) = (27r)-"/2 1141-1/2 exp  -  (z - Ft)TVt-'(z - pt) . (A.1)
From (A.1) the partial differential quotient Oln hi/Ot can be calculated as follows:
a ln ht 1      C    _,dVt)      1-at     -   -itr (Vt   -Iir) + 2(z - pt)T Vt-' (Z - Ft) +
df  1. _ ,
+- 7,    CZ - Ft)· (A.2)
dt
This differential quotient is also obtained from reformulating the extended
Kolmogorov-Fokker-Planck equation (7.20) as
aln hi r*     aln ht      IL Da,
m        -    -  2«°L'Bzi   -  2-' -BII +
1-1 1=l
„             C 82 1n h• Dlnht alnht)
+ 2  E  01'  C Ozioz,
. - · -1-A t At. (A.3)
Dz,    azi  )
i, j= 1
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Using expressions (7.22), (7.1) and (A.1) into (A.3) produces
alnht
at
(ao + Az)7'Vt-'(z - Bi) - tr(A) -  tr(EV,-') + (A.4)
t (z - Ft)TVt-'EVE-'(z - pt) -Bo - BTz -  zTBz + At.
Assuming that (A.2) and (A.4) are identical functions of z, one may equate the terms
of (A.2) and (A.4) that are quadratic in z, yielding equation (7.23). Similarly, one
may equate the terms of (A.2) and (A.4) that are linear in z and use result (7.23)already found, yielding equation (7.24). Finally, equating the remaining terms of (A.2)
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Abstract
Survival analysis only concerns the effect of covariate values on a subject's sur-
vivorship. Continuous covariables are assumed to have (approximately) a multivariate
Gaussian distribution in a population of subjects and to evolve with time within sub-
jects as a consequence of ageing.  In a more elaborate model these dynamics in the
continuous covariables are incorporated and are kept in balance by an appropriately
modelled mortality selection, so that the multivariate distribution of the covariables re-
Inains (approximately) Gaussian in a population while ageing. An analytically tractable
model due to Woodbury et al. will be used in this paper in order to show how the ef-
fect of population-based health intervention programmes on the population's life time
distribution can be evaluated from a decision-theoretical point of view.
1 Submitted for publication in the European Journal of Epidemiology
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8.1 Introduction
Survival analysis is a widely used statistical tool in epidemiologic research. What epi-
demiologists may not realize, is that, by only performing a survival analysis, they are
focusing on a smaller part of the real world than they mean to. Survival analysis is only
concerned with modelling and estimating a relationship between a number of (possibly
time-dependent) explanatory variables as observed in individuals and survivorship of
these individuals. In a real world situation, concerning some population, the epidemio-
logically relevant question often is (or should be): how do certain explanatory variables
affect the life time distribution in that population. Notice that survival analysis is a
micro approach, while the above question requires a macro one. The following example
will serve to make this distinction clearer.
From survival analysis it is known that there is a relationship between cholesterol
content and (cardiovascular) mortality. This micro result of numerous survival stud-
ies all over the world has led to macro recommendations in the field of population-
based health education: "eat less saturated fats" and "have your cholesterol regularly
checked". The epidemiologically relevant question  is:   what  can we expect  to  be  the
effects of these macro recommendations on the life time distribution in the population.
Do they increase life expectancy and by how much? Do they increase the cardiovas-
cular disease-free proportion of the population and its disease-free component of life
expectancy and by how much? Survival analysis suggests qualitative answers to these
questions, but cannot give numerical answers.
Woodbury and Manton [8] have incorporated the survival analysis in a more elab-
orate model with which the above questions can be answered. A technical overview of
this model and its development is given in Chapter 6. In this paper, first the argu-
mentation leading to the model and an introduction to the model are presented. The
main purpose of this paper is to show how the outcomes of the model can be used to
evaluate life time from a decision-theoretical point of view. An illustrative application
is presented which shows how population based health intervention scenarios can be
evaluated after being incorporated in the model.
8.2   Definition of the Problem
The presently living population is an aggregate of the currently surviving portions of all
historical birth cohorts. Throughout this paper we will define our starting population
as a birth cohort, which is the elementary population in which we may properly define
the problem at hand. Suppose that we follow a birth cohort in the course of time as of
a certain age (which need not be the age of birth). We observe in this cohort mortality
of its individuals and we measure yearly in surviving individuals a continuous vector
of variables zt that we find relevant for explaining mortality. The subscript t denotes
time, which, by definition, is perfectly correlated with age in a birth cohort, so that we
will use age and time interchangeably. By means of survival analysis we can estimate
the effect  of the vector of covariables  zt  on the mortality rate A(tlzt),  if we postulate
some mathematical relationship, e.g.,
A(tlzt) = Ao(t) · exp (BTzt) ,
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which  is the well-known Cox proportional hazards model  [ll.    In this model  the  mor-
tality rate is proportional to an arbitrary baseline hazard function Ao(t). Usually, a
multiplicative dependency on zt is specified: the coefficients in the vector B, denoting
the effects to be estimated, may be interpreted as logarithms of rate ratios of unit in-
crements in the variables zt. Throughout this paper the superscript T denotes vector
(or matrix) transposition.
Now, it is important to note that in the above relation we consider zt to be a given,
non-stochastic vector and that we rather ad hoc, for statistical convenience, postulated
the above mentioned dependency model  of  A  on zt. Actually,   we  have  kept  our  eyes
Closed for the, in principle, directly observable distribution of zt and the way in which
this distribution evolves with time (= age) t in the surviving cohort. This distribution is
affected i.a. by the way in which mortality (or survival) selects individuals, and it may
well be possible that the postulated mortality relation is incompatible with the actual
evolution of this distribution. Hence, discarding the assumption that the vector zt is
.giyen_and-non-slgchastic,_In_eans that_wf_masile longer ad hec postulate a_dependency_
model of A on zt, and that we have to confine ourselves to a model of mortality selection
that is compatible with the (evolution of the) distribution of zt in the surviving cohort.
Aside from the mortality process, there is another process that also affects the dis-
tribution of the covariables zt in the surviving cohort, viz., the "ageing process" of
the individuals in whom ze is measured. The subscript t is meant to denote that the
covariables zt vary with time (= age) within individuals as long as they survive. This
variation  with  age  can be modelled by some tracking model,  i.e., the currently observed
value of zt in an individual subject may partly be explained by ante-dependency on
the observed values  of zt-„zt-7,  · · · ,zo, which  are the so-called regression effects  in
Zt. Further, there may be some shift with age t of the distribution of zt and there is
a stochastic error term which  is also called "random  walk". This random  walk  term
causes a diffusion in the way individual subjects keep their relative position in the dis-
tribution of zt in the surviving cohort when growing older. This whole process is called
the ageing process, which also has to be compatible with the distribution of zt in the
surviving cohort.
We can conclude that, when a birth cohort is followed as of a certain time t=0
(which need not be the time of birth) with a known original distribution of the vector
of covariables z in the cohort, then the time path of this distribution is completely
determined by the following two simultaneous stochastic processes to which the cohort
is subjected when growing older: mortality selection and ageing. As this time path
has to satisfy certain requirements, one cannot ad hoc choose a relationship between
the covariable vector zt and the mortality rate A for the stochastic mortality selection
process, nor can one, for the stochastic ageing process, ad hoc choose a tracking model
for zt, describing the evolution  of zt in individuals of the cohort  as  long  as they survive.
These two simultaneous processes should be modelled in such a way that they keep
each other in balance and that they are compatible with the time path of the directly
observable distribution of zt in the surviving cohort.
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8.3 The Model
Woodbury and Manton [81 found that a multivariate normal (Gaussian) distribution
of a vector of covariables zt in the surviving cohort is compatible with (i) a mortality
selection process, where the mortality rate of a subject i can be specified as a U-shaped
(positive definite) quadratic function of z.,t:
1(zit) = Bo + BTZ,1 -1-  zl;Bz, (8.1)
and (ii) an ageing process, specifying that the change Azit in zit is a linear function of
the level  zil  plus a so-called random walk  term  E,t:
dz,t = ao + Azit -1- Eit· (8.2)
In the quadratic dependency model  (8.1)  Bo  is a constant scalar,  B a vector of linear
effects of zil and B a matrix with elements B · of quadratic and cross-product effects,]
of zit on A. These /3 coefficients have to be restricted so as to keep the mortality rate
A  U-shaped and positive for all zit;  see the Appendix.   In the ageing process  (8.2)  ao  is
a  vector of shift parameters  and  A a matrix of regression parameters  aij.   The  random
walk Eit is Gaussian with mean vector zero and (co)variance matrix E (also called the
diffusion matrix)   with   elements   a,j. For notational   sake  all   a,   B  and  a   coefficients
are considered time-independent, although this is not a necessary restriction. In the
illustrative application (Section 8.6), concerning a bivariate case, i.e., two z variables,
we will use time-dependent B coefficients; see expressions (8.6) and (8.7). A bivariate
example of the ageing process (8.2) is given by the two expressions (8.8).
Starting from time t=0 with a cohort in which the explanatory vector of covariables
zo   is normally distributed  with iriean vector  Bo and (co)variance matrix  Vo,  it   can
be shown that, when the cohort is subjected to the simultaneously acting stochastic
processes (8.1) and (8.2) while growing older, the vector of explanatory variables zt
remains normally distributed  with  mean  Ft and (co)variance matrix Vt, which  can
be  expressed  into   the B parameters  of the mortality process  (8.1)   and   the   a   and  a
parameters of the ageing process (8.2). The exact expressions for the time paths of the
mean  vector and (co)variance matrix (which  can be derived  from the processes  (8.1)
and (8.2) acting truly simultaneously in continuous time) are not directly empirically
applicable. Therefore, Woodbury and Manton [9] developed a discrete approximation,
which is close to the practice with whicli epicleiniologic observational studies are carried
out and hence is empirically applicable. They go about as follows.
As in the previous section, suppose that a birth cohort is followed in time, that at
yearly time intervals a vector of explanatory variables is measured in surviving individu-
als and that also their mortality is monitored. Within the relatively small time interval
of a year (small with respect to the total life time of the cohort) Woodbury and Man-
ton [9] assume that the mortality process and the ageing process operate consecutively:
first mortality and then ageing. The effect of the two simultaneously acting processes in
continuous time is mimicked by dividing time into small equidistant intervals in which
the two stochastic processes operate consecutively.
At the start of year i the explanatory vector of variables zi is measured in all
surviving individuals of the cohort, with z, having a normal distribution with mean
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vector Ft and (co)variance matrix It. During year t the variables zt are assumed to
remain constant within individuals, so that the same holds for the mortality rate A.
During the year only mortality selection takes place, which affects the mean vector
Ft   and the (co)variance matrix  Vt,  so  as to become  B;   and  Vi*;   see the Appendix,
formulas (A.2) to (A.4). The starred parameters hold for the proportion qi of the
cohort that, after having entered  year t alive, survives  till  the  end  of  the  year,  with  qt
given by formula (A.5) of the Appendix. The parameters p;, Vi' and qi result only
from mortality selection during year t while assuming zt constant and so are affected
only by the B coefficients in the mortality rate (8.1).
At the end of the year t the ageing process (8.2) produces a change Azt = Zt+1 - zt·
This process operates  now  on  the  mean  B; and variance  Vt; just before the surviving
proportion qi of the cohort enters year t + 1, causing B; and 1/,* to be updated towards
Ft+1 and Vt+1, given by formulas (A.6) and (A.7) of the Appendix.  Here, of course,
only the a and a parameters of the ageing process (8.2) play their part. Now the circle
is round for the-next  year-t  +-1.-
In each year t the probability qt (formula (A.5) of the Appendix) is calculated, which
is the probability of surviving during year t for an arbitrary subject of the cohort who
enters year t alive. These probabilities can be used to evaluate life expectancy of the
cohort.
8.4 Life Expectancy
The survivor function for the cohort describes how the size of the cohort drops off while
ageing. The survivor function is 1 at the start of year 0, it becomes qo at the start of
year  1,  qo  x  qi   at the start of year 2, qo x qi x q2 at the start of year 3, and so on.  So,
the survivor function Qi at the start of year t equals:
fl for t=0
Qi =    liSt q,   for t 21. (8.3)
Under certain regularity conditions (see the Appendix) life expectancy of the cohort
can be defined  as  the area under the survivor function  Qt.   This  area  can be approxi-
niated by
LE =   +   ot,                                            (8.4)
t=1
where LE denotes life expectancy.
By means of population based health intervention strategies the a and a parameters
of the ageing process can be changed. Through successive application of the equations
(A.2) to (A.4) and (A.6), (A.7) of the Appendix, those changes also affect the year-
specific survival probabilities qt in equation (A.5) of the Appendix, which in their turn
affect life expectancy LE through the eqiiations (8.3) and (8.4). Hence, effects on life
expectancy are readily and quickly calculated by simply looping through a series of
analytical expressions. Hence, also all kinds of sensitivity analyses can be performed on
the Hy
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8.5 Proper Evaluation of Life Time
In the previous section it was seen how intervention-induced changes in the cohort
survivor function can be evaluated through life expectancy, which simply is the mean of
the cohort life time distribution. However, it is well known that the mean is not always
an adequate parameter for judging changes in a distribution.  A more appropriate and
unique way of evaluation is offered by the statistical decision theory. According to
this theory, changes in a distribution can be judged through expected utility, of course
after first having defined a utility function U(t) on the random variable life time t. The
function U(t) is a positive, monotonically increasing function, unique up to an increasing
linear transformation. Its form may be convex, linear or concave, corresponding with
the behaviour of the decision-making agency as, respectively, risk-taking. risk-neutral or
risk-avoiding.  A life time probability function with higher expected utility is preferred to
one with lower expected utility by the decision-making agency; see for instance DeGroot
[2, Ch 7].
From the utility function U(t) of life time t, one may define the marginal utility
function u(t) = dU/dt, which is the utility of the t-th year of life, whereas U(t) is the
utility of the whole accumulated life time as of age 0 to age t. Under certain regularity
conditions (see the Appendix), it can be derived that expected utility E(U) can be
approximated by
00
E(U) = ug) + X u(t)Qt, (8.5)
t=1
where Qt is the survivor function (8.3) of the cohort.
We will now show that the marginal utility function u(t) may, less formally, also
be called the discounted QALY-function (Quality Adjusted Life Year); see for instance
Weinstein and Stason [7}. In order to specify the utility function U(t), it is more natural
to specify the marginal utility function u(t), which is the utility of the t-tli year of life.
Suppose that at t=0 the decision-making agency has to decide upon the introduction
of a population-based health intervention policy for a 30 years old male cohort. The
decision-making agency has to take into account that in a birth cohort time t means
time as well  as age: actually, age equals  30 + t  in this cohort. Hence, the marginal utility
function has to be considered a composite preference index of a single point t of time
and  of a single point  30 +  t  (in this cohort)  of  age.    As an example  of age preference,
the decision-making agency might prefer, on average, a person in his fortieth year as
more productive to society than when that person would be in his thirtieth year of age.
Time preference may, however, be the opposite: society prefers having the productivity
of a person coming available now to having it ten years later coming available. Both
components   (the age preference  part   and   the time preference  part)   of the marginal
utility function u(t) can be scaled between 0 and 1, so that the time (age) of maximum
preference gets value  1. The marginal utility function  may then simply be composed  as
the product of these two components. When we realize that, in an economic context,
time preference can be represented by a discount rate and that productivity and quality
may be considered synonyms, the marginal utility function u(t) can be, less formally,
called the discounted QALY-function. An example will be given in the next section.
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8.6 Illustrative Application
In 1972/73 a representative sample, drawn from the male population aged 45-59 of
the city of Rotterdam (The Netherlands), was screened for a number of cardiovascular
risk factors because of the Kaunas-Rotterdam Intervention Study (KRIS), initiated by
the World Health Organization [31.  Part of this study was a monitoring of time and
cause of death during 10 years of follow-up after the screening examination.  For an
application of the model dealt with in this paper, we are interested in the dependency
of mortality on the cardiovascular risk factors systolic blood pressure (SBP) and choles-
terol content  ( CH).  In a former analysis [5], where this dependency was specified  as  a
multiplicative model, we already found a U-shaped relationship. Now we specify an
additive quadratic relationship (after logarithmic transformation of SBP and CH) by
means of the proportional hazards model
As(t :1,22) =
As(t) ·  1 + dlzl + 19212 +  #112  +  1322122+ #121122 ,        (8.6)
where S denotes two strata (smokers and non-smokers), t is age, zl is ln(SBP) (with
SBP in mm Hg) and z2 is ln(CH) (with CH in mg/100 ml plasma). The baseline hazard
function As(t) is specified and estimated in a second stage (after estimation of the B
coefficients in model (8.6)) as
As(t) = exp (70 + 7sS + lit) (8.7)
where S equals 0 for non-smokers and 1 for smokers. Note that this is a Gompertz
function  of age  [4]. Both expressions  (8.6)  and (8.7) constitute the mortality process
(8.1) with age-dependent B coefficients.
The B coefficients in the model (8.6) are estimated under the condition that expres-
Sion (8.6) is positive.  We use age (instead of follow-up time) as the time variable t in
the smoking-specific baseline hazard function AS(t), meaning that we have to deal with
so-called delayed entry times. Each person enters the follow-up, not at a fixed study
time t = 0, but at a certain age which is the age at entry, varying between persons over
the range 45-59 along the age axis. The follow-up of each person ends along the age
axis at the age that he dies or is censored. Each time that a person in the cohort dies.
the  "risk set", typical for the partial likelihood  [11, is defined as  the set of persons alive
in the follow-up at the same age as the person who dies. In contrast. t.0 the capability
of the model to take account of time-dependency (ageing) in the covariables, the KRIS
offers  only one measurement  wave  (viz., at entry)  in the population  as a whole for  esti-
mating the models (8.6) and (8.7). Given the estimated B coefficients, the values of the
baseline hazard function As(t), obtained each time a mortality case occurs in each of
both smoking strata, are summed so as to get yearly rates for each year-of-age available
and then, in a second stage, regressed upon smoking status S and age t according to the
model (8.7) by means of a non-linear regression method with an additive error ternn.
When testing the goodness-of-fit of the model, this appears to better reproduce the ob-
served age-dependency and the observed total number of mortality cases in the sample
than using ordinary linear regression of the logarithmically transformed baseline hazard











Table 8.1: Estimated B and 7 coefficients of the dependency models (8.6) and (8.7) for
the mortality rate.
part of the effect of age t in model (8.7) might be due to the ageing process of the co-
variables. This might have harmed somewhat the estimated 71 coefficient (and possibly
also the B coefficients) as they are listed in Table 8.1, presumably not so much as to
become useless for this illustrative application. The coefficients are estimated from 2892
men in whom 206 deaths occurred during the 10 years follow-up. These men have been
selected as free of cardiovascular disease (CVD-free) from 3284 participants entering the
study with complete observations. CVD-free is defined as: no signs of angina pectoris
or ECG-anomalies indicative of a previous myocardial infarction.
The a coefficients of the ageing process (8.2) cannot be estimated with only one
measurement wave. Using the information available from the KRIS about the correla-
tion  of  zl = ln(SBP)  with  z2   =  ln(CH) and about the cross-sectional dependency  of
these variables on age, we settle the following relationship for the ageing process (8.2)
as not too unrealistically for illustrative purposes only:
Zlt   -   0.672 + 0.80zl,t-1 + 0·06z2,t-1 + El (8.8)
Z2t   =   0.567 + 0.10zl,t-1 + 0.80z2,1-1 + 62·
For annual measurement waves   we   set the autoregression coeflicients   at    0.80   for   zi
and z2. Woodbury et al. [10] found autoregression coefilcients of 0.58 and 0.73 for the
logarithm of diastolic blood pressure and of cholesterol from the biennial measurement
waves of the Framingham heart study. The residual terins Ei and E2 have variances
aA and aj set at 0.0061 and 0.01, respectively, and are considered to be uncorrelated:
a12 = 0. Starting values for the mean vector po and (co)variance matrix Vo of zl and
22 are estimated from the KRIS as follows: means 4.910 and 5.287, variances 0.019 and
0.029 and covariance 0.00235. Systolic blood pressure and cholesterol are assumed to
be independent of smoking in this illustration.
Given the mortality selection process (8.6) and (8.7) with the estimated B and 7
coefficients as in Table 8.1 we may now compute life expectancy for smokers and non-
smokers separately and its sensitivity to a number of alternative scenarios for the ageing
process (8.8). It should be emphasized that all forthcoming results are based upon partly
fictitious parameter values and hence serve illustrative purposes only. The illustration
is concerned with life expectancy of a CVD-free male cohort of age 50. But first we
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differentiating the mortality rate (8.1) with respect to zit, it follows that these levels
are given by -B-'B and equal 4.896 and 5.289 respectively. Hence, the means in the
cohort, 4.910 for ln(SBP) and 5.287 for ln(CH), approximately equal those minima. As
a consequence, scenarios that only deal with a drift in ln(SBP) and in ln(CH) away from
their means, are expected to show a decrease of longevity. Scenarios that also reduce
the variance of these variables are relevant for illustrating an increase of longevity. We
will consider only a linear class of scenarios where new values for the covariables z are
linear functions of their old values so as to keep the ageing process (8.2) linear with
only parameter values differing from those in (8.8); for the mathematical consequences,
see the Appendix.
The following scenarios are considered: status quo life expectancy, i.e., with all
parameters as above, life expectancy with a 10 (or 20) percent shift (incremental as well
as decremental) for SBP and CH (separately as well as simultaneously) for all subjects
throughout their total life time as of age 50. As stated above, we expect a decrease of
longevity under these scenarios that are in fact linear transformations of ln(SBP) and
ln(CH) with slopes equal to one.  As our favourite variance-reducing scenario, from which
we may expect an increase of longevity, we consider a linear transformation of ln(SBP)
and In(CH) with slopes 0.7 and respective intercepts 1.4 and 1.52; see Figures 8.1 and 8.2
for an illustration of these scenarios as represented in terms of SBP and CH respectively.
This is also done for ln(SBP) and ln(CH) separately as well as simultaneously. The
results are given in Table 8.2. These results show that the effect of smoking is more
than a 5 years decrement of life expectancy as of age 50.  In the status quo situation life
expectancy is 31.0 years for a 50 years old male CVD-free non-smoker and 25.7 years for
a smoker. As expected, variance-stable drifts of ln(SBP) and ln(CH) generally shorten
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Scenario Non-smoker Smoker
status quo 31.0 25.7
zl t 0.095 30.1 24.9
(SBP + 10%)
Z2 + 0.095 30.6 25.4
(CH + 10%)
both 29.9 24.7
Zl + 0.182 28.8 23.7
(SBP + 20%)
22 + 0.182 29.7 24.6
(CH + 20%)
both 28.1 23.0
Zl - 0.095 31.0 25.7
(SBP - 10%)
22 - 0.095 30.7 25.5
(CH - 10%)
both 30.9 25.6
zi - 0.182 30.3 25.1
(SBP - 20%)
Z2 - 0.182 30.0 24.7
(CH - 20%)
both 29.7 24.5
0.721 + 1.40 31.6 26.3
(see Figure 8.1)
0.7z2 + 1.52 31.5 26.2
(see Figure 8.2)
both 32.1 26.8
Table 8.2: Life expectancy (years) in a 50 years old male cohort (CVD-free at entry)
and its sensitivity to various scenarios.
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Scenario Non-smoker Snnoker
status quo 15.0 14.0
0.721 + 1.40 15.1 14.1
(see Figure 8.1)
0.7z2 + 1.52 15.1 14.1
(see Figure 8.2)
both 15.2 14.2
Table 8.3: Expected utility in a 50 years old male cohort (CVD-free at entry) with
rl - 0.03 and r2 - 0.0011 in the marginal utility function (8.9).
lifetime, irrespective of these drifts being positive or negative. Our favourite scenario
(Figures 8.1 and 8.2) leads to an increase of longevity: about half a year for each of SBP
and  CH  sep_arately and slightly more than_one  ar_for  tlfse variables imdttle9usly
Each scenario represents actually a certain distribution of life time. As illustrated
above the scenarios are mutually compared as for life expectancy or, identically, the
mean of the life time distribution. A more unique way of evaluating a scenario is by
means of expected utility of life time. Suppose that a decision-making agency has to
decide upon our above mentioned favourite scenario for the future life time of a 50 years
old male CVD-free cohort. The effect will accrue in the future, so that we will adopt the
economic principle of discounting in order to quantify our preference for present time
to future time. At the same time we have to take account of age preference, which we
may quantify in terms of productivity: on the average, 50 years old men will be more
productive to society than 60 years old men. Time preference can be mathematically
specified by assuming that only a proportion exp(-rl t) of one life year now is considered
equivalent to one future life time at time t, irrespective of age preference, with rl > 0
the  discount  rate. Age preference  can be specified for example as exp(-7·212),  with
parameter r2 > 0 describing how rapidly productivity decreases in a cohort while ageing
as of the age of 50, irrespective of time preference. These two mathematical functions
are assumed to act multiplicatively so as to yield the marginal utility function u(t) as
dealt with in Section 8.5:
u(t) = exp (-rlt- Be). (8.9)
We will now evaluate our favourite scenario and compare it with the status quo
situation through expected utility calculated as in expression (8.5) with rl - 0.03 and
r2 = 0.0011. The marginal utility function and its time and age preference parts are
depicted in Figure 8.3. The results of the analysis in terms of expected utility are given in
Table 8.3.  One unit of expected utility equals one present life year of an average 50 years
old CVD-free man. In the status quo situation expected utility is 15 for smokers and
14 for non-smokers. With each of both scenarios separately, expected utility increases
by 0.1 and, with both scenarios simultaneously, by 0.2 for smokers as well as non-
smokers. The effect on mean life expectancy of each of both scenarios (0.5 years) and
of smoking (5 years) is about five times as large as the effect on expected utility: 0.1
and 1 unit for either scenario and smoking, respectively. The five fold magnitude of this
difference is, of course, determined by our chosen values for the parameters rl and r2
in the marginal utility function (8.9). The explanation is that the effect on mean life
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Figure 8.3: Marginal utility function as in equation (8.9): (a) time preference only, with
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Figure 8.4: The smoking effect (5 years clecrement of life expectancy) as it builds up
with age
expectancy substantially builds up late in time at older (less preferred) ages as can for
instance be seen in Figure 8.4 for smoking.
8.7 Discussion
The model used in this paper and developed by Woodbury et al. [8,9] appears to be a
tractable approach for forecasting and evaluating the effect in a population (cohort) of
a population-based health-intervention programme. The outcome variable is life time,
which may be considered a random variable of which the unconditional distribution in
a cohort may be influenced by intervening into the dynamics of risk factor development
and its relation to mortality.  One of the advantages of this approach is that intervention
policies can be mathematically specified and quantified in the model. A certain price
has to be paid for the advantage of analytical tractability though. The first condition
is that the risk factors have to be continuous and have (approximately) a multivariate
Gaussian distribution (or have so after a suitable transformation). Categorical variables
generated by some jump process, for instance marital status or place of residence, can
only be taken into account by means of stratification, unless they can be represented by
a number of underlying continuous (and approximately Gaussian) variables. A second
condition is that the dependency of the mortality rate on the continuous covariables is U-
shaped quadratic. Theoretical arguments in favour of this condition come from biology
(the principle of homeostasis), and empirical evidence for this is available from various
studies [5,6]. Other (dis)advantages are of a more practical nature. The maximum
likelihood estimation procedure for estimating the B coefficients in the mortality rate
(8.1) has to be performed under the constraint that the symmetric matrix (A.1) in the
Appendix is positive-definite.    As  A(z) is usually very small, non-standard statistical
problems may arise in interval estimation and testing of the B coefficients near the
boundary of the restricted parameter space. In the illustration (Section 8.6) only the
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restriction  was  made  that A(z) remained positive  over the observed range  of z values,
which suffices for the data set at hand to yield estimates satisfying positive-definiteness
of the quadratic form. An advantage of this dependency model is  that,  when k mutually
exclusive death causes j=1, . . . ,k are considered, each with mortality rate Aj(z) with
own matrix of dj coefficients, then the B coefficients of the total (all causes) mortality
rate are the sums over j of the cause specific /9, coefficients. This should hold also for
their consistent ML-estimates.
Intervention induced changes in the unconditional distribution of the random vari-
able life time can be evaluated by means of expected utility, of course after having
defined a macro utility function on life time. We saw in Section 8.5 that the concept of
QALY (quality adjusted life year) can so be formally embedded in the statistical deci-
Sion theory as the marginal utility function of life time. So far a very simple two-states
situation (healthy-dead) was considered, with the random variable time to death as the
only outcome and thus the only argument of the utility function. An obvious extension
(beyond the scope of this paper however) is a three-states situation with an intermediate
irreversible chronic disease state and with life time decomposed into two states: disease-
free life time and, if not dead while disease-free, life time with the disease. Of course,
state then becomes an additional stochastic argument of the utility function, along with
these two life times, constituting the three outcomes of the stochastic process.
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Positiveness of the mortality rate  (8.1)
In order that the model is mathematically valid, the mortality rate has to be positive
for all values  of zit, meaning  that the following matrix  has  to be positive definite:
(
 0    107 \
19  1  ) ,                           (A.1)2 M 2
which is tantamount to all its naturally ordered principal minors being positive.
Effect of mortality selection on the covariables
The mean vector Ft and covariance matrix Vt after mortality selection in year t
becorne:
Bi   =   DICpi _ 110) (A.2)
4.       = DM (A.3)
with Di given by
Dt - (I + 1/IB)-' (A.4)
Of the cohort entering year t alive, the proportion that survives till the end of the year
equals:
qi = ID:11/2 exp (-Bo - BTD,#LI +  1BTDt VtB -  5511'BDtft) ·             (A.5)
Effect of ageing on the covariables
At the end of year t the ageing effect (8.2) applies, causing B; and Vi* to be updated
towards ft+1 and V:+1 as follows:
Ft+,   =  Fi + ao + Ap; (A.6)
Vt+1   -   11* +E t Vt'AT + Avt* + Avt.AT. (A.7)
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Life expectancy of the cohort
The cohort survivor function Qi equals the decumulative distribution function of life
time T:
01 = Pr IT> tl
Life expectancy LE thus equals
f.0
LE = - 1        tdQt,
Jo
which can be reformulated as
f c*>
LE = / Q, dt
Jo
as follows from integration by parts and from the regularity condition:
lim tqi = 0.
t-00
Expected utility of life time
When instead of life time T a utility function U(t) of life time T is used, then
expected utility equals
r-
E(U) =  /    u(t)Qi dt,
Jo
with u(t) = dU idt, under the regularity condition
lim U(t)Qt = 0.t=..O
Linear class of scenarios
A linear class of scenarios is a set of scenarios where the vector of covariables is
linearly transformed from =111 to 42 :
Z 2) = 710 + Hzl' ,
where 90 is a vector and H is a diagonal matrix of transformation coefficients typical
for a scenario. Application of this transformation to the ageing process (8.2) before the
scenario
1)zE+, = ao + (I + A)zp  + Et
leads to the following ageing process after the scenario:
z .-Hao- HAH-'not H (I + A)H-'z  + H4,
(2)which is again a first order autoregressive structure with zt normally distributed with




Expected Utility of Life Time in the
Presence of a Chronic
Noncommunicable Disease State'
Paul G.H. Mulder and Anton L. Hempenius
Abstract
Interventive action aimed at reducing the incidence of an irreversible chronic non-
communicable disease in a population has various effects. Hopefully, it increases total
longevity in the population and it causes the disease to develop later in time in a smaller
portion of the population.  In this paper a statistical model is built by which these effects
can be estimated. A three dimensional probability density function that underlies this
model is changed by the interventive action. It is shown how a three dimensional utility
function can be defined to appropriately judge this change.
1 Submitted for publication in Heatih Economics
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MiD                    111            ,         deathdisease
( disease)
Al                                  2
M2
H                             X2                            deathdisease-free
(other)
Figure 9.1: The illness-death model.
9.1 Introduction
In this paper a model is presented for evaluating an intervention programme, aimed at
reducing the incidence of a chronic (irreversible) noncommunicable disease in a popu-
lation.   Such an intervention programme influences two competing incidence rates,  viz.,
the chronic disease incidence rate and the mortality rate from other causes. The effects
of the programme are translated into changes in the population life time distribution,
where life time may be decomposed into life time without tlie chronic disease and, if
the disease develops, life time with the disease. Therefore, a stochastic illness-death
model is described, in which changes of the stochastic structure (induced by interven-
tion) can be evaluated by means of expected utility so that alternative intervention
strategies can be ranked in terms of preference. The model is defined for an initially
disease-free birth cohort of subjects, followed from a certain age (which need not be the
age of birth). This theoretical paper offers a more formal approach to the concept of
"Quality-Adjusted  Life Year"  (QALY)  [8,  71 or "weighted life expectancy"  [2].
In Section 9.2 the illness-death model, used to describe the various states, from a
disease-free state towards the final state of death, is presented. Section 9.3 is concerned
with life expectancy and a decomposition of life expectancy which is useful for evaluating
an intervention programme. In Section 9.4 form and construction of a utility function
are discussed.  Also in Section 9.4 the actual computation of expected utility is presented.
Section 9.5 treats the problem of how intervention is incorporated iii the model. Section
9.6 concerns the practical evaluation.
9.2 The Illness-Death Model
At any time each subject of the cohort is in one of the mutually exclusive states of
Figure 9.1. A subject is either dead or alive.  In the latter case lie is in one of the
following two states:
state  H: the disease-free ("healthy") state, which applies  if the disease  has  as  yet  not
developed;
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state D: the state of chronic disease, which applies as soon as the disease starts to
develop.
When the subject dies, he dies either from the disease or from other causes. In the
latter case he was either in state H or in state D, previous to the time of his death.
Hence, the following mortality states are considered:
state Afl: the state of mortality caused by the disease;
state  M,: the state of mortality caused by other diseases, which is reached from states
H or D.
It remains to specify the intensities of the flows from one state to another. These
intensities are also called hazard functions or hazard rates. These hazard functions are
defined in such a way that they describe how the size of the original cohort in state H
drops off in the course of time by absorption in the states Afl (through the state D)
and  M2.   It can easily be proved that these hazard functions are simply mean hazard
functions relating to an arbitrary subject of the cohort being in a certain state at a
certain_ tinie.  Time, I,_is_supposed to coincide with the age of the cohort. The disease
free state H can be left at time x as a result of two competing risk causes: either the
start of the disease, with mean rate Al (x), or mortality from other diseases, with mean
rate  AY (x)   in a disease-free cohort. Return  to the disease free state  H is impossible.
The disease state D can also be left as a result of two competing risk causes: either
mortality  from the disease,  with  mean  rate  Al (Ily),  with  y f x the starting  time  of
the disease, or mortality from other diseases, with mean rate #2(x) in the cohort part
having entered state D at time y and still being in state D at time r 2 y
This completes the description of the illness-death process. Similar models may be
found in  [5,6,11.   In  the next section expected  life  time  for this model  and a relevant
decomposition of expected life tillie is presented.
9.3 Life Expectancy and Its Decomposition
A first measure for evaluating the effects of intervention is life expectancy.  Life ex-
pectancy of an arbitrary subject in the cohort is equal to the weighted sum of two
expectations: the expectation of life time in the subcohort that will develop the chronic
disease and the expectation of life time in the subcohort that will not develop the dis-
ease, with weights  7rl  and  7r2  =  1 - 7rl, where  7rl  is the portion that will develop  the
disease and 71 2 is the portion that will die from other diseases without having developed
the chronic disease.
Life expectancy LE for an arbitrary subject of the original cohort thus equals:
LE = (1 - 1rl)EHIX|2) + irl {EH(Xll) + ED(Z)}, (9.1)
where EH(Xll) denotes expected life time in state H, given development of the disease,
EH(X12) denotes expected life time in state H, given no development of the disease,
and ED(Z) denotes expected life time in the disease state D. In Appendix A it is
shown how these expectations can be expressed in the mean hazard rates as defined in
the previous section. The decomposition of LE in the right hand side of (9.1) is useful
for explaining the effects of a population-based health intervention programme aimed
at reducing the incidence At (z) of the disease in the cohort: a change in Al, induced by
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the intervention programme, results in changes in the disease probability 7rl and in the
expectations EH(Xll), EH(X12) and ED(Z).
By combining two components in (9.1) life expectancy LE simplifies to
LE = EH(X) + 71'IED(Z) (9.2)
with EHCX) defined as
EH ( X ) = ( 1 - :rl )EH (X 12 ) + 7rl EH (X | l ) .
In the simpler decomposition as in (9.2) it is reasonably supposed that it is not relevant
to distinguish life in state H with respect to the way in which this state will be left.
9.4  Evaluating the Stochastic Process
9.4.1 Expected Utility
Life expectancy LE is one evaluation parameter for the illness-death process.  It does not
define uniquely all situations of an illness-death process between which a decision maker
may be indifferent. For instance, a second process with a higher value of EH(X12), that
is exactly cancelled out by a lower value of ED(Z), produces the same value of LE, while
it is reasonable to assume that this second process is preferred by the decision maker to
the first process. As the decision maker is facing changes, induced by intervention, of
the stochastic illness-death process, the "rational" decision maker would not only look
at expected life time, but also take the more general approach of calculating expected
utilities of life times of two different processes. The decision maker is supposed to be
an agency which has to decide on the introduction of a population based intervention
programme for the cohort. The stochastic process with which this agency is confronted
is the stochastic process of an arbitrary subject in the original cohort, which process is
specified in the mean hazard rates as dealt with above.
A particular illness-death process can be described by the following joint density
function of the triplet (X, W, J), with X disease free life time, W disease duration and
J an indicator for the disease, having the value 1 if the disease develops and 2 if not:
h(z, w,j) = (1 - 11)f2(Z) for x 2 0,w=0,j=2 (9.3)< Tifi(z)9(wIT) forl:20'wt 0,j= 10                      otherwise,
as follows from Appendix A. The random variable W coincides with the random variable
Z o f Appendix A, except that for w =0 there is an additional probability mass of 1- irl·
The parameters At,  12, fil  and #2 determine h(I, w,j)
The decision maker is assumed to evaluate changes  in  h(:r, w, j), induced  for  ex-
ample by certain intervention measures, by means of his expected utility of the triplet
(X, W, J). The utility function U is defined as UH<.r) for a disease free life time of z
time units and as Ub(x, w) for a life time in which the disease starts to develop at time
z and lasts for w time units. So formally U is defined as:
U(x, w, j) = (j - 1)UH(z) + (2 - j)Ub(Z, w).
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Expected utility equals:
E(U(X, W, J))  = (1- Al)E(UH(X)|J =2) + 7riE(Ub(X, W)).
For the sequel Ub(r, w) is assumed to be as follows:
Ub (Z,w)  =  UH (Z)  +  CD(x,w),
i.e. the utility of a life time tv with the disease, which started at time z, may be
separately added to the utility of the disease free time of life. The utility function then
becomes:
U(x, w, j) = UH(z) + (2- j)UD(I, w),
with expectation:
E(U(X, W, J)) = (1-,rl)E(UH(X)IJ=2) +
+ X1 {E(UH(X)IJ = 1) + E(ITD(X, W)) } , (9.4)
which is analogous to (9.1). Analogously to (9.2) the deconiposition in (9.4) may be
simplified to:
E(U(X, W, J)) = E(UH(X)) + 7ri E(UD(X, W)), (9.5)
with  E (ITH (X))  equal to expected utility in state H, irrespective of the cause by which
state H is left. Using (9.3) in (9.5) gives:
foc
E(U) = / CH(x)Clrifi(x)+(1 -11·1)f2(x)}dxt
Jo
r °0    foo
+ El / UD(Z,Z).fi(z)9(zlz)dzdz,
O JO
which for computational purposes may be written as:
r 00
ECU)  -  -1   UHCL)dSH +
Jo
foc (  roo
- I  At(.r)SH(z)  j   UD(z, z)dSD(zlx)  dz.      (9.6)
Jo
Integrating (9.6) by parts results iii:
f *;
E(U) = 1 UH<z)SH(z)di: +
JO
r 00 C flo
+ /   11(z)S,ICI)       UD(z, z)SD(zix)dz  dz,         (9.7)Jo
where   u H(I) = dETH(.r)/dir and uD(·r, z)  =  OUD(:r, z)IDz are marginal utilities and
where it has been assumed that UH(Z)SH(z) = 0 as z -+ 00 and UD(Z, z)SD(z Z) --+ 0
as z -4 00. An alternative formulation is obtained after interchanging the order of
integration and changing of variables in the second term on the righthand side of (9.7):
foo
E(U)   =   /   UH(I)SH(z)dz +
JO
r°° fz
+ / / Al(y)SH(y)UD(Y,z -y)St)(z -yly)dydz, (9.8)
Jo Jo
128
where y s z i s the time of developing the disease. The usefulness of (9.7) and (9.8) will
become clear after more has been said about the specification of the utility function.
9.4.2  Specifying the Utility Function
In order to specify the utility function further, it is supposed that the decision maker
is able to comparatively judge the health condition in both states H and D at different
time points and disease durations, respectively. Therefore, the decision-making agency
considers the average health condition of all subjects in a particular state at a particular
age or sojourn time in that state. There should be political consensus about the way in
which the comparative judgement is made by a decision-making agency. For example,
in an economic context some kind of capacity index of the cohort at a certain time point
may be defined as the mean productivity across the subjects in the cohort at that time.
Throughout this paper the term health index will be used.
Two assumedly independent types of health indices are distinguished: a general
health index in state H, i.e. when not suffering from the chronic disease considered,
and a (disease) specific health index in state D, when suffering from the chronic disease.
The decision maker is supposedly able to compare the general health index at one age
with that at another age, and to compare the (disease) specific health index for any
given age and disease duration with the general health index. The decision maker is
also supposed to include time preference in his judgements, independently of the health
index. A comparison of the health indices at two different ages, also means a comparison
of two different points in time, as age coincides with time in a birth cohort. According
to the economic principle of time preference, the decision maker is supposed to prefer
an increase in the health index arising now (at the present age) to that same increase
arising later in time (at a higher age). It is also supposed that this time preference can
be quantified by the decision maker when comparing one age (= one time point) with
another age (= another time point), independently of the way in which the health index
at these ages is quantified.
Let qH (y) denote the general health index at age y. The function qH(V) assurnedly
is a non-negative tiumber, that is equal to 1 at age y* where the general health index is
maximal. This function can be determined from the decision maker's judged indifference
between one unit of life time at age y (without the disease) and qH(Y qH Y'  = qH Y 
units of life time at age y-, for all pairs (y, 9' ), irrespective of time preference. Similarly,
a time preference function qT(y) of time y can be defined with a maximum of 1, which
acts  multiplicatively on  qu (Y). Irrespective of the general health index, present  time  is
preferred to future time by the decision maker, which can be quantilled by means of
discounting. The utility of a life time z without the disease is by reasonable assumption
equal to the weighted sum (integral) of the successive health conditions (with the time
preferences as weights), starting from time 0 (which generally is not the time of birth):
fz
UH(Z) - /  qH(Y)qT(y)dy.
JO
With this construction of UH(x), it follows for marginal utility u H(Z)
UH(Z) = q/,(Z)97'(.r). (9.9)
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Further, let qD(Y) denote the disease specific health index for an average subject
already having the disease for a time period y. Without loss of generality, it is assumed
that qD(Y) has a maximum of 1.  The time z of the start of the disease is introduced
as follows. The general health index weighted by time preference at time x t y i s
represented by the value qH(I + Y)q:r(z + y), on which value the disease specific health
index qo(y ) is assumed to act multiplicatively in order to produce the weighted overall
health index at time I t y with value VH(I + V)q:r(z + y)qD(y). The utility of a life
time z with the disease that started at time I, is by assumption equal to the weighted
sum (integral) of the successive health conditions, starting from time I:
rz
UD(x, Z) =  /  qH(z + y)qT(K + y)qD(y) dy.
Jo
With this construction of UD(Z, z) it follows for marginal utility uD(Z, z):
UDOE, Z)-= gH(Z +-Z)-q:r(-Z + Z)qD -z).-    --    -  -    -  - - (9710)-     -       -
Returning to E(U) in (9.7), it is seen that, given the above construction of UH(x) and
UD(x, z), uH(x) and uD(x, z) in (9.7) may be replaced by (9.9) and (9.10), respectively.
The special case qH(X) - qT(Z) = qI)(z) = 1, meaning that the decision maker
judges the marginal utilities as constant, so that UH(x) = x and UD(x,z) = z, specifies
the case of the previous section, i.e. life expectancy LE; see (9.5) and (9.2).  Life
expectancy LE may simply be deduced from (9.7) or (9.8) with uH = UD = 1.  For
example, LE follows from (9.8) as
r'Dc
LE =  1   {SH(x) + SD(x)} dz,
JO
where SD(x) is the probability that a subject is in state D at time z. This probability
can be considered to be the net result at time x of the flows in and out of state D before
time x:
rZ
SD(Z) =  /   11(Y)SH(Y)SD(Z - yly)dy,
Jo
of which the integral over x is the second term in the righthand side of (9.8).
9.4.3 Example
An example of a general health index qH(Z) is:
qH(x) =exp(-rHZ),
specifying that the general health index of the cohort is at its maximum at age 0 and
decreases at rate TH > 0, due to increasing non-vitality when the cohort grows older.
A time preference index q:r(z) may be similarly defined:
qT(r) = exp(-rTI),
specifying that the highest preference 1 holds for the present time, decreasing at a
discount rate rT > 0 for future time points. The utility U H(z)  of a disease free life time
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from 0 to x then becomes:
7*                                 1 -exp(-(rH + rT)Z)UH(z) =     exp(-(TH + rT)y) dy =
Jo                          TH+rT
with UH(z) --+ 1/(rH + rT) as  I  -4   00.
Two examples of a disease specific health index are:
qD(z) = exp(-rDZ) (9.11)
qD(z) =l- {1- qD(0)} exp(-rDZ). (9.12)
(9.11) specifies a disease that becomes more serious with the disease duration: it causes
the disease specific health index to decay exponentially with the disease duration. It
implies that, from the start of the disease at age I, the weighted overall health index
at time Y 2 Z i s q·r(y)qH(y) exp(-rD(y - x)), (9.12) specifies a disease by which
weighted overall health index immediately jumps downwards  by a factor  qD (0)  at  the
disease onset, whereafter this decrement exponentially decays towards zero, meaning
that the disease becomes less serious with its duration. It implies that, at the start
of the disease at age x, the weighted overall health index decreases by an amount
qT(z)q/,(x){l-qD(0)}, while at time y>z this decrement has become q.r(1/)qH(Y){1 -
qD(O)} exp(-rD(y- I)).
9.5  Intervention
An intervention strategy is by definition only effective for the cohort in state H. Such
a strategy influences the stochastic structure (9.3) of the whole process through the
mean  rates  Al (z)  and  .\2(x)  in the cohort. The individual rates  Al   and A2 depend  on
a vector of covariables which have a certain multivariate distribution in the cohort in
state H. In the course of time this cohort is subjected to two simultaneously acting
stochastic processes: disease-free survivor selection (described  by the rates  A i   and  A2)
and ageing. The ageing process is defined as a stochastic model that describes how the
values of the covariables evolve in time in individuals as long as they survive disease-
free in state H. The parameters of this ageing process are supposed to be influenced
by an intervention programme. An analytically tractable model with two simultaneous
equations  has been built by Woodbury  et  al. [9], which is consistent  with the assumed
multivariate Gaussian distribution of the covariables in the cohort in state H. In this
model the rates Al and A, are positive-definite quadratic forms in the covariables, the
ageing process is a stochastic linear differential equation in the covariables (including
random walk). This model makes the mean vector and the (co)variance matrix of the
vector of covariables analytically expressible in the tv,0 sets of parameters, viz. those of
the disease-free survivor selection process and those of the ageing process. The latter
set of parameters is supposed to be influenced by intervention, of which the effects on
the time paths of the mean vector and (co)variance matrix of the covariables can be
directly translated into effects  on  the mean rates  Al (t)  and  12(LE)
The original model developed by Woodbury et al. [9] is a continuous time model,
which is not directly empirically applicable, as epidemiological observations are usually
made at discrete time points only.
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9.6 Applicability
For practical applications it is assumed that the continuous stochastic process can be
discretely approximated by assuming the mean rates to be constant in time intervals of
predetermined width.  It is supposed that  the mean incidence of the disease Al (x)  and
the mortality rates A2(I) and #2(I) of other diseases  are  so  slow  in  time  as to justify
these rates being constant in unit (= one year) intervals [z, z + 1), z = 0,1,2,....  On
the other hand, the disease mortality rate Fi (.rly) may vary so fastly with time z after
the disease onset at time y 5 z, that constancy in time may only be assumed in much
smaller time intervals of width 1/T, with T an integer greater than one. For example,
T = 12 for months.  So each unit time interval [I, I + 1) is subdivided in T subintervals
[z + 1/T, x + (7- + 1)/T) for T = 0,1,2, . . . ,T-1.I n Appendix B the discrete version
of formula (9.8) for expected utility is presented, using these two time scales, as well as
the discrete versions of the survivor functions (A.1) and (A.2) of Appendix A that are
part of the expected utility formula-
Because the covariables are in practice only measured at discrete (equidistant) time
points, Woodbury et al. [10] developed and applied a discrete time version of their
model, in which it is assumed that the total dynamics of two simultaneously acting
stochastic processes in continuous time are mimicked by two separate processes acting
consecutively in relatively small (say, one year) discrete time intervals. In this discrete
approach, of which the technical details can be found in Appendix C, the covariables
C Z are supposed to be only measured at the start of these time intervals z and to be
constant during such an interval. Given the values of the covariables at the start of
the one-year interval, the disease-free survivor selection is applied during that interval
through the rates Al  and A2 , see equations (C.1) and (C.2) of Appendix C. Just before
leaving the interval, the ageing process is applied in order to update the mean vector 7*
and (co)variance matrix K of the covariables towards the next time interval x + l for
the portion s H (x)  of the cohort that remains to enter  the  next time interval alive  and
disease-free; see equations (C.3) to (C.6) of Appendix C. This updating of the covari-
ables at the end of each time interval is done by means of a first order autoregressive
structure (C.3) as the discrete alternative to a continuous linear differential equation.
Intervention is supposed to influence the parameters of this first order autoregressive
structure and hence it influences, through the mean vector 7. and (co)variance matrix
1/* of the covariables in (C.4) of Appendix C, the survivor function (B.2) of Appendix
B, which leads to changes in expected utility (B.1) of Appendix B. Within the model
described in Appendix C intervention strategies are defined as linear transformations of
the covariables cx. An application for a simpler model (without an intermediate chronic
disease state D) is given in Chapter 7.
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9.7 Discussion
In this paper a stochastic illness-death process is defined for a chronic disease, it is shown
how changes in this process are evaluated by means of expected utility.  It is only after
the definition of the stochastic process that it makes sense to define a utility function,
because the random outcome variables of the stochastic process are the arguments of
the utility function. Hence, defining the stochastic process is of primary importance.
The way in which this process is defined in this paper is. as any model, of course, a
simplifying abstraction.  Yet, if one realizes that the stochastic process holds for an
arbitrary subject of the birth cohort, meaning, for example, that the "healthy" state is
a state of average health of an arbitrary subject in the cohort not suffering from the
chronic disease considered, the approach is valid and may be useful for planning health
intervention policies in a society.
After having defined the stochastic process, its random outcome variables are identi-
fled and a utility function can be defined. Within the model settings of Sections 9.5 and
9.6 only linear transformations of the explanatory variables can be considered typical
intervention strategies. As practical examples of intervention strategies one could think
of health education or of government's support of screening and treatment facilities.  Of
course, it is always the individual's choice to participate in an intervention programme.
The term "participation" is broadly defined here: besides true participation in a screen-
ing programme, it may also be understood as picking up a health education message.
All kinds of detailed complications on the micro level (consumers behaviour) may play
their part here, eventually leading to changes in the coefficients of the evolution and
diffusion process (called ageing process) of the covariables as specified in (C.3) of Ap-
pendix C. These are the (anticipated) changes of which the effect can be evaluated in
terms of expected utility; also sensitivity analyses of various scenarios can be done by
a decision-making agency using the theory described in this paper. This may lead to
quantitatively supported conclusions about the type of population based intervention
programmes that are most beneficial to society.
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Let  SH (I) denote  the so called survivor function for an arbitrary subject  of the original
cohort in the disease free state H, i.e. SH(x) is the mean probability of surviving in
state H at time z in the original cohort. SH(Z) is expressed in  the mean rates  At (x)
and X2(z) as follows:
1 r
SH(z)=exp <-   {11(t) + 12(t)}dt . (A.1)
The density function of time z, given "failure" from cause j,  (j  =  1,2),  is:
fitz)-., (j = 1,2),Ajfz) SH (I)
,r j
see e.g. [3, 41 Evidently, 1rj equals:
llc)
Ej =  /   Aj(x)SH(x)dz,      (j = 1,2).
Jo
Expected  life  time  EH(X 12) in state H, given no development  of the disease, is equal
to:
fo°
EH(X 12) =  I    zf2(x) dx.
JO
Expected  life time EH(X I l)i n state H, given development  of the disease, equals:
f oc
EH(Xll)=  I    x.fi(z) dz.
Jo
Expected life time ED(Z) in state D equals:
r 00    [00
ED(Z) = / i  z.fi(x)9(zlz) dz dz,
Jo Jo
where g(zlz) is the density function of z, life time with the disease, given that z is the
starting time of the disease. The density function g(z x) is derived from the survivor
function S D(z   Z) :
Z
SD(zlz) = exp <-     {111(I + y|I) +  12(T + y)}  dy.                (A.2)
\  JO
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From this one derives 9(711:) as -dSD/dz:
9(ZIZ) = {111(1, + Z|I) + 112(I + Z)}SD(ZIZ)
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Appendix B
Assuming that the mortality process #1 is properly approximated in smaller time in-
tervals [z + r/T, x + (T + 1)/T), with integers z 2 0'T 2 1 and O S T S T-1, the
discrete approximation to expected utility in (9.8) becomes
E(U) = (B.1)
1                           Al(0)
 UH    + E UH(X)SH(z) + -UD(0,0) +2T
r>l
-tp {,( 1,)t,(;· )}t
t=l
T-1 f
- iF X E ts,(,)S (, t ;'.0) + 1,(,)S (, + ;'' + ;')} t*21 t=o
T-1 r-1 T-1
1   7\
+  E Z E 1,(C) E S( + -,(+-1+x21 t=0 6.0 r-0 T  TJ
T-1      i
+  X Z 1,(x}ES  x + 1,x + I.j ,
r l t=0 T=0 T  TJ
with
/  t   r)
S <x + T' E + T) =
/ T\ 1 T t-« / 1 r   7-\
SH (4+ T) UD <6 + T,1'- 4+ --F) SD 1.I - 6+ --T  |4 + T./1.
For the clarification of (B.1) it is mentioned that time is represented by two variables:
the (larger) unit intervals are counted by I or 6 and the (smaller) subintervals are
counted  by  t  or  ·r.   For the outer integrals  in  (9.8)  z  and  t  are  used  and  for the inner
integral 6 and T. Function values at the lower and upper limit of a time interval are
only counted half in approximating the area under the curve in this time interval; the
relevant corrections are made in (B.1).
The discrete version  of the survivor function  SH  in  (A.1) of Appendix  A is defined
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as follows:
/           T)                                                                                     T/  (-1
SH (4 + T) - exp <- I {11(y) + 12(y)} - 7 {11(4) + 12(6)}  .         (B.2)
Y=0
For 4 -0, the summation f r o m y=O t o y= (i s suppressed. For <t l z-2, the discrete
version of the survivor function SD in (A.2) of Appendix A is defined as follows:
t-TI  r\
SO (x-(+ -ir-1(+ i )=
< T-T
I-1
t         )
exp   ---T#2(<) -  X 1112(y) - TA,(ir)yl xy=6+1
i  1 1-1 ( t-rl  v\ 
*exp-(-  6111 1%--4+I-T- C+T)   x
   1 *-1 T-1 / t-ri  u\ 
x exp  1 -T X A, t" - ( + -T    ' + T )  I x
          ,-6-1-1  v=o
(   1 T-1 f t-T I  v \ 
x expl- T 6: A,  t,-(+-T     x+T) )
F o r< =z-1, the summations from y= (t l t o y=z-1 are suppressed. For x= <
and t> r, SD reduces to
(t-Tj     T 1-1      /t-r I       v\ 
s„ l.-T- IC + T) =exp (-t-TTA,CE) -   E #1 1- I C+ -1 1.
I2T C T I TJ)
If,  moreover, t equals  7-,  then SD equals  1.
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Appendix C
At the start of the one-year time interval [T, I + 1) a vector of covariables c. is normally
(Gaussian) distributed in the disease-free cohort in state H with mean vector 7* and
(co)variance matrix 1/x During year z the covariables c* are assumed to be constant,
so  that the subjects  of the cohort are subjected to constant rates  Al (cg)  and  12(cz),
which are specified as positive quadratic functions of the covariables c.:
Aj(cz) = Bojz + BjTxczt cIBjzcg,       (j = 1,2), (C.1)
with Boix a constant scalar, Bjz a vector of coefficients for the linear effects of cx on Aj
and Bj: a symmetric matrix of coefficients for the quadratic (and cross-product) effects
of cr on Aj. Just before the end of year z, after the disease-free survival selection during
year x, the mean and (co)variance matrix of the covariables have become:
7;   =   Dx (7g - VZBZ) (C.2)
V; = D®V.
with the matrix Dx given by
D.=(I + V.B.)-',
with  I the identity matrix,  and Br  =  Ej Bjg  and  B:  =  Ej Bjg.  In the portion SH(z)
of the cohort entering year I that  remains  alive  and  disease-free  to  enter year  .r + 1,  the
covariables cr are updated towards cr+, just before entering year z + las follows:
CZ+1 = aor + A.C*   t€  * , (C.3)
with a.g a vector of shift parameters, A. a matrix of regression parameters and Er a
vector of residuals, normally distributed with mean vector zero and (co)variance matrix
Eg, called the diffusion matrix. The portion SH(I) can be calculated as
SH(Z) = (C.4)
1Di 'l' exp  -Box - BID,7*+1BTD. V.B.-17TB.D.7,  .2: 2 I-
implying for (B.2) of Appendix B:
E-1
SH  < t    = SH(4)rIT II SH(y)'
Y=0
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After updating 7; and V; of (C.2) according to (C.3) as follows
7=+1  =  aox + A=7; (C.5)
1/*+,   =  E. + A.VIA:,
the circle is round for the next year z + 1. An approximation for the proportion SH(x)
is obtained by using
SH(z) = exp (-Al(z) - A2(z))
and by substituting herein  Al (T)  and  12(T)  by




faul G.H-Mulder  -     -    -       -     -     -     -     -          -     - -                               -      - - - - -      -        -     -            -
Abstract
In survival analysis subjects of a cohort satisfying certain values for the observed
covariables may still be heterogeneous with respect to a number of other, unobserved,
covariables. This so called unobserved heterogeneity causes a distinction between the
empirical (observable) mortality rate of the cohort and the theoretical (unobservable)
mortality rate of a particular subject. Conditioning, as it should, lets conclusions only
pertain to the cohort considered (or to an "arbitrary subject" of the cohort) and not to
a particular subject. However, theoretical interest lets one investigate the nature of this
distinction by comparing the empirical situation where there is unobserved heterogeneity
with a theoretical situation where this heterogeneity is absent. This is done under the
assumption that unobserved heterogeneity is represented by a constant "frailty" term
in the mortality rate.
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10.1 Introduction
Unobserved heterogeneity characterizes a situation where individual subjects with the
same value for a vector of observed explanatory variables (covariables) do not have the
same mortality rate. There is another set of explanatory variables, unobserved and
therefore not incorporated in the model, which represents this (unobserved) between-
individual heterogeneity in the mortality rate. If there is unobserved heterogeneity, the
mortality rate for given values of the observed covariables, can be considered the mean
(expected) rate of the individual subjects' unobserved true rates, with the expectation
taken with respect to the hypothetical distribution of the unobserved covariables in the
cohort of subjects with the same values for the observed covariables. The practical
consequence is that the mortality rate (and the effect of covariables on it) relates to an
arbitrary subject with a particular value of the vector of covariables, as it should from
conditioning, and not to a particular subject. The two mortality rates are distinguished
here by their terminology: the "mean" or "empirical" mortality rate and the "true"or
"theoretical" mortality rate.  The mean (empirical) mortality rate is the rate of practical
importance that is correct in the cohort of subjects having a certain value for the vector
of observed covariables.  The true (theoretical) mortality rate is only a theoretical num-
ber for a particular subject, which in case of unobserved heterogeneity is unknown and
irrelevant from an epidemiological point of view. Although unobserved heterogeneity
thus in practice does not harm the usefulness of the estimated effects, there may be
theoretical interest in investigating how it causes the mean rate for an arbitrary subject
to differ from the true rate of a particular subject.  In case of homogeneity, the mortality
rate automatically becomes the subject's true rate.
The obvious way to treat unobserved heterogeneity is to include a random effect
term in the dependency model for the mortality rate, giving a particular subject his
own theoretical true level and representing all unobserved covariables, like the error
term in an ordinary linear regression model. However, in contrast to the ordinary
linear regression model, the distribution of the random effect term in a mortality rate is
influenced by survival selection and becomes time-dependent even when the individual
random effects are constant in time. This causes the theoretical time-dependency of the
mortality rate to become confounded with an artificial time-dependency due to survivor
selection, together constituting the empirical time-dependency in the mean mortality
rate.  As this confounding effect varies with the values of the observed explanatory
variables, a consequence is that the relevant empirical effects of the covariables become
different from their theoretical effects. In the next section this theoretical problem will
be illustrated with an unobserved individual "frailty" component in the mortality rate.
The term "frailty" for heterogeneity of mortality rates within a cohort is introduced
by VAUPEL, MANTON et  al.  [6], on which we will lean heavily. More recently,  this
concept is also used as a common random effect component in models for bivariate
(or multivariate) survival time distributions, for example in stydying mortality in twin
pairs or in father-son pairs; see OAKES [41, HOUGAARD, HARVALD et al. [21 and
CLAYTON and CUZICK [1].
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10.2 Frailty
A given cohort of subjects is followed in time t as of t = 0. The cohort may be a very
specific cohort, for example all subjects with the same particular value of a vector of
covariables (or a narrow bandwidth around this particular value). Each subject in the
cohort at tiine t=0 randomly gets his own true level of the mortality rate by means
of an unobserved frailty term v, drawn from some probability distribution. The frailty
term u remains constant in time for each subject and the subject's true mortality rate
is assumed to be
At(v) = Btv (10.1)
with Ft >0 the same for all subjects in the cohort and with v>0 considered an
unobserved multiplicative random effect expressing the heterogeneity between subjects
in the cohort.
Although frailty v is constant in time within subjects, its distribution between sub-
jects is time-dependent, due to survivor selection. It is shown by VAUPEL, MANTON        -
et   al.   [6]  that,ifin the initial cohort  at   time t=0 frailty v i s assumed  to be gamma
distributed with scale parameter 70 and shape parameter k, then frailty v remains
gamma distributed over time t with constant shape parameter k and scale parameter
71 depending on time t as follows:
rt
71  =  70  +   /    Budu.
JO
It is obvious that one may specify without loss of generality that the expectation k/70
of the frailty term v at time 0 equals 1; one may therefore assume throughout that the
scale parameter  70   at  time 0 equals  k,  so  that the expectation and variance of gamma







(k + f; B. d.)'
It can be concluded from the variance (10.3) that the effect of heterogeneity caused by
the frailty term u decreases as the parameter k increases and, of course, also as time t
progresses. When k = 00, there is no heterogeneity and v has unit probability mass at
v = l for all t, so that all subjects of the cohort have the same true mortality rate.
The mean mortality rate in the cohort can be considered the mortality rate of an
arbitrary subject of the cohort and is calculated as the expectation of the true individual
mortality rate (10.1) with respect to the time dependent gamma distribution of u:
Blk
At = BlE,(v) = (10.4)
k + f. B.du
from which it follows that, if one knows k, Bt could be calculated from the mean mor-
tality rate At. Comparison of expressions (10.1)  and (10.4) clearly shows that  the mean
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mortality rate At grows less rapidly in time than a subject's true mortality rate A,(v)
with given (though unobserved) frailty v, especially when k is low.
The empirical survivor function Qt, which equals the probability  that an arbitrary
subject of the original cohort still survives at time t, cari be expressed in the mean
mortality rate as
4,-exp (- f' ,' d.) (10.5)




and from (10.4) it follows that Qi can be expressed as
/   k   \k
Qt =
Ck + fo' B. du)
. (10.6)
An alternative calculation of (10.6) is obtained from considering Qi the moment gen-
erating function E{exp(-v f; Bu du)} with respect  to the gamma distribution of v  at
time 0 with both parameters equal to k, see OAKES [4]. Provided that one knows the
parameter k, it follows from expression (10.6) that the individual theoretical survivor
function Qt(v) for a subject with frailty u in the specific cohort can be expressed into
the empirical survivor function Qt of the cohort as
Qi(v) = exp  -v  t Bu du  = exp (-vk (Ofl/k - 1   .
If in the subject's true mortality rate (10.1) no assumption is made about the distri-
bution of the frailty term v > 0, except that, without loss of generality, Eo(u) equals 1,
 general expression can be derived for the time-behaviour of the mean mortality rate
At:
dli   dFt- = -Et(v) - Bt · vart(u), (10.7)dt    dt
where  in the absence of heterogeneity  vart (V)  =0  and  Et(v)  =v=l  for  all  t. A proof
of this general expression is given in Appendix B. This clearly shows that, in general,
unobserved heterogeneity causes the cohort to age slower in time than a particular
subject:
d ln Al       d ln Be vart(v)
-dt       -dt    - Bt.  Et(v)
10.3  Comparing Two Cohorts by means of a Rate
Ratio
Mortality between two homogeneous cohorts is compared by means of a theoretical rate
ratio e. When unobserved heterogeneity is present in at least one of both cohorts, the
relevant empirical rate ratio differs from the theoretical rate ratio. Theoretical interest
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lets one investigate the nature of this empirical rate ratio as compared to the theoretical
rate ratio as follows. The individual subject's true mortality rate may be specified as
At(v,w)= Bit,ew,
with  w  =  0 for cohort  0  and  w  =  1 for cohort  1.   In this specification  w  is the observed
and v the unobserved covariable (frailty) and e is the theoretical rate ratio if there would
be no unobserved heterogeneity. Let ko and kl denote the respective heterogeneity
parameters  of the gamma distributions of frailty in cohort  0  and   1. The relationship
between the empirical rate ratio 26 and the theoretical rate ratio e becomes:
C l t *fo, a. du) Al/klVtl
(10.8)
e;  =  e.  (1 + t ·1 11. du)  =  e.  854
with  Oto  and  Oti the empirical survivor functions  ( 10.5) of cohort  0  and  1  respectively.
Equation (10.8) clearly shows that the empirical rate ratio-is no longer a constant and
that the difference between 2; and e depends on e itself, time t and the parameters ko
and ki·  Calculation of e from e; is possible if one knows ko  and kl ·  If ko = kl  = k, that
is, if the variables v and w are mutually independent at t - 0, then, for t > 0, 25 < e for
e>land 95>e for 0<2<1.I f k o=k l - 0 0 , i.e. homogeneity in both cohorts, then
d= e. RIDDER and VERBAKEL [5 have shown under general conditions in the Cox
proportional hazards model that the difference between the empirical and theoretical
coefficients is a result of the dependence of the observed covariables and the frailty term
among the survivors at a particular point in time.
10.4  A Special Case
A special case of the frailty distribution is the following. For k= the gamma distri-
bution of frailty v a t time t=0 reduces to a Chi-square distribution with 1 degree of
freedom, so that the subject's true mortality rate (10.1) can be written as
At(z) = Btz 2
with z a standard normal variable at time t = 0. Note that this is a special one-
dimensional case of a quadratic dependency specification for the mortality rate on
normally distributed covariables. According to WOODBURY and MANTON [7] and
YASHIN, MANTON et al. [8} one may expect the variable z to remain normally dis-
tributed in the surviving cohort with constant mean zero and with time-dependent
variance 14 equal to
dg
-Iii-- = -20'L42
of which the solution is
1
Pi M              '
1 +2 fot#,du
which,  as  E,(v)  =  Et(Z2 ), indeed equals expression  (10.2)  for  k=   .A  nice side result
is that in this case the cohort survivor function Qt equals the standard deviation of z
at time t, as follows from expression (10.6).
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10.5 Interval Estimation
From expression (10.5) it can be concluded that unobserved heterogeneity does not
invalidate the point estimates of the mortality rate and of the survivor function if it is
realized that these estimates pertain (as they should) to a subject with average frailty in
the specific cohort of subjects with the same value for the vector of observed covariables.
This does not hold for the estimates' standard errors, which are underestimated in case
of unobserved heterogeneity. A simple model assumption will make this clear. If there is
no unobserved heterogeneity in the specific cohort and if the mortality rate is assumed
to be constant in time, then time to death in this cohort is an exponentially distributed
variable  and the corresponding traditional likelihood function is correct. If there  is
unobserved heterogeneity, then the distribution of time to death in the cohort becomes
some unknown mixture of a number of different exponential distributions. The variance
of such a mixture exceeds the nominal variance of an exponential distribution having
the  empirical mean mortality  rate as parameter.   This is called "over-dispersion".   The
traditional likelihood function is based upon this latter exponential distribution and so
provides too low standard errors of estimates.  In the total cohort as the union of all
specific cohorts (= classes of observed covariables) a correction factor can be calculated
to  increase the underestimated standard errors. The correction factor  is in principle
calculated as the square root of the sum of squared standardized (to units of their
nomimal standard deviation) residuals, divided by the number of degrees of freedom.
The way in which this calculation is done depends on whether the number of subjects per
specific cohort is sparse or non-sparse. In the sparse case the assumption has to be made
that the fitted dependency model for the mortality rate on the observed covariables is
correct; see McCULLAGH and NELDER  3, page 127}
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Appendix A
Proof of Expression (10.5)
The empirical survivor function Qt of the cohort by definition equals the mathematical
expectation of the theoretical individual survivor function Qt(v) with respect to the
probability density function ho(v) of the frailty term v at time 0:
,+00




Qt(v) = exp  - /  A.(v) du 
Jo
the theoretical survivor function for an individual subject with known v.
The distribution of frailty u at time t in the surviving cohort is given by the probabil-
ity density function ht(v) which by definition results from ho(v) after survival selection
as follows:
ho(u)Qt(V)ht(v) = - (A.2)
Qt
It follows from expression (A.1)  that  d ln Qddtis calculated as
d ln Qi 1 1+00
C it
di--   Qt J -0. 1,(u)exp <-1 A.(v)du  ho(v)du
1 7+°o= -/ At(u)Qt(v)ho(v)dv. (A.3)
Qt J -0.
Substituting expression (A.2) into (A.3) produces
dlnQf  -   +00 At(v)ht(u)dv,At          J -00
which is solved as






This concludes the proof that the empirical survivor function Qi can be expressed in
the mean mortality  rate  Au·
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Appendix B
Proof of Expression (10.7)
The constant frailty term v in the subject's true mortality rate (10.1) has an arbitrary
probability density function ht(v), expressing the unobserved heterogeneity in the spe-
cific cohort. As v is constant in time, the time-behaviour of ht(v) can be deduced from
the extended Kolmogorov-Fokker-Planck forward differential equation (see YASHIN,
MANTON  et  al. [8]) as
dht(u)
-3-   - ht(u) {At - At(V) , (B.1)
with At given by
fo°
At = ME,(u)= A  /    vht(v) dv. (B.2)
Jo
Differentiating (B.2) with respect to time t results in:
dAt dlit f r" dht(v)
(B.3)-= - / vht(v)dvtd, / v-dv.dt     dt Jo Jo      dt
Substituting in (B.3) dht(v)/dt by (B.1) yields expression (10.7):
dAt     dd
-   =    Et(v) + Bi  {E,(v)}2 - Et(v2)1 ,dt     dt
dBiEi(v)  - 02· vart (v)
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Samenvatting
Het moment waarop een chronische ziekte ontstaat (de incidentie), wordt vaak
voorafgegaan door een periode waarin zich prodroinale factoren ontwikkelen. Met de
incidentie van het hartinfarct, bijvoorbeeld, wordt vaak een periode afgesloten waarin de
patiEnt blootgesteld is geweest aan hoge bloeddruk of een hoog cholesterolgehalte.  Door
tijdens deze periode in te grijpen, kan men wellicht trachten de incidentie uit te stellen of
zelfs helemaal te voork6men. Dit ingrijpen wordt interventie genoemd. In de ontwikke-
ling van hartvaatziekten, bijvoorbeeld, kan men interveniliren door mensen bewust te
maken van het belang van kennis van het niveau van hun bloeddruk of cholesterolgehalte.
Ook kan men door middel van voorlichting het belang benadrukken van een gezonde
leefwijze gericht op verlaging van het bloeddruk- of cholesterolniveau, en tenslotte kan
men een gerichte mogelijkheid tot medische controle en behandeling propageren.
In dit proefschrift worden, uitgaande van een epidemiologische aanpak, de-bofieste-
nen aangedragen voor de ontwikkeling van een statistisch model waarin het mogelijk
is interventiemaatregelen en hun effect te kwantificeren op het zgn. macro niveau van
een totale bevolking. Interventiemaatregelen bestaan uit het beinvloeden van de pa-
rameters van het kansproces waarmee de relevante verklarende variabeleIi (bijv bloed-
druk) evolueren in de tijd in een ziektevrij (bijv. zonder eerste hartinfarct) overlevend
cohort personen. Dit proces wordt ook wel verouderingsproces genoemd. Het spoor
dat deze verklarende variabelen (ook wel covariabelen genoemd) voorwaarts in de tijd
zullen volgen binnen ziektevrij overlevende personen is deels gepredetermineerd (van
te voren bepaald) en deels stochastisch (berustend op toeval) van aard. Met name
dit stochastische element in het verouderingsproces laat slechts toe dat statistische uit-
spraken omtrent het moment van de incidentie van de ziekte in relatie tot de evoluerende
verklarende variabelen gelden voor een populatie en niet voor een individuele persoon.
Hierop wordt later teruggekomen. Zodra een ziektevrij persoon de desbetreffende ziekte
krijgt of ziektevrij overlijdt aan andere oorzaken, valt hij uit het beschouwde cohort.  Er
is hier sprake van twee elkaar beconcurrerende uitvalsrisico's die beide van (gedeeltelijk)
dezelfde covariabelen afnankelijk kunnen zijn. De beinvloeding van de kansverdeling van
de ziektevrije overlevingsduur in een populatie door het verouderingsproces (en door in-
terventie ge'induceerde veranderingen hierin) vindt dus langs twee wegen plaats.
Als gevolg van interventiemaatregelen ontstaan op een gecompliceerde manier ver-
anderingen in de ziektevrije overlevingsduur in een populatie. Daariiaast is er ook nog
de levensduur met de ziekte na het moment van de eerste incidentie van de chronische
ziekte. Theoretisch zouden de interventiemaatregelen van v66r de incidentie ook nog een
rechtstreekse invloed kunnen hebben op de verdeling van levensduur na de incidentie;
hier wordt evenwel deze direkte beinvloeding als afwezig verondersteld. Al met al gaat
het om drie simultaan verdeelde kansvariabelen in een populatie, op de verdeling waar-
van interventiemaatregelen effect hebben: de ziektevrije overlevingsduur, het al dan niet
krijgen van de chronische ziekte en, als men de ziekte krijgt, de overlevingsduur met de
ziekte. Het effect dat men door interventie hoopt te bereiken is dat de totale levens-
verwachting in de populatie toeneemt, dat het percentage mensen dat de ziekte krijgt
afneemt en dat de gemiddelde leeftijd waarop de ziekte ontstaat (de ziektevrije levens-
verwachting) toeneemt. Het op deze wijze kwantificeren van het effect is om tweeSrlei
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redenen niet zo geschikt om verschillende interventiestrategiedn met elkaar te vergelij-
ken. In de eerste plaats is deze effectmaat een driedimensionale score, wat het onderling
ordenen van strategie6n bemoeilijkt. Ten tweede is het gemiddelde als parameter niet
uniek genoeg om een verdeling te karakteriseren: tussen verschillende verdelingen met
hetzelfde gemiddelde kunnen er duidelijke verschillen in voorkeur bestaan als het om
overleving gaat. Een oplossing wordt geboden door de risiconutstheorie.
De risiconutstheorie gaat ervan uit dat het mogelijk is om een nutsfunctie te definidren
op een kansvariabele. Veranderingen in de verdeling van die kansvariabele kunnen dan
op een unieke wijze gekwantificeerd worden via de verwachting van de nutsfunctie ten
opzichte van die verdeling. Doordat het op deze wijze mogelijk is preferenties te orde-
nen kan een beslisser tot een rationele keuze komen. De nutsfunctie is een monotoon
stijgende functie van de kansvariabele; voor een beslisser die graag risico's neemt zal die
functie convex zijn en concaaf voor een risicomijdende beslisser. Hier wordt veronder-
steld dat de beslisser een instantie is en dat het gaat om een maatschappelijk aanvaarde
nutsfunctie. Zoals hierboven behandeld, is de nutsfunctie hier gedefinieerd op drie
gezamenlijk verdeelde kansvariabelen: de ziektevrije overlevingsduur, het al dan niet
krijgen van de ziekte en de overlevingsduur met de ziekte. De nutsfunctie vergelijkt
dus niet alleen twee toestanden (ziek, niet-ziek), maar ook tijdsduren; de nutsfunctie
is dus gedeeltelijk een zgn. intertemporele nutsfunctie. In de praktijk wordt vaak de
zgn. marginale nutsfunctie (de eerste afgeleide van de nutsfunctie, hier naar de tijd)
gehanteerd; in deze functie vindt het door medisch besliskundigen gehanteerde concept
"kwaliteit van leven" zijn formele representatie.
Zoals hierboven aangekondigd, wordt hier teruggekomen op de wijze waarop de over-
levingsfunctie gedefinieerd kan worden als er sprake is van zgn. interne tijdsafhankelijke
covariabelen. In het algemeen is het gedrag van deze covariabelen voorwaarts in de tijd
niet (helemaal) gepredetermineerd binnen een individu. Als we een verandering voor-
waarts in de tijd over een bepaald tijdsinterval als een gegeven waarde van een individu
zouden beschouwen, dan zou dat per definitie alleen maar kunnen als de overlevings-
functie   van dat individu  over het beschouwde tijdsinterval gelijk  is   aan 1. Hierdoor
is het dus niet mogelijk de aannemelijkheidsfunctie op te bouwen als een produkt van
individuele overlevingsfuncties en kansdichtheden van overlevingsduren. Een mogelijk-
heid om de aannemelijkheidsfunctie op een formeel juiste manier op te bouwen kan
gevonden worden door een meer epidemiologische benadering te kiezen en te veronder-
stellen dat de covariabelen een bepaalde verdeling hebben in de populatie (het cohort)
van individuen. De overlevingsfunctie die dan gehanteerd kan worden is de gemiddelde
overlevingsfunctie van het cohort. Deze gemiddelde overlevingsfunctie bestaat en heeft
een voorwaarts tijdpad via de voorwaartse differentiaalvergelijking van Kolmogorov-
Fokker-Planck (KFP) waarmee het voorwaartse gedrag in de tijd van de kansverdeling
van de covariabelen kan worden beschreven, rekening houdend met zowel het stochas-
tische element (de zgn. diffusie) als het systematische element in het tijdpad van de
covariabelen. Dat voor de relevante overlevingsfactor in de aannemelijkheidsfunctie in
het algemeen het produkt van de gemiddelde overlevingsfuncties kan worden genomen
(ook als de covariabelen constant zijn of een gepredetermineerd tijdsverloop hebben) is
in essentie een Markov eigenschap.
Het tijdpad van de verdeling van de covariabelen in een overlevend cohort wordt
niet alleen bepaald door het verouderingsproces in de covariabelen maar ook door de
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covariabelen-afhankelijke uitval ten gevolge van de incidentie van de chronische ziekte of
sterfte; hiermee wordt ook rekening gehouden in de KFP-vergelijking. Woodbury et al.
vonden dat een verouderingsproces, gespecificeerd als een le orde lineaire stochastische
differentiaalvergelijking, en een uitvalsfunctie, gespecificeerd als een U-(of J-)vormige
2e graads functie van de covariabelen, corresponderen met een multivariate normale
verdeling van de covariabelen. Als analytische oplossing resulteert hieruit een stelsel
vergelijkingen dat het tijdsverloop van de gemiddelde vector en de covariantie matrix
van de covariabelen en de gemiddelde hazardfunctie beschrijft als functie van de pa-
rameters van het verouderings- en uitvalsproces. Het geheel wordt echter pas empirisch
toepasbaar na discretisering van de tijd. Hierop wordt uitgebreid ingegaan en ook wordt
een illustratieve toepasssing van een eenvoudig model met alleen sterfte gepresenteerd,
met gebruikmaking van veronderstelde nutsfuncties.
Tenslotte dient nog te worden opgemerkt dat dit alles gezien kan worden als een
uitbreiding van overlevingsanalyse. Derhalve wordt overlevingsanalyse ook nog tamelijk
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1. Bij het klinisch-besliskundig optimaliseren van een levensverlengende therapie
voor een individuele patiint, dient de individuele overlevingsfunctie gebruikt  te
worden. Deze overlevingsfunctie bestaat in het algemeen niet.
2. Levensverwachting dient gedefinieerd te worden als het gemiddelde van de oncon-
dikionele_levensduurverdling in_een Pepulatk.   Om  te_ kunnen  onderzoeken  hoe
dit gemiddelde beinvloed wordt door bepaalde verklarende variabelen in een po-
pulatie, is het noodzakelijk dat men naast overlevingsanalyse ook de verdeling van
die variabelen in de populatie erbij betrekt.
3. In het algemeen kan in de van de covariabele zi afhankelijke kansdichtheidsfunc-
tie  p(t  zt) van overlevingsduur  t  in een coliort  de  kans  op de overlevingsconditie
beschouwd worden als de gemiddelde (onconditionele) overlevingskans van het
cohort:
p(tizt) I. 4 t · Actizt),
waarbij Qi de gemiddelde (onconditionele) overlevingskans van het coliort en
A(tlzt) de van z, aftiankelijke hazarclfunctie op tijdstip t is.
4.  Als A,(v) = B, v de niet-observeerbare individuele hazardfunctie eii 1, een constante
niet-geobserveerde frailty term met gemiddelde Et(v) en variantie vart(u) is, daii
geldt voor de geobserveerde hazardfunctie Al = DE,(v)
dln At d ln At(v) var,(v)-
=             - at·dt          dt            Et(v) '
wat wil zeggen: het individu veroiidert sneller dan het cohort waartoe hij of zij
belloort.
5. Als met overlevingsanalyse meer beoogd wordt dan het louter schatten van re-
latieve risico's, dan is het Coz proportional hazards niodel minder geschikt vaiiwege
het niet-parametrische karakter van de referentie-hazardfunctie.
6. Het conditioneren op de uitgangswaarde van een tijdsafhankelijke covariabele
om overleving te voorspellen, verhindert doorgaans niet dat die variabele niet-
geobserveerde heterogeniteit induceert.
7. Het logistische regressiemodel is theoretisch ongeschikt voor overlevingsaiialyse.
8. De epidemiologische methode van zgn. (in)directe standaardisatie om sterfte
tussen twee verschillend opgebouwde populaties te kunnen vergelijken, heeft
slechts een ad hoc basis. Het is verbazingwekkend hoe lang het duurt voordat een
goede, reeds decennia bestaande en formeel-statistisch gefundeerde alternatieve
methode begint door te dringen in het epidemiologische vakgebied.
9.  Het fenomeen van regressie naar het geniiddelde kan, onder algenienere condities,
beter regressie naar de modus getioenid worden in het geval van een unimodale
verdeling.
10. Het is nogal naief om te denken dat het mogelijk is coinmunicatie tot stand te
brengen met buitenaards leven,  als  dit op aarde  al  niet  eens  lukt.
11. Het besluit te promoveren is zeker niet op kosten-/batenoverwegingen gebaseerd.
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